﻿<?xml version="1.0" encoding="utf-8"?>
<Return xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2015v3.0" xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2017-08-15T11:01:48-05:00</ReturnTs>
    <TaxPeriodEndDt>2016-09-30</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmName>
        <BusinessNameLine1Txt>PricewaterhouseCoopers LLP</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>101 SEAPORT BLVD SUITE 500</AddressLine1Txt>
        <CityNm>BOSTON</CityNm>
        <StateAbbreviationCd>MA</StateAbbreviationCd>
        <ZIPCd>02210</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2015-10-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>042103591</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>MASSACHUSETTS EYE &amp; EAR INFIRMARY</BusinessNameLine1Txt>
      </BusinessName>
      <InCareOfNm>% JACK MALLEY</InCareOfNm>
      <BusinessNameControlTxt>MASS</BusinessNameControlTxt>
      <PhoneNum>6175733942</PhoneNum>
      <USAddress>
        <AddressLine1Txt>243 CHARLES STREET</AddressLine1Txt>
        <CityNm>BOSTON</CityNm>
        <StateAbbreviationCd>MA</StateAbbreviationCd>
        <ZIPCd>02114</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>CAROLANN WILLIAMS</PersonNm>
      <PersonTitleTxt>CFO &amp; VP FIN &amp; ADMIN</PersonTitleTxt>
      <PhoneNum>6175733012</PhoneNum>
      <SignatureDt>2017-08-01</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>ERIN COUTURE</PreparerPersonNm>
      <PTIN>P01390592</PTIN>
      <PhoneNum>6175305000</PhoneNum>
    </PreparerPersonGrp>
    <TaxYr>2015</TaxYr>
    <BuildTS>2021-01-29 14:40:06Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="14">
    <IRS990 documentId="IRS990" referenceDocumentId="IRS990ScheduleO">
      <PrincipalOfficerNm>CAROLANN WILLIAMS</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>243 CHARLES STREET</AddressLine1Txt>
        <CityNm>BOSTON</CityNm>
        <StateAbbreviationCd>MA</StateAbbreviationCd>
        <ZIPCd>02114</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>260117429</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>false</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.MASSEYEANDEAR.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1827</FormationYr>
      <LegalDomicileStateCd>MA</LegalDomicileStateCd>
      <ActivityOrMissionDesc>SEE SCHEDULE O.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>19</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>15</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>2144</TotalEmployeeCnt>
      <TotalVolunteersCnt>207</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <PYContributionsGrantsAmt>47770745</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>48376154</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>183938391</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>206825055</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>482536</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>131842</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>3539923</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>4784378</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>235731595</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>260117429</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>17006831</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>19338997</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>113683907</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>113508491</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>206143</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>329030</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>2641774</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>121887519</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>127477258</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>252784400</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>260653776</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>-17052805</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>-536347</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>212622120</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>330811290</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>215069116</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>334042965</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>-2446996</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>-3231675</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>SEE SCHEDULE O.</MissionDesc>
      <SignificantNewProgramSrvcInd>false</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>false</SignificantChangeInd>
      <ExpenseAmt>42961443</ExpenseAmt>
      <GrantAmt>4336273</GrantAmt>
      <RevenueAmt>7731293</RevenueAmt>
      <Desc>SEE SCHEDULE O</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>4809573</ExpenseAmt>
        <Desc>SEE SCHEDULE O</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <ExpenseAmt>142433872</ExpenseAmt>
        <GrantAmt>15002724</GrantAmt>
        <RevenueAmt>199093762</RevenueAmt>
        <Desc>SEE SCHEDULE O</Desc>
      </ProgSrvcAccomActy3Grp>
      <TotalProgramServiceExpensesAmt>190204888</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="IRS990ScheduleA">true</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="IRS990ScheduleB">true</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd referenceDocumentId="IRS990ScheduleC">false</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd referenceDocumentId="IRS990ScheduleC">true</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd referenceDocumentId="IRS990ScheduleC">false</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="IRS990ScheduleD">false</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="IRS990ScheduleD">false</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="IRS990ScheduleD">true</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="IRS990ScheduleD">false</CreditCounselingInd>
      <TempOrPermanentEndowmentsInd referenceDocumentId="IRS990ScheduleD">true</TempOrPermanentEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="IRS990ScheduleD">true</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="IRS990ScheduleD">false</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="IRS990ScheduleD">false</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="IRS990ScheduleD">true</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="IRS990ScheduleD">true</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="IRS990ScheduleD">true</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="IRS990ScheduleD">false</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="IRS990ScheduleD">true</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>false</SchoolOperatingInd>
      <ForeignOfficeInd>false</ForeignOfficeInd>
      <ForeignActivitiesInd referenceDocumentId="IRS990ScheduleF">true</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd referenceDocumentId="IRS990ScheduleF">true</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd referenceDocumentId="IRS990ScheduleF">false</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd referenceDocumentId="IRS990ScheduleG">true</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd referenceDocumentId="IRS990ScheduleG">false</FundraisingActivitiesInd>
      <GamingActivitiesInd referenceDocumentId="IRS990ScheduleG">false</GamingActivitiesInd>
      <OperateHospitalInd referenceDocumentId="IRS990ScheduleH">true</OperateHospitalInd>
      <AuditedFinancialStmtAttInd referenceDocumentId="BinaryAttach BinaryAttachN1 BinaryAttachN2">true</AuditedFinancialStmtAttInd>
      <GrantsToOrganizationsInd referenceDocumentId="IRS990ScheduleI">true</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="IRS990ScheduleI">false</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="IRS990ScheduleJ">true</ScheduleJRequiredInd>
      <TaxExemptBondsInd referenceDocumentId="IRS990ScheduleK">true</TaxExemptBondsInd>
      <InvestTaxExemptBondsInd>false</InvestTaxExemptBondsInd>
      <EscrowAccountInd>false</EscrowAccountInd>
      <OnBehalfOfIssuerInd>false</OnBehalfOfIssuerInd>
      <EngagedInExcessBenefitTransInd referenceDocumentId="IRS990ScheduleL">false</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd referenceDocumentId="IRS990ScheduleL">false</PYExcessBenefitTransInd>
      <LoanOutstandingInd referenceDocumentId="IRS990ScheduleL">false</LoanOutstandingInd>
      <GrantToRelatedPersonInd referenceDocumentId="IRS990ScheduleL">false</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd referenceDocumentId="IRS990ScheduleL">true</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd referenceDocumentId="IRS990ScheduleL">true</BusinessRlnWithFamMemInd>
      <BusinessRlnWithOfficerEntInd referenceDocumentId="IRS990ScheduleL">false</BusinessRlnWithOfficerEntInd>
      <DeductibleNonCashContriInd>false</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>false</DeductibleArtContributionInd>
      <TerminateOperationsInd>false</TerminateOperationsInd>
      <PartialLiquidationInd>false</PartialLiquidationInd>
      <DisregardedEntityInd referenceDocumentId="IRS990ScheduleR">false</DisregardedEntityInd>
      <RelatedEntityInd referenceDocumentId="IRS990ScheduleR">true</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>true</RelatedOrganizationCtrlEntInd>
      <TransactionWithControlEntInd referenceDocumentId="IRS990ScheduleR">true</TransactionWithControlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd referenceDocumentId="IRS990ScheduleR">true</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd referenceDocumentId="IRS990ScheduleR">false</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>true</ScheduleORequiredInd>
      <IRPDocumentCnt>152</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>true</BackupWthldComplianceInd>
      <EmployeeCnt>2144</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>true</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>false</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>false</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>false</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>false</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>false</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>false</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>false</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>false</IndoorTanningServicesInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>19</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>15</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>false</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>false</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>false</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>false</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>false</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>true</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>true</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>true</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>true</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>false</OfficerMailingAddressInd>
      <LocalChaptersInd>false</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>true</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>true</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>true</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>true</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>true</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>true</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>true</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>true</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>false</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>MA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NY</StatesWhereCopyOfReturnIsFldCd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <PersonNm>JACK MALLEY</PersonNm>
        <PhoneNum>6175733235</PhoneNum>
        <USAddress>
          <AddressLine1Txt>243 CHARLES STREET</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02114</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>JOHN R FERNANDEZ</PersonNm>
        <TitleTxt>PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>37.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>23.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>1073655</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>251186</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>WYCLIFFE GROUSBECK</PersonNm>
        <TitleTxt>CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>3.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>7.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JONATHAN UHRIG</PersonNm>
        <TitleTxt>TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>3.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>7.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>RICHARD H ALDRICH</PersonNm>
        <TitleTxt>DIRECTOR (UNTIL 12/2015)</TitleTxt>
        <AverageHoursPerWeekRt>2.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>2.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DEWALT PETE ANKENY</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>2.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>6.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JAMES CARLISLE</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>2.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>2.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>CHARLES DE GUNZBERG</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>2.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>6.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SAMUEL FLEMING</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>2.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>2.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>HARVEY FREISHTAT</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>2.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>2.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>LYLE HOWLAND</PersonNm>
        <TitleTxt>SECRETARY</TitleTxt>
        <AverageHoursPerWeekRt>2.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>6.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DIANE E KANEB</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>2.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>2.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JONATHAN KUTCHINS</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>2.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>4.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>VICTORIA MCCULLOUGH</PersonNm>
        <TitleTxt>DIRECTOR (UNTIL 12/2015)</TitleTxt>
        <AverageHoursPerWeekRt>2.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>6.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JOAN W MILLER MD</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>27.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>33.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>882170</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>58456</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ANNETTE NOVA</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>2.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>6.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>WILLIAM ROMAN</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>2.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>2.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>FREDERICK THORNE</PersonNm>
        <TitleTxt>DIRECTOR (UNTIL 08/2016)</TitleTxt>
        <AverageHoursPerWeekRt>2.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>2.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>EUGENE HILL</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>2.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>2.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ROBERT ATCHINSON</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>2.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>2.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ROBERT KNAPP</PersonNm>
        <TitleTxt>DIRECTOR (AS OF 12/2015)</TitleTxt>
        <AverageHoursPerWeekRt>2.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>2.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>D BRADLEY WELLING</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>29.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>31.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>1028145</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>58456</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>THOMAS LAUER</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>2.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>2.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MAUREEN KELLEY</PersonNm>
        <TitleTxt>ASST SECRETARY</TitleTxt>
        <AverageHoursPerWeekRt>53.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>7.0</AverageHoursPerWeekRltdOrgRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>193850</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>26570</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>CAROLANN WILLIAMS</PersonNm>
        <TitleTxt>CFO &amp; VP FINANCE AND ADMIN</TitleTxt>
        <AverageHoursPerWeekRt>49.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>11.0</AverageHoursPerWeekRltdOrgRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>482121</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>34184</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MARTHA PYLE FARRELL</PersonNm>
        <TitleTxt>ASST SECRETARY</TitleTxt>
        <AverageHoursPerWeekRt>49.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>11.0</AverageHoursPerWeekRltdOrgRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>363042</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>32265</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>BARBARA J SCULLY</PersonNm>
        <TitleTxt>DIRECTOR PROF REV CYCLE</TitleTxt>
        <AverageHoursPerWeekRt>30.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>30.0</AverageHoursPerWeekRltdOrgRt>
        <KeyEmployeeInd>X</KeyEmployeeInd>
        <ReportableCompFromOrgAmt>184488</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>35991</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>EILEEN O LOWELL</PersonNm>
        <TitleTxt>CNO &amp; VP PAT CARE SVS</TitleTxt>
        <AverageHoursPerWeekRt>60.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <KeyEmployeeInd>X</KeyEmployeeInd>
        <ReportableCompFromOrgAmt>306437</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>37050</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ALAN K LONG</PersonNm>
        <TitleTxt>VP RESEARCH ADMINISTRATION</TitleTxt>
        <AverageHoursPerWeekRt>30.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>30.0</AverageHoursPerWeekRltdOrgRt>
        <KeyEmployeeInd>X</KeyEmployeeInd>
        <ReportableCompFromOrgAmt>237656</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>27519</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KENNETH HOLMES</PersonNm>
        <TitleTxt>CFO MEEA</TitleTxt>
        <AverageHoursPerWeekRt>30.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>30.0</AverageHoursPerWeekRltdOrgRt>
        <KeyEmployeeInd>X</KeyEmployeeInd>
        <ReportableCompFromOrgAmt>288233</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>38688</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JEFFREY J PIKE</PersonNm>
        <TitleTxt>CHIEF OPERATING OFFICER</TitleTxt>
        <AverageHoursPerWeekRt>60.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <KeyEmployeeInd>X</KeyEmployeeInd>
        <ReportableCompFromOrgAmt>367537</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>20661</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>RALPH T PELOSI</PersonNm>
        <TitleTxt>DIRECTOR FACILITIES PLANNING</TitleTxt>
        <AverageHoursPerWeekRt>60.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <KeyEmployeeInd>X</KeyEmployeeInd>
        <ReportableCompFromOrgAmt>185343</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>26226</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DEBRA ROGERS</PersonNm>
        <TitleTxt>VP OPHTHALMOLOGY</TitleTxt>
        <AverageHoursPerWeekRt>20.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>40.0</AverageHoursPerWeekRltdOrgRt>
        <KeyEmployeeInd>X</KeyEmployeeInd>
        <ReportableCompFromOrgAmt>297181</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>30995</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>RACHEL WASSERSTROM</PersonNm>
        <TitleTxt>VP OTOLARYNGOLOGY</TitleTxt>
        <AverageHoursPerWeekRt>30.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>30.0</AverageHoursPerWeekRltdOrgRt>
        <KeyEmployeeInd>X</KeyEmployeeInd>
        <ReportableCompFromOrgAmt>280670</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>30667</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MICHAEL RICCI</PersonNm>
        <TitleTxt>CHIEF INFORMATION OFFICER</TitleTxt>
        <AverageHoursPerWeekRt>60.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <KeyEmployeeInd>X</KeyEmployeeInd>
        <ReportableCompFromOrgAmt>249389</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>31507</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JENNIFER STREET</PersonNm>
        <TitleTxt>VP COMMUNICATIONS &amp; PLANNING</TitleTxt>
        <AverageHoursPerWeekRt>60.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>382363</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>34043</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MELISSA M PAUL</PersonNm>
        <TitleTxt>CHIEF DEVELOPMENT OFFICER</TitleTxt>
        <AverageHoursPerWeekRt>60.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>270975</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>41008</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>GLENN W BUNTING</PersonNm>
        <TitleTxt>VOICE &amp; SPEECH CLINICAL DIR</TitleTxt>
        <AverageHoursPerWeekRt>60.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>185563</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>40991</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>GREGORY J DONNELLY</PersonNm>
        <TitleTxt>EXEC. DIRECTOR, CLINICAL SRVCS</TitleTxt>
        <AverageHoursPerWeekRt>60.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>206244</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>23518</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>BARBARA H GRAY</PersonNm>
        <TitleTxt>CLINICAL RESOURCE NURSE</TitleTxt>
        <AverageHoursPerWeekRt>60.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>183879</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>30971</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>5738626</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>1910315</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>910952</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>195</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>false</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>true</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>false</CompensationFromOtherSrcsInd>
      <ContractorCompensationGrp>
        <ContractorName>
          <PersonNm>FISH RICHARDSON PC</PersonNm>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>PO BOX 3295</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02241</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>LEGAL</ServicesDesc>
        <CompensationAmt>545407</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <PersonNm>PRICEWATERHOUSECOOPERS</PersonNm>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>PO BOX 7247-8001</AddressLine1Txt>
            <CityNm>PHILADELPHIA</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>19170</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>AUDIT</ServicesDesc>
        <CompensationAmt>461490</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <PersonNm>GOODWIN PROCTER</PersonNm>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>53 State St</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02109</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>LEGAL</ServicesDesc>
        <CompensationAmt>196588</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <PersonNm>DLA PIPER LLP</PersonNm>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>33 ARCH STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02110</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>LEGAL</ServicesDesc>
        <CompensationAmt>183778</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <PersonNm>LFREP SERVICES</PersonNm>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>260 FRANKLIN STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02110</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>CONSULTANT</ServicesDesc>
        <CompensationAmt>153914</CompensationAmt>
      </ContractorCompensationGrp>
      <CntrctRcvdGreaterThan100KCnt>7</CntrctRcvdGreaterThan100KCnt>
      <RelatedOrganizationsAmt>23104712</RelatedOrganizationsAmt>
      <GovernmentGrantsAmt>16625069</GovernmentGrantsAmt>
      <AllOtherContributionsAmt>8646373</AllOtherContributionsAmt>
      <TotalContributionsAmt>48376154</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>INPATIENT AND OUTPATIENT</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>181092232</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>181092232</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>CAFETERIA/FOOD SERVICE</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>1859697</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>1859697</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>RESEARCH INDIRECT REVENUE</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>7731293</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>7731293</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>HEARING AID CENTERS</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>4735526</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>4735526</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>KPRO INCOME</Desc>
        <BusinessCd>722210</BusinessCd>
        <TotalRevenueColumnAmt>3174515</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>3174515</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalOthProgramServiceRevGrp>
        <TotalRevenueColumnAmt>8231792</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>8231792</RelatedOrExemptFuncIncomeAmt>
      </TotalOthProgramServiceRevGrp>
      <TotalProgramServiceRevenueAmt>206825055</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>82059</TotalRevenueColumnAmt>
        <ExclusionAmt>82059</ExclusionAmt>
      </InvestmentIncomeGrp>
      <IncmFromInvestBondProceedsGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </IncmFromInvestBondProceedsGrp>
      <RoyaltiesRevenueGrp>
        <TotalRevenueColumnAmt>4784378</TotalRevenueColumnAmt>
        <ExclusionAmt>4784378</ExclusionAmt>
      </RoyaltiesRevenueGrp>
      <RentalIncomeOrLossGrp>
        <RealAmt>0</RealAmt>
        <PersonalAmt>0</PersonalAmt>
      </RentalIncomeOrLossGrp>
      <NetRentalIncomeOrLossGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </NetRentalIncomeOrLossGrp>
      <GrossAmountSalesAssetsGrp>
        <SecuritiesAmt>49783</SecuritiesAmt>
      </GrossAmountSalesAssetsGrp>
      <GainOrLossGrp>
        <SecuritiesAmt>49783</SecuritiesAmt>
      </GainOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>49783</TotalRevenueColumnAmt>
        <ExclusionAmt>49783</ExclusionAmt>
      </NetGainOrLossInvestmentsGrp>
      <NetIncmFromFundraisingEvtGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </NetIncmFromFundraisingEvtGrp>
      <NetIncomeFromGamingGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </NetIncomeFromGamingGrp>
      <NetIncomeOrLossGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </NetIncomeOrLossGrp>
      <OtherRevenueTotalAmt>0</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>260117429</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>206825055</RelatedOrExemptFuncIncomeAmt>
        <ExclusionAmt>4916220</ExclusionAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>19252758</TotalAmt>
        <ProgramServicesAmt>19252758</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <GrantsToDomesticIndividualsGrp>
        <TotalAmt>0</TotalAmt>
      </GrantsToDomesticIndividualsGrp>
      <ForeignGrantsGrp>
        <TotalAmt>86239</TotalAmt>
        <ProgramServicesAmt>86239</ProgramServicesAmt>
      </ForeignGrantsGrp>
      <BenefitsToMembersGrp>
        <TotalAmt>0</TotalAmt>
      </BenefitsToMembersGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>4329329</TotalAmt>
        <ProgramServicesAmt>1420238</ProgramServicesAmt>
        <ManagementAndGeneralAmt>2909091</ManagementAndGeneralAmt>
      </CompCurrentOfcrDirectorsGrp>
      <CompDisqualPersonsGrp>
        <TotalAmt>73935</TotalAmt>
        <FundraisingAmt>73935</FundraisingAmt>
      </CompDisqualPersonsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>84921468</TotalAmt>
        <ProgramServicesAmt>65626692</ProgramServicesAmt>
        <ManagementAndGeneralAmt>17859938</ManagementAndGeneralAmt>
        <FundraisingAmt>1434838</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>1715593</TotalAmt>
        <ProgramServicesAmt>1328312</ProgramServicesAmt>
        <ManagementAndGeneralAmt>355741</ManagementAndGeneralAmt>
        <FundraisingAmt>31540</FundraisingAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>14731620</TotalAmt>
        <ProgramServicesAmt>11640622</ProgramServicesAmt>
        <ManagementAndGeneralAmt>2829880</ManagementAndGeneralAmt>
        <FundraisingAmt>261118</FundraisingAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>7736546</TotalAmt>
        <ProgramServicesAmt>5889128</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1710210</ManagementAndGeneralAmt>
        <FundraisingAmt>137208</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesManagementGrp>
        <TotalAmt>0</TotalAmt>
      </FeesForServicesManagementGrp>
      <FeesForServicesLegalGrp>
        <TotalAmt>1644699</TotalAmt>
        <ProgramServicesAmt>130385</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1514314</ManagementAndGeneralAmt>
      </FeesForServicesLegalGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>322823</TotalAmt>
        <ProgramServicesAmt>4714</ProgramServicesAmt>
        <ManagementAndGeneralAmt>318109</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForServicesLobbyingGrp>
        <TotalAmt>128500</TotalAmt>
        <ManagementAndGeneralAmt>128500</ManagementAndGeneralAmt>
      </FeesForServicesLobbyingGrp>
      <FeesForServicesProfFundraising>
        <TotalAmt>329030</TotalAmt>
        <FundraisingAmt>329030</FundraisingAmt>
      </FeesForServicesProfFundraising>
      <FeesForSrvcInvstMgmntFeesGrp>
        <TotalAmt>0</TotalAmt>
      </FeesForSrvcInvstMgmntFeesGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>3174203</TotalAmt>
        <ProgramServicesAmt>2842456</ProgramServicesAmt>
        <ManagementAndGeneralAmt>330947</ManagementAndGeneralAmt>
        <FundraisingAmt>800</FundraisingAmt>
      </FeesForServicesOtherGrp>
      <AdvertisingGrp>
        <TotalAmt>1169070</TotalAmt>
        <ProgramServicesAmt>36262</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1052231</ManagementAndGeneralAmt>
        <FundraisingAmt>80577</FundraisingAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>2194793</TotalAmt>
        <ProgramServicesAmt>1333919</ProgramServicesAmt>
        <ManagementAndGeneralAmt>837498</ManagementAndGeneralAmt>
        <FundraisingAmt>23376</FundraisingAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>4108533</TotalAmt>
        <ProgramServicesAmt>8755</ProgramServicesAmt>
        <ManagementAndGeneralAmt>4128778</ManagementAndGeneralAmt>
        <FundraisingAmt>-29000</FundraisingAmt>
      </InformationTechnologyGrp>
      <RoyaltiesGrp>
        <TotalAmt>0</TotalAmt>
      </RoyaltiesGrp>
      <OccupancyGrp>
        <TotalAmt>12601482</TotalAmt>
        <ProgramServicesAmt>1519093</ProgramServicesAmt>
        <ManagementAndGeneralAmt>11082332</ManagementAndGeneralAmt>
        <FundraisingAmt>57</FundraisingAmt>
      </OccupancyGrp>
      <TravelGrp>
        <TotalAmt>922286</TotalAmt>
        <ProgramServicesAmt>600026</ProgramServicesAmt>
        <ManagementAndGeneralAmt>288862</ManagementAndGeneralAmt>
        <FundraisingAmt>33398</FundraisingAmt>
      </TravelGrp>
      <PymtTravelEntrtnmntPubOfclGrp>
        <TotalAmt>0</TotalAmt>
      </PymtTravelEntrtnmntPubOfclGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>529332</TotalAmt>
        <ProgramServicesAmt>240574</ProgramServicesAmt>
        <ManagementAndGeneralAmt>288746</ManagementAndGeneralAmt>
        <FundraisingAmt>12</FundraisingAmt>
      </ConferencesMeetingsGrp>
      <InterestGrp>
        <TotalAmt>4032830</TotalAmt>
        <ProgramServicesAmt>2583922</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1448908</ManagementAndGeneralAmt>
      </InterestGrp>
      <PaymentsToAffiliatesGrp>
        <TotalAmt>0</TotalAmt>
      </PaymentsToAffiliatesGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>19128859</TotalAmt>
        <ProgramServicesAmt>12256277</ProgramServicesAmt>
        <ManagementAndGeneralAmt>6872582</ManagementAndGeneralAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>1717677</TotalAmt>
        <ProgramServicesAmt>72890</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1644787</ManagementAndGeneralAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>MEDICAL SUPPLIES</Desc>
        <TotalAmt>47893063</TotalAmt>
        <ProgramServicesAmt>47693748</ProgramServicesAmt>
        <ManagementAndGeneralAmt>199298</ManagementAndGeneralAmt>
        <FundraisingAmt>17</FundraisingAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>PHYSICIANS ADMINISTRATION</Desc>
        <TotalAmt>6092177</TotalAmt>
        <ProgramServicesAmt>5949044</ProgramServicesAmt>
        <ManagementAndGeneralAmt>143112</ManagementAndGeneralAmt>
        <FundraisingAmt>21</FundraisingAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>SERVICE CONTRACT</Desc>
        <TotalAmt>5720309</TotalAmt>
        <ProgramServicesAmt>1594152</ProgramServicesAmt>
        <ManagementAndGeneralAmt>4108645</ManagementAndGeneralAmt>
        <FundraisingAmt>17512</FundraisingAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>FOOD</Desc>
        <TotalAmt>1508053</TotalAmt>
        <ProgramServicesAmt>1222026</ProgramServicesAmt>
        <ManagementAndGeneralAmt>268789</ManagementAndGeneralAmt>
        <FundraisingAmt>17238</FundraisingAmt>
      </OtherExpensesGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>14588569</TotalAmt>
        <ProgramServicesAmt>6872656</ProgramServicesAmt>
        <ManagementAndGeneralAmt>7485816</ManagementAndGeneralAmt>
        <FundraisingAmt>230097</FundraisingAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>260653776</TotalAmt>
        <ProgramServicesAmt>190204888</ProgramServicesAmt>
        <ManagementAndGeneralAmt>67807114</ManagementAndGeneralAmt>
        <FundraisingAmt>2641774</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>1824021</BOYAmt>
        <EOYAmt>1194722</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <PledgesAndGrantsReceivableGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </PledgesAndGrantsReceivableGrp>
      <AccountsReceivableGrp>
        <BOYAmt>25258060</BOYAmt>
        <EOYAmt>34429492</EOYAmt>
      </AccountsReceivableGrp>
      <ReceivablesFromOfficersEtcGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </ReceivablesFromOfficersEtcGrp>
      <RcvblFromDisqualifiedPrsnGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </RcvblFromDisqualifiedPrsnGrp>
      <OthNotesLoansReceivableNetGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </OthNotesLoansReceivableNetGrp>
      <InventoriesForSaleOrUseGrp>
        <BOYAmt>3856230</BOYAmt>
        <EOYAmt>4047488</EOYAmt>
      </InventoriesForSaleOrUseGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>4183591</BOYAmt>
        <EOYAmt>5002989</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipCostOrOtherBssAmt>388730597</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>235826860</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>137847296</BOYAmt>
        <EOYAmt>152903737</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <InvestmentsOtherSecuritiesGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </InvestmentsOtherSecuritiesGrp>
      <InvestmentsProgramRelatedGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </InvestmentsProgramRelatedGrp>
      <IntangibleAssetsGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </IntangibleAssetsGrp>
      <OtherAssetsTotalGrp>
        <BOYAmt>39652922</BOYAmt>
        <EOYAmt>133232862</EOYAmt>
      </OtherAssetsTotalGrp>
      <TotalAssetsGrp>
        <BOYAmt>212622120</BOYAmt>
        <EOYAmt>330811290</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>105438414</BOYAmt>
        <EOYAmt>111343756</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <GrantsPayableGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </GrantsPayableGrp>
      <DeferredRevenueGrp>
        <BOYAmt>13280726</BOYAmt>
        <EOYAmt>11260223</EOYAmt>
      </DeferredRevenueGrp>
      <TaxExemptBondLiabilitiesGrp>
        <BOYAmt>81686932</BOYAmt>
        <EOYAmt>118496159</EOYAmt>
      </TaxExemptBondLiabilitiesGrp>
      <EscrowAccountLiabilityGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </EscrowAccountLiabilityGrp>
      <LoansFromOfficersDirectorsGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </LoansFromOfficersDirectorsGrp>
      <MortgNotesPyblScrdInvstPropGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </MortgNotesPyblScrdInvstPropGrp>
      <UnsecuredNotesLoansPayableGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </UnsecuredNotesLoansPayableGrp>
      <OtherLiabilitiesGrp>
        <BOYAmt>14663044</BOYAmt>
        <EOYAmt>92942827</EOYAmt>
      </OtherLiabilitiesGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>215069116</BOYAmt>
        <EOYAmt>334042965</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsSFAS117Ind>X</OrganizationFollowsSFAS117Ind>
      <UnrestrictedNetAssetsGrp>
        <BOYAmt>-2446996</BOYAmt>
        <EOYAmt>-3231675</EOYAmt>
      </UnrestrictedNetAssetsGrp>
      <TemporarilyRstrNetAssetsGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </TemporarilyRstrNetAssetsGrp>
      <PermanentlyRstrNetAssetsGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </PermanentlyRstrNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>-2446996</BOYAmt>
        <EOYAmt>-3231675</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>212622120</BOYAmt>
        <EOYAmt>330811290</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <InfoInScheduleOPartXIInd>X</InfoInScheduleOPartXIInd>
      <ReconcilationRevenueExpnssAmt>-536347</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>-3586313</NetUnrlzdGainsLossesInvstAmt>
      <OtherChangesInNetAssetsAmt>3337981</OtherChangesInNetAssetsAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>false</AccountantCompileOrReviewInd>
      <FSAuditedInd>true</FSAuditedInd>
      <FSAuditedBasisGrp>
        <ConsolidatedBasisFinclStmtInd>X</ConsolidatedBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>true</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>true</FederalGrantAuditRequiredInd>
      <FederalGrantAuditPerformedInd>true</FederalGrantAuditPerformedInd>
    </IRS990>
    <IRS990ScheduleA documentId="IRS990ScheduleA">
      <HospitalInd>X</HospitalInd>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>33572100</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>39413484</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>41532901</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>47770745</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>48376154</CurrentTaxYearAmt>
        <TotalAmt>210665384</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TaxRevLeviedOrgnztnlBnft170Grp>
        <TotalAmt>0</TotalAmt>
      </TaxRevLeviedOrgnztnlBnft170Grp>
      <GovtFurnSrvcFcltsVl170Grp>
        <TotalAmt>0</TotalAmt>
      </GovtFurnSrvcFcltsVl170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>33572100</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>39413484</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>41532901</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>47770745</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>48376154</CurrentTaxYearAmt>
        <TotalAmt>210665384</TotalAmt>
      </TotalCalendarYear170Grp>
      <SubstantialContributorsTotAmt>0</SubstantialContributorsTotAmt>
      <PublicSupportTotal170Amt>210665384</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>15165483</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>16370797</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>14057593</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>3644064</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>4866437</CurrentTaxYearAmt>
        <TotalAmt>54104374</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <UnrelatedBusinessNetIncm170Grp>
        <TotalAmt>0</TotalAmt>
      </UnrelatedBusinessNetIncm170Grp>
      <OtherIncome170Grp>
        <TotalAmt>0</TotalAmt>
      </OtherIncome170Grp>
      <TotalSupportAmt>264769758</TotalSupportAmt>
      <GrossReceiptsRltdActivitiesAmt>877459284</GrossReceiptsRltdActivitiesAmt>
      <PublicSupportCY170Pct>0.79566</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.76170</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsCY170Ind>X</ThirtyThrPctSuprtTestsCY170Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="IRS990ScheduleB">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleC documentId="IRS990ScheduleC">
      <TotalGrassrootsLobbyingGrp />
      <TotalDirectLobbyingGrp />
      <TotalLobbyingExpendGrp />
      <OtherExemptPurposeExpendGrp />
      <TotalExemptPurposeExpendGrp />
      <LobbyingNontaxableAmountGrp />
      <GrassrootsNontaxableGrp />
      <TotLbbyngGrassrootMnsNonTxGrp />
      <TotLbbyExpendMnsLbbyngNonTxGrp />
      <VolunteersInd>false</VolunteersInd>
      <PaidStaffOrManagementInd>true</PaidStaffOrManagementInd>
      <MediaAdvertisementsInd>false</MediaAdvertisementsInd>
      <MailingsMembersInd>true</MailingsMembersInd>
      <PublicationsOrBroadcastInd>false</PublicationsOrBroadcastInd>
      <GrantsOtherOrganizationsInd>false</GrantsOtherOrganizationsInd>
      <DirectContactLegislatorsInd>true</DirectContactLegislatorsInd>
      <DirectContactLegislatorsAmt>128500</DirectContactLegislatorsAmt>
      <RalliesDemonstrationsInd>false</RalliesDemonstrationsInd>
      <OtherActivitiesInd>false</OtherActivitiesInd>
      <TotalLobbyingExpendituresAmt>128500</TotalLobbyingExpendituresAmt>
      <NotDescribedSection501c3Ind>false</NotDescribedSection501c3Ind>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE C, PART II-B, LINE 1(I):</FormAndLineReferenceDesc>
        <ExplanationTxt>During Fiscal Year 2016, MEE paid consulting fees to Rasky Baehrlein and Travaglini, Kiley &amp; Eisenberg for assistance in advocacy for a budget amendment in the State House and Senate. Mass. Eye and Ear is a member of certain trade associations that may lobby on its behalf.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleC>
    <IRS990ScheduleD documentId="IRS990ScheduleD">
      <ArtPublicExhibitionAmountsGrp />
      <HeldWorksArtGrp />
      <CollectionUsedPubExhibitionInd>X</CollectionUsedPubExhibitionInd>
      <CollUsedScholarlyRsrchInd>X</CollUsedScholarlyRsrchInd>
      <CollectionUsedPreservationInd>X</CollectionUsedPreservationInd>
      <CollUsedLoanOrExchProgInd>X</CollUsedLoanOrExchProgInd>
      <SolicitedAssetsSaleInd>false</SolicitedAssetsSaleInd>
      <CYEndwmtFundGrp>
        <BeginningYearBalanceAmt>72613174</BeginningYearBalanceAmt>
        <ContributionsAmt>1960347</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>2728854</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>3796280</OtherExpendituresAmt>
        <AdministrativeExpensesAmt>1045439</AdministrativeExpensesAmt>
        <EndYearBalanceAmt>72460656</EndYearBalanceAmt>
      </CYEndwmtFundGrp>
      <CYMinus1YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>78511651</BeginningYearBalanceAmt>
        <ContributionsAmt>1229040</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>-274466</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>5028553</OtherExpendituresAmt>
        <AdministrativeExpensesAmt>1824498</AdministrativeExpensesAmt>
        <EndYearBalanceAmt>72613174</EndYearBalanceAmt>
      </CYMinus1YrEndwmtFundGrp>
      <CYMinus2YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>87204661</BeginningYearBalanceAmt>
        <ContributionsAmt>746394</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>5114694</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>12790645</OtherExpendituresAmt>
        <AdministrativeExpensesAmt>1763453</AdministrativeExpensesAmt>
        <EndYearBalanceAmt>78511651</EndYearBalanceAmt>
      </CYMinus2YrEndwmtFundGrp>
      <CYMinus3YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>89724541</BeginningYearBalanceAmt>
        <ContributionsAmt>2692680</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>3521682</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>7238559</OtherExpendituresAmt>
        <AdministrativeExpensesAmt>1495683</AdministrativeExpensesAmt>
        <EndYearBalanceAmt>87204661</EndYearBalanceAmt>
      </CYMinus3YrEndwmtFundGrp>
      <CYMinus4YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>86399272</BeginningYearBalanceAmt>
        <ContributionsAmt>1269332</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>6139492</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>2803513</OtherExpendituresAmt>
        <AdministrativeExpensesAmt>1280042</AdministrativeExpensesAmt>
        <EndYearBalanceAmt>89724541</EndYearBalanceAmt>
      </CYMinus4YrEndwmtFundGrp>
      <BoardDesignatedBalanceEOYPct>0.03980</BoardDesignatedBalanceEOYPct>
      <PrmnntEndowmentBalanceEOYPct>0.76480</PrmnntEndowmentBalanceEOYPct>
      <TermEndowmentBalanceEOYPct>0.19540</TermEndowmentBalanceEOYPct>
      <EndowmentsHeldUnrelatedOrgInd>false</EndowmentsHeldUnrelatedOrgInd>
      <EndowmentsHeldRelatedOrgInd>true</EndowmentsHeldRelatedOrgInd>
      <RelatedOrgListSchRInd>true</RelatedOrgListSchRInd>
      <LandGrp>
        <OtherCostOrOtherBasisAmt>535324</OtherCostOrOtherBasisAmt>
        <BookValueAmt>535324</BookValueAmt>
      </LandGrp>
      <BuildingsGrp>
        <OtherCostOrOtherBasisAmt>195548712</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>126530347</DepreciationAmt>
        <BookValueAmt>69018365</BookValueAmt>
      </BuildingsGrp>
      <LeaseholdImprovementsGrp>
        <OtherCostOrOtherBasisAmt>76497</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>0</DepreciationAmt>
        <BookValueAmt>76497</BookValueAmt>
      </LeaseholdImprovementsGrp>
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>173925882</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>109241117</DepreciationAmt>
        <BookValueAmt>64684765</BookValueAmt>
      </EquipmentGrp>
      <OtherLandBuildingsGrp>
        <OtherCostOrOtherBasisAmt>18644182</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>55396</DepreciationAmt>
        <BookValueAmt>18588786</BookValueAmt>
      </OtherLandBuildingsGrp>
      <TotalBookValueLandBuildingsAmt>152903737</TotalBookValueLandBuildingsAmt>
      <OtherAssetsOrgGrp>
        <Desc>DUE FROM AFFILIATES</Desc>
        <BookValueAmt>101766589</BookValueAmt>
      </OtherAssetsOrgGrp>
      <OtherAssetsOrgGrp>
        <Desc>FUNDS HELD FOR RESEARCH</Desc>
        <BookValueAmt>1074862</BookValueAmt>
      </OtherAssetsOrgGrp>
      <OtherAssetsOrgGrp>
        <Desc>DEBT SERVICE FUND</Desc>
        <BookValueAmt>6297491</BookValueAmt>
      </OtherAssetsOrgGrp>
      <OtherAssetsOrgGrp>
        <Desc>SPECIAL CASH &amp; CAPITAL RESERVE</Desc>
        <BookValueAmt>3252410</BookValueAmt>
      </OtherAssetsOrgGrp>
      <OtherAssetsOrgGrp>
        <Desc>QLT</Desc>
        <BookValueAmt>92927</BookValueAmt>
      </OtherAssetsOrgGrp>
      <OtherAssetsOrgGrp>
        <Desc>DEFERRED FINANCING COSTS</Desc>
        <BookValueAmt>16135884</BookValueAmt>
      </OtherAssetsOrgGrp>
      <OtherAssetsOrgGrp>
        <Desc>TAX DEFERRED PLAN</Desc>
        <BookValueAmt>2171219</BookValueAmt>
      </OtherAssetsOrgGrp>
      <OtherAssetsOrgGrp>
        <Desc>CRICO</Desc>
        <BookValueAmt>2441098</BookValueAmt>
      </OtherAssetsOrgGrp>
      <OtherAssetsOrgGrp>
        <Desc>CAPITAL RESERVE</Desc>
        <BookValueAmt>382</BookValueAmt>
      </OtherAssetsOrgGrp>
      <TotalBookValueOtherAssetsAmt>133232862</TotalBookValueOtherAssetsAmt>
      <FederalIncomeTaxLiabilityAmt>0</FederalIncomeTaxLiabilityAmt>
      <OtherLiabilitiesOrgGrp>
        <Desc>DUE TO AFFILIATES</Desc>
        <Amt>79372619</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>ESTIMATE 3RD PARTY SETTLEMENT</Desc>
        <Amt>4155733</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>PROFESSIONAL LIABILITY RESERVE</Desc>
        <Amt>3006550</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>TAX DEFERRED LIABILITY</Desc>
        <Amt>2371219</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>MDFA REVENUE BONDS INTR RATE SWAP</Desc>
        <Amt>4036706</Amt>
      </OtherLiabilitiesOrgGrp>
      <TotalLiabilityAmt>92942827</TotalLiabilityAmt>
      <FootnoteTextInd>X</FootnoteTextInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE D, PART III, LINE 4:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE RARE BOOKS COLLECTION CONSISTS MAINLY OF SEVERAL HUNDRED BOOKS IN THE MEEI SPECIALTIES OF OPHTHALMOLOGY AND OTOLARYNGOLOGY AS WELL AS A FEW ON THE MEDICAL HISTORY OF BOSTON AND MASSACHUSETTS. THE MAJORITY WERE DONATED ORIGINALLY BY MOSES LURIE, MD AND MRS. LUCIEN HOWE (WIFE OF LUCIEN HOWE, MD). A FEW WERE DONATED BY OTHER PHYSICIANS THROUGH THE YEARS. ENDOWMENT FUNDS SET UP BETWEEN MRS. HOWE AND DR. LURIE WERE DESIGNATED FOR THE OCCASIONAL PURCHASE OF RARE BOOKS TO SUPPLEMENT THE ORIGINAL DONATIONS. THE RARE BOOKS ARE AVAILABLE TO THE SCIENTIFIC, MEDICAL AND ACADEMIC COMMUNITY FOR PURPOSES OF RESEARCH AND EDUCATION.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE D, PART V, LINE 4:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ENDOWMENT FUNCTIONS TO SUPPORT THE MISSION OF THE MASSACHUSETTS EYE AND EAR INFIRMARY TO PROVIDE SUPERIOR PATIENT CARE AND RESEARCH. THE INCOME FROM THE ENDOWMENT FUNDS IS SUBJECT TO DONOR-IMPOSED STIPULATIONS USUALLY FOR RESEARCH, EDUCATION AND PATIENT CARE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE D, PART X, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE MASSACHUSETTS EYE AND EAR INFIRMARY ("INFIRMARY") WAS INCLUDED IN CONSOLIDATED FINANCIAL STATEMENTS WITH ITS AFFILIATED ORGANIZATIONS. THE INCOME TAX FOOTNOTE IS AS FOLLOWS: THE FOUNDATION AND ITS AFFILIATES QUALIFY AS TAX-EXEMPT ORGANIZATIONS UNDER THE INTERNAL REVENUE CODE. THE FOUNDATION, INFIRMARY, ASSOCIATES, SCHEPENS AND EMBANKMENT ARE TAX-EXEMPT UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND CIRCLE IS TAX-EXEMPT UNDER 501(C)(25) OF THE INTERNAL REVENUE CODE. ACCORDINGLY, NO PROVISION FOR INCOME TAXES HAS BEEN MADE IN THE ACCOMPANYING FINANCIAL STATEMENTS. MANAGEMENT HAS EVALUATED ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES AND THERE WAS NO IMPACT TO THE FOUNDATION'S FINANCIAL STATEMENTS FOR THE YEAR ENDED SEPTEMBER 30, 2016.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleF documentId="IRS990ScheduleF">
      <GrantRecordsMaintainedInd>true</GrantRecordsMaintainedInd>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <TypeOfActivitiesConductedTxt>Grantmaking</TypeOfActivitiesConductedTxt>
        <RegionTotalExpendituresAmt>69523</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>North America</RegionTxt>
        <TypeOfActivitiesConductedTxt>Grantmaking</TypeOfActivitiesConductedTxt>
        <RegionTotalExpendituresAmt>16716</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>South Asia</RegionTxt>
        <TypeOfActivitiesConductedTxt>Program Services</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>Conferences</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>2097</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>Central America and the Caribbean</RegionTxt>
        <TypeOfActivitiesConductedTxt>Program Services</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>Conferences</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>5439</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <TypeOfActivitiesConductedTxt>Program Services</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>Conferences</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>108030</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>East Asia and the Pacific</RegionTxt>
        <TypeOfActivitiesConductedTxt>Program Services</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>Conferences</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>10522</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>North America</RegionTxt>
        <TypeOfActivitiesConductedTxt>Program Services</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>Conferences</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>5820</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>South America</RegionTxt>
        <TypeOfActivitiesConductedTxt>Program Services</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>Conferences</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>15266</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>Central America and the Caribbean</RegionTxt>
        <TypeOfActivitiesConductedTxt>Investments</TypeOfActivitiesConductedTxt>
        <RegionTotalExpendituresAmt>24200</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <SubtotalSpentAmt>257613</SubtotalSpentAmt>
      <TotalSpentAmt>257613</TotalSpentAmt>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>BASIC RESEARCH</PurposeOfGrantTxt>
        <CashGrantAmt>69523</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK</MannerOfCashDisbursementTxt>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>North America</RegionTxt>
        <PurposeOfGrantTxt>BASIC RESEARCH</PurposeOfGrantTxt>
        <CashGrantAmt>16716</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK</MannerOfCashDisbursementTxt>
      </GrantsToOrgOutsideUSGrp>
      <Total501c3OrgCnt>2</Total501c3OrgCnt>
      <TotalOtherOrgCnt>0</TotalOtherOrgCnt>
      <TransferToForeignCorpInd>false</TransferToForeignCorpInd>
      <InterestInForeignTrustInd>false</InterestInForeignTrustInd>
      <ForeignCorpOwnershipInd>true</ForeignCorpOwnershipInd>
      <PassiveForeignInvestmestCoInd>false</PassiveForeignInvestmestCoInd>
      <ForeignPartnershipInd>false</ForeignPartnershipInd>
      <BoycottCountriesInd>false</BoycottCountriesInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE F, PART I, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>SUBRECIPIENT MONITORING POLICY AND PROCEDURES SUBAWARDS ARE ISSUED THROUGH A CONSORTIUM AGREEMENT BETWEEN THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") AND THE RECIPIENT INSTITUTION. THE AGREEMENT SPECIFIES THE TERMS OF THE SUBAWARD AND INCLUDES A DETAILED BUDGET AND SCOPE OF WORK TO BE PERFORMED BY THE RECIPIENT INSTITUTION. AWARDED FUNDS ARE ENCUMBERED BY A PURCHASE ORDER THAT IS ASSIGNED TO A UNIQUE FUND NUMBER. PAYMENTS TO RECIPIENT INSTITUTIONS MADE AGAINST THE PURCHASE ORDER ARE RECORDED IN THE INFIRMARY ACCOUNTING SYSTEM SO THAT INDIVIDUAL PAYMENTS AND PURCHASE ORDERS BALANCES CAN BE MONITORED. DISBURSEMENT OF FUNDS FOR SUBAWARDS REQUIRES THE WRITTEN APPROVAL OF THE PRINCIPAL INVESTIGATOR ("PI"). FREQUENT PROGRESS REPORTS AND OTHER FORMS OF COMMUNICATION ARE REQUIRED BETWEEN THE PI AND THE SUBAWARD RECIPIENT INSTITUTE TO ENSURE THAT THE SCOPE OF WORK IS PROGRESSING AT A SATISFACTORY PACE. RESEARCH ADMINISTRATION ALSO CONDUCTS AN ANNUAL INVENTORY OF INSTITUTIONS TO WHICH RESERACH HAS BEEN SUBAWARDED. A RISK ASSESSMENT MATRIX IS EMPLOYED, ALONG WITH A REVIEW OF THE SUBRECEPIENTS' MOST RECENT A133 AUDIT REPORT, TO DETERMINE TO DETERMINE THE LEVEL OF RISK REGARDING THE SUBRECEPIENTS' ABILITY TO COMPLY WITH FEDERAL GUIDELINES.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE F, PART I, LINE 3, COLUMN (F) AND PART II, LINE 1:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE INFIRMARY USES THE ACCRUAL METHOD OF ACCOUNTING AND SEPARATELY IDENTIFIES FOREIGN ACTIVITY ON ITS GENERAL LEDGER.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleF>
    <IRS990ScheduleG documentId="IRS990ScheduleG">
      <MailSolicitationsInd>X</MailSolicitationsInd>
      <EmailSolicitationsInd>X</EmailSolicitationsInd>
      <InPersonSolicitationsInd>X</InPersonSolicitationsInd>
      <SolicitationOfNonGovtGrantsInd>X</SolicitationOfNonGovtGrantsInd>
      <SolicitationOfGovtGrantsInd>X</SolicitationOfGovtGrantsInd>
      <AgrmtProfFundraisingActyInd>true</AgrmtProfFundraisingActyInd>
      <FundraiserActivityInfoGrp>
        <PersonNm>VISION PHILANTHROPY GROUP</PersonNm>
        <ActivityTxt>CAPITAL CAMPAIGN</ActivityTxt>
        <FundraiserControlOfFundsInd>false</FundraiserControlOfFundsInd>
        <RetainedByContractorAmt>100352</RetainedByContractorAmt>
      </FundraiserActivityInfoGrp>
      <FundraiserActivityInfoGrp>
        <PersonNm>HUNTSINGER JEFFER</PersonNm>
        <ActivityTxt>ANNUAL FUND</ActivityTxt>
        <FundraiserControlOfFundsInd>false</FundraiserControlOfFundsInd>
        <RetainedByContractorAmt>228678</RetainedByContractorAmt>
      </FundraiserActivityInfoGrp>
      <TotalRetainedByContractorsAmt>329030</TotalRetainedByContractorsAmt>
      <LicensedStatesCd>CA</LicensedStatesCd>
      <LicensedStatesCd>CT</LicensedStatesCd>
      <LicensedStatesCd>FL</LicensedStatesCd>
      <LicensedStatesCd>GA</LicensedStatesCd>
      <LicensedStatesCd>IL</LicensedStatesCd>
      <LicensedStatesCd>ME</LicensedStatesCd>
      <LicensedStatesCd>MD</LicensedStatesCd>
      <LicensedStatesCd>MA</LicensedStatesCd>
      <LicensedStatesCd>MI</LicensedStatesCd>
      <LicensedStatesCd>MN</LicensedStatesCd>
      <LicensedStatesCd>NH</LicensedStatesCd>
      <LicensedStatesCd>NJ</LicensedStatesCd>
      <LicensedStatesCd>NY</LicensedStatesCd>
      <LicensedStatesCd>NC</LicensedStatesCd>
      <LicensedStatesCd>OH</LicensedStatesCd>
      <LicensedStatesCd>PA</LicensedStatesCd>
      <LicensedStatesCd>RI</LicensedStatesCd>
      <LicensedStatesCd>SC</LicensedStatesCd>
      <LicensedStatesCd>VA</LicensedStatesCd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE G, PART I, LINE 2B, COLUMN (V):</FormAndLineReferenceDesc>
        <ExplanationTxt>DURING THE FISCAL YEAR ENDED SEPTEMBER 30, 2016, MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") CONTRACTED WITH HUNTSINGER &amp; JEFFER, A FUNDRAISING CONSULTING COMPANY, TO ASSIST WITH THE FOUNDATION'S MAILING CAMPAIGN BY DRAFTING LETTERS AND WORKING WITH A MAIL HOUSE TO SEND LETTERS AND EMAILS TO PATIENTS ON THE INFIRMARY'S BEHALF. THE INFIRMARY ALSO CONTRACTED WITH VISION PHILANTHROPY TO ASSIST WITH THE INFIRMARY'S CAPITAL FUNDRAISING CAMPAIGN. HUNTSINGER AND JEFFER 809 BROOK HILL CIRCLE RICHMOND, VA 23227 VISION PHILANTHROPY GROUP 401 BOWLING AVENUE #1 NASHVILLE, TN 37205</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleG>
    <IRS990ScheduleH documentId="IRS990ScheduleH">
      <FinancialAssistancePolicyInd>true</FinancialAssistancePolicyInd>
      <WrittenPolicyInd>true</WrittenPolicyInd>
      <FPGReferenceFreeCareInd>true</FPGReferenceFreeCareInd>
      <FreeCareOthPercentageGrp>
        <OtherInd>X</OtherInd>
        <FreeCareOtherPct>400.</FreeCareOtherPct>
      </FreeCareOthPercentageGrp>
      <FPGReferenceDiscountedCareInd>true</FPGReferenceDiscountedCareInd>
      <Percent400Ind>X</Percent400Ind>
      <FreeCareMedicallyIndigentInd>true</FreeCareMedicallyIndigentInd>
      <FinancialAssistanceBudgetInd>true</FinancialAssistanceBudgetInd>
      <ExpensesExceedBudgetInd>true</ExpensesExceedBudgetInd>
      <UnableToProvideCareInd>false</UnableToProvideCareInd>
      <AnnualCommunityBnftReportInd>true</AnnualCommunityBnftReportInd>
      <ReportPublicallyAvailableInd>true</ReportPublicallyAvailableInd>
      <FinancialAssistanceAtCostTyp>
        <TotalCommunityBenefitExpnsAmt>3698468</TotalCommunityBenefitExpnsAmt>
        <DirectOffsettingRevenueAmt>1465731</DirectOffsettingRevenueAmt>
        <NetCommunityBenefitExpnsAmt>2232737</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.00860</TotalExpensePct>
      </FinancialAssistanceAtCostTyp>
      <UnreimbursedMedicaidGrp>
        <TotalCommunityBenefitExpnsAmt>21386821</TotalCommunityBenefitExpnsAmt>
        <DirectOffsettingRevenueAmt>15279511</DirectOffsettingRevenueAmt>
        <NetCommunityBenefitExpnsAmt>6107310</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.02340</TotalExpensePct>
      </UnreimbursedMedicaidGrp>
      <UnreimbursedCostsGrp>
        <TotalCommunityBenefitExpnsAmt>2389303</TotalCommunityBenefitExpnsAmt>
        <DirectOffsettingRevenueAmt>885178</DirectOffsettingRevenueAmt>
        <NetCommunityBenefitExpnsAmt>1504125</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.00580</TotalExpensePct>
      </UnreimbursedCostsGrp>
      <TotalFinancialAssistanceTyp>
        <TotalCommunityBenefitExpnsAmt>27474592</TotalCommunityBenefitExpnsAmt>
        <DirectOffsettingRevenueAmt>17630420</DirectOffsettingRevenueAmt>
        <NetCommunityBenefitExpnsAmt>9844172</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.03780</TotalExpensePct>
      </TotalFinancialAssistanceTyp>
      <CommunityHealthServicesGrp>
        <TotalCommunityBenefitExpnsAmt>428425</TotalCommunityBenefitExpnsAmt>
        <NetCommunityBenefitExpnsAmt>428425</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.00160</TotalExpensePct>
      </CommunityHealthServicesGrp>
      <HealthProfessionsEducationGrp>
        <TotalCommunityBenefitExpnsAmt>7642621</TotalCommunityBenefitExpnsAmt>
        <DirectOffsettingRevenueAmt>1371424</DirectOffsettingRevenueAmt>
        <NetCommunityBenefitExpnsAmt>6271197</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.02410</TotalExpensePct>
      </HealthProfessionsEducationGrp>
      <SubsidizedHealthServicesGrp>
        <ActivitiesOrProgramsCnt>2</ActivitiesOrProgramsCnt>
        <PersonsServedCnt>566</PersonsServedCnt>
        <TotalCommunityBenefitExpnsAmt>1378017</TotalCommunityBenefitExpnsAmt>
        <DirectOffsettingRevenueAmt>990435</DirectOffsettingRevenueAmt>
        <NetCommunityBenefitExpnsAmt>387582</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.00150</TotalExpensePct>
      </SubsidizedHealthServicesGrp>
      <ResearchGrp>
        <TotalCommunityBenefitExpnsAmt>41008082</TotalCommunityBenefitExpnsAmt>
        <DirectOffsettingRevenueAmt>34636640</DirectOffsettingRevenueAmt>
        <NetCommunityBenefitExpnsAmt>6371442</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.02440</TotalExpensePct>
      </ResearchGrp>
      <CashAndInKindContributionsGrp>
        <TotalCommunityBenefitExpnsAmt>51775</TotalCommunityBenefitExpnsAmt>
        <NetCommunityBenefitExpnsAmt>51775</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.00020</TotalExpensePct>
      </CashAndInKindContributionsGrp>
      <TotalOtherBenefitsGrp>
        <ActivitiesOrProgramsCnt>2</ActivitiesOrProgramsCnt>
        <PersonsServedCnt>566</PersonsServedCnt>
        <TotalCommunityBenefitExpnsAmt>50508920</TotalCommunityBenefitExpnsAmt>
        <DirectOffsettingRevenueAmt>36998499</DirectOffsettingRevenueAmt>
        <NetCommunityBenefitExpnsAmt>13510421</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.05180</TotalExpensePct>
      </TotalOtherBenefitsGrp>
      <TotalCommunityBenefitsGrp>
        <ActivitiesOrProgramsCnt>2</ActivitiesOrProgramsCnt>
        <PersonsServedCnt>566</PersonsServedCnt>
        <TotalCommunityBenefitExpnsAmt>77983512</TotalCommunityBenefitExpnsAmt>
        <DirectOffsettingRevenueAmt>54628919</DirectOffsettingRevenueAmt>
        <NetCommunityBenefitExpnsAmt>23354593</NetCommunityBenefitExpnsAmt>
        <TotalExpensePct>0.08960</TotalExpensePct>
      </TotalCommunityBenefitsGrp>
      <BadDebtExpenseReportedInd>true</BadDebtExpenseReportedInd>
      <BadDebtExpenseAmt>3446770</BadDebtExpenseAmt>
      <BadDebtExpenseAttributableAmt>15103</BadDebtExpenseAttributableAmt>
      <ReimbursedByMedicareAmt>47885564</ReimbursedByMedicareAmt>
      <CostOfCareReimbursedByMedcrAmt>53924248</CostOfCareReimbursedByMedcrAmt>
      <MedicareSurplusOrShortfallAmt>-6038684</MedicareSurplusOrShortfallAmt>
      <CostingMethodologyUsedGrp>
        <CostAccountingSystemInd>X</CostAccountingSystemInd>
      </CostingMethodologyUsedGrp>
      <WrittenDebtCollectionPolicyInd>true</WrittenDebtCollectionPolicyInd>
      <FinancialAssistancePrvsnInd>true</FinancialAssistancePrvsnInd>
      <HospitalFacilitiesCnt>1</HospitalFacilitiesCnt>
      <HospitalFacilitiesGrp>
        <FacilityNum>1</FacilityNum>
        <BusinessName>
          <BusinessNameLine1Txt>MASSACHUSETTS EYE &amp; EAR INFIRMARY</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>243 CHARLES STREET</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02114</ZIPCd>
        </USAddress>
        <WebsiteAddressTxt>http://www.masseyeandear.org/</WebsiteAddressTxt>
        <StateLicenseNum>2167</StateLicenseNum>
        <LicensedHospitalInd>X</LicensedHospitalInd>
        <TeachingHospitalInd>X</TeachingHospitalInd>
        <ResearchFacilityInd>X</ResearchFacilityInd>
        <EmergencyRoom24HrsInd>X</EmergencyRoom24HrsInd>
      </HospitalFacilitiesGrp>
      <HospitalFcltyPoliciesPrctcGrp>
        <HospitalFacilityName>
          <BusinessNameLine1Txt>MASSACHUSETTS EYE &amp; EAR INFIRMARY</BusinessNameLine1Txt>
        </HospitalFacilityName>
        <FirstLicensedCYOrPYInd>false</FirstLicensedCYOrPYInd>
        <TaxExemptHospitalCYOrPYInd>false</TaxExemptHospitalCYOrPYInd>
        <CHNAConductedInd>true</CHNAConductedInd>
        <CommunityDefinitionInd>X</CommunityDefinitionInd>
        <CommunityDemographicsInd>X</CommunityDemographicsInd>
        <ExistingResourcesInd>X</ExistingResourcesInd>
        <HowDataObtainedInd>X</HowDataObtainedInd>
        <CommunityHealthNeedsInd>X</CommunityHealthNeedsInd>
        <OtherHealthIssuesInd>X</OtherHealthIssuesInd>
        <CommunityHlthNeedsIdProcessInd>X</CommunityHlthNeedsIdProcessInd>
        <ConsultingProcessInd>X</ConsultingProcessInd>
        <InformationGapsInd>X</InformationGapsInd>
        <CHNAConductedYr>15</CHNAConductedYr>
        <TakeIntoAccountOthersInputInd>true</TakeIntoAccountOthersInputInd>
        <CHNAConductedWithOtherFcltsInd>false</CHNAConductedWithOtherFcltsInd>
        <CHNAConductedWithNonFcltsInd>false</CHNAConductedWithNonFcltsInd>
        <CHNAReportWidelyAvailableInd>true</CHNAReportWidelyAvailableInd>
        <RptAvailableOnOwnWebsiteInd>X</RptAvailableOnOwnWebsiteInd>
        <OwnWebsiteURLTxt>SEE SECTION C</OwnWebsiteURLTxt>
        <PaperCopyPublicInspectionInd>X</PaperCopyPublicInspectionInd>
        <ImplementationStrategyAdoptInd>true</ImplementationStrategyAdoptInd>
        <ImplementationStrategyAdptYr>15</ImplementationStrategyAdptYr>
        <StrategyPostedWebsiteInd>true</StrategyPostedWebsiteInd>
        <StrategyWebsiteURLTxt>SEE SECTION C</StrategyWebsiteURLTxt>
        <StrategyAttachedInd>false</StrategyAttachedInd>
        <OrganizationIncurExciseTaxInd>false</OrganizationIncurExciseTaxInd>
        <EligCriteriaExplainedInd>true</EligCriteriaExplainedInd>
        <FPGFamilyIncmLmtFreeDscntInd>X</FPGFamilyIncmLmtFreeDscntInd>
        <FPGFamilyIncmLmtFreeCarePct>400.</FPGFamilyIncmLmtFreeCarePct>
        <FPGFamilyIncmLmtDscntCarePct>400.</FPGFamilyIncmLmtDscntCarePct>
        <AssetLevelCriteriaInd>X</AssetLevelCriteriaInd>
        <MedicalIndigencyCriteriaInd>X</MedicalIndigencyCriteriaInd>
        <InsuranceStatusCriteriaInd>X</InsuranceStatusCriteriaInd>
        <UnderinsuranceStatCriteriaInd>X</UnderinsuranceStatCriteriaInd>
        <ExplainedBasisInd>true</ExplainedBasisInd>
        <AppFinancialAsstExplnInd>true</AppFinancialAsstExplnInd>
        <DescribedInfoInd>X</DescribedInfoInd>
        <DescribedSuprtDocInd>X</DescribedSuprtDocInd>
        <ProvidedHospitalContactInd>X</ProvidedHospitalContactInd>
        <ProvidedNonprofitContactInd>X</ProvidedNonprofitContactInd>
        <IncludesPublicityMeasuresInd>true</IncludesPublicityMeasuresInd>
        <FAPAppAvailableOnWebsiteInd>X</FAPAppAvailableOnWebsiteInd>
        <FAPAppAvailableOnWebsiteURLTxt>SEE SECTION C</FAPAppAvailableOnWebsiteURLTxt>
        <FAPSummaryOnWebsiteInd>X</FAPSummaryOnWebsiteInd>
        <FAPSummaryOnWebsiteURLTxt>SEE SECTION C</FAPSummaryOnWebsiteURLTxt>
        <FAPAvlblOnRequestNoChargeInd>X</FAPAvlblOnRequestNoChargeInd>
        <FAPAppAvlblOnRequestNoChrgInd>X</FAPAppAvlblOnRequestNoChrgInd>
        <FAPSumAvlblOnRequestNoChrgInd>X</FAPSumAvlblOnRequestNoChrgInd>
        <FAPNoticeDisplayedInd>X</FAPNoticeDisplayedInd>
        <FAPActionsOnNonpaymentInd>true</FAPActionsOnNonpaymentInd>
        <PermitNoActionsInd>X</PermitNoActionsInd>
        <CollectionActivitiesInd>false</CollectionActivitiesInd>
        <NoneMadeInd>X</NoneMadeInd>
        <NondisEmergencyCarePolicyInd>true</NondisEmergencyCarePolicyInd>
        <OtherMethodUsedInd>X</OtherMethodUsedInd>
        <AmountsGenerallyBilledInd>false</AmountsGenerallyBilledInd>
        <GrossChargesInd>false</GrossChargesInd>
      </HospitalFcltyPoliciesPrctcGrp>
      <SupplementalInformationGrp>
        <FormAndLineReferenceDesc>PART V, SECTION B, LINE 5</FormAndLineReferenceDesc>
        <ExplanationTxt>TO GAIN A BETTER UNDERSTANDING OF NEEDS IN MISSION HILL SPECIFICALLY, THE CONSULTANTS WORKED WITH THE MASS. EYE AND EAR CB WORKING GROUP TO IDENTIFY MISSION HILL SERVICE PROVIDERS, ADVOCATES AND EDUCATORS POSITIONED TO SPEAK TO THE NEEDS OF THE COMMUNITY. THE CONSULTANTS THEN CONDUCTED TEN IN-DEPTH INTERVIEWS WITH THE IDENTIFIED KEY INFORMANTS. AMONG THEM WAS A MEMBER OF THE NEW ENGLAND BAPTIST HOSPITAL, WHICH OPERATES A SMALLER BUT HIGHLY REGARDED COMMUNITY BENEFITS PROGRAM TARGETING MISSION HILL. THE EXPERIENCES OF THE BWH AND NEW ENGLAND BAPTIST PROVIDED GREAT INSIGHTS THAT INFORMED THE ASSESSMENT AND PLANNING PROCESSES DESCRIBED BELOW. THE INTERVIEWS YIELDED IMPORTANT AND USEFUL INFORMATION ABOUT NEIGHBORHOOD CHARACTERISTICS, METHODS FOR BUILDING AND SUSTAINING STRONG RELATIONSHIPS IN MISSION HILL, THE NEEDS OF THE NEIGHBORHOOD, AND PARTNERSHIP OPPORTUNITIES.</ExplanationTxt>
      </SupplementalInformationGrp>
      <SupplementalInformationGrp>
        <FormAndLineReferenceDesc>PART V, SECTION B, LINE 7A &amp; LINE 10A</FormAndLineReferenceDesc>
        <ExplanationTxt>THE INFIRMARY'S COMMUNITY HEALTH NEEDS ASSESSMENT CAN BE VIEWED AT HTTP://WWW.MASSEYEANDEAR.ORG/ABOUT-US/OUTREACH</ExplanationTxt>
      </SupplementalInformationGrp>
      <SupplementalInformationGrp>
        <FormAndLineReferenceDesc>PART V, SECTION B, LINE 11</FormAndLineReferenceDesc>
        <ExplanationTxt>THE MASSACHUSETTS EYE AND EAR COMMUNITY BENEFITS TEAM CONDUCTS AN ASSESSMENT AND PLANNING PROCESS THAT IDENTIFIES UNMET NEEDS IN TARGET POPULATIONS AND SERVICE AREAS, SPECIFICALLY ON POPULATIONS THAT FACE GREATER OBSTACLES TO CARE AND/OR ARE DISPROPORTIONALLY AFFECTED BY CONDITIONS THAT AFFECT THEIR DAILY FUNCTIONING AND QUALITY OF LIFE. THESE KEY AREAS ARE: CHILDREN, ELDERLY, LOW-INCOME PATIENTS AND PATIENTS OF COLOR. OUR PLAN IS DESIGNED TO IMPROVE THE VISION, HEARING, AND OTHER CONDITIONS OF THE HEAD AND NECK AMONG VULNERABLE POPULATIONS IN OUR AREA. HEALTH SCREENINGS MASS. EYE AND EAR PROVIDES VISION SCREENINGS AND HEARING EXAMS AND FOLLOW UP CARE FOR INDIVIDUALS WITH LIMITED ACCESS TO SERVICES. SCREENINGS INCLUDED CAMP HARBOR VIEW, NEIGHBORHOOD HOUSE CHARTER SCHOOL, VISION COALITION/YEAR UP, AND ROXBURY TENANTS OF HARVARD. COMMUNITY EDUCATION AND SUPPORT GROUPS MASS. EYE AND EAR CLINICIANS AND SOCIAL WORKERS DELIVER EDUCATION AND SUPPORT TO INDIVIDUALS DEALING WITH VARIOUS MEDICAL CONDITIONS OR CHALLENGES, INCLUDING SINUSITIS, HEARING LOSS, VISION LOSS, FACIAL PARALYSIS. THEY ALSO ATTEND SEVERAL COMMUNITY HEALTH FAIRS. EVENTS INCLUDE "KNOW YOUR NOSE," LOW VISION SUPPORT GROUP, BOSTON CURED CANCER CLUB SUPPORT GROUP, FACIAL PARALYSIS SUPPORT GROUP, HEAR @ BOSTON, GRAVES DISEASE SUPPORT GROUP AND VISION REHABILITATION. HEALTH FAIRS INCLUDED MISSION HILL, EMERSON HEALTH AND WELLNESS AND STONEHAM TOWN DAY. ACCESS TO SERVICES/RESOURCES/WORK EXPERIENCE MASS. EYE AND EAR PROVIDES SERVICES AND RESOURCES TO INDIVIDUALS WHO MIGHT NOT BE ABLE TO ACCESS THEM AND PROVIDES TARGETED POPULATIONS WITH OPPORTUNITIES TO GAIN WORK EXPERIENCE. THIS INCLUDES PROJECT SEARCH, A PROGRAM THAT PROVIDED INTERNSHIPS FOR INDIVIDUALS WITH VISUAL IMPAIRMENT. OTHER SUPPORT INCLUDES TRANSPORTATION AND PARKING FOR NEEDY PATIENTS, VOLUNTEER ESCORTS, FREE EYEGLASSES, FREE MEDICATIONS, SOCIAL WORK CONSULTATIONS, FINANCIAL COUNSELING, HEARING AID CENTER SUPPORT AND CHARITABLE CARE. MASS. EYE AND EAR PROVIDES FREE OR DISCOUNTED CARE TO PATIENTS WHO ARE UNABLE TO COVER THE FULL COST OF THE SERVICES THEY UTILIZE. FINANCIAL SUPPORT MASS. EYE AND EAR PROVIDES FINANCIAL SUPPORT TO A SELECT NUMBER OF ORGANIZATIONS WHOSE MISSIONS ALIGN WITH OURS AND SUPPORT OUR COMMUNITY BENEFITS GOALS AND ADDRESSES ISSUES AS OUTLINED EARLIER IN THIS DOCUMENT. ORGANIZATIONS INCLUDE PERKINS SCHOOL FOR THE BLIND, NEW ENGLAND WALK FOR HEARING, ABCD FIELD OF DREAMS, SCHWARTZ CENTER FOR COMPASSIONATE CARE, ROXBURY TENANTS OF HARVARD, AND THE UNITED WAY. THESE STRATEGIES WERE EFFECTIVE IN ACHIEVING OUR COMMUNITY BENEFITS OBJECTIVES. MISSION HILL - OPPORTUNITY IDENTIFIED ONE AREA THAT WAS IDENTIFIED IN OUR LAST ASSESSMENT AS A NEW FOCUS AREA IS THE MISSION HILL NEIGHBORHOOD. MASS. EYE AND EAR OPENED A MULTI-SPECIALTY AMBULATORY CARE CENTER AT 800 HUNTINGTON AVENUE IN 2012. MASS. EYE AND EAR HAS DETERMINED A NEED TO BROADEN ITS COMMUNITY BENEFITS PROGRAM TO PROVIDE TARGETED PROGRAMMING IN THIS SMALL, DIVERSE COMMUNITY OF LOWER-INCOME RESIDENTS. MASS. EYE AND EAR PARTNERED WITH A HIGH SCHOOL (FENWAY HIGH SCHOOL) IN THE SPRING OF 2016 TO WELCOME THREE HIGH SCHOOL SENIORS FOR AN INTERNSHIP, IS ENGAGING LEADERS IN THE COMMUNITY TO CREATE NEIGHBORHOOD SPECIFIC PROGRAMMING AND HOSTING EVENTS AT ITS FACILITY LOCATED AT 800 HUNTINGTON AVENUE. MASS. EYE AND EAR WILL FOCUS ON FURTHER INTEGRATION INTO THE NEIGHBORHOOD AND EXPLORE ADDITIONAL OPPORTUNITIES TO PROVIDE ADDITIONAL VISION AND HEARING SCREENINGS FOR SENIORS, FOLLOW-UP CARE AND EYE GLASSES, SPONSORSHIPS OF NEIGHBORHOOD EVENTS, PARTICIPATION IN HEALTH FAIRS, AND CONTRIBUTIONS TO COMMUNITY EVENTS. DURING THE REVIEW PROCESS, MASS. EYE AND EAR REVIEWED UNMET NEEDS, INCLUDING MISSION HILL, AND SET GOALS THAT ALIGN WITH THE GOAL OF THE ORGANIZATION'S COMMUNITY BENEFITS PLAN. AS A SPECIALTY HOSPITAL WITH 18 LOCATIONS (INCLUDING 243 CHARLES STREET AND 800 HUNTINGTON AVENUE), MASS. EYE AND EAR WORKS TO MEET NEEDS IN ITS SPECIALTY AREA, INCLUDING IMPROVING VISION AND HEARING, ENSURING TARGET POPULATIONS HAVE ACCESS TO EDUCATION AND SUPPORT. OTHER IDENTIFIED NEEDS OF THE COMMUNITY OUTSIDE OF OUR SPECIALTY AREAS ARE ADDRESSED BY OTHER INSTITUTIONS IN OUR COMMUNITY.</ExplanationTxt>
      </SupplementalInformationGrp>
      <SupplementalInformationGrp>
        <FormAndLineReferenceDesc>PART V, SECTION B, LINE 16B &amp; 16C</FormAndLineReferenceDesc>
        <ExplanationTxt>THE INFIRMARY'S FINANCIAL ASSISTANCE POLICY CAN BE VIEWED AT HTTP://WWW.MASSEYEANDEAR.ORG/FOR-PATIENTS/PATIENT-GUIDE/FINANCIAL-ASSISTAN CE</ExplanationTxt>
      </SupplementalInformationGrp>
      <SupplementalInformationGrp>
        <FormAndLineReferenceDesc>PART V, SECTION B, LINE 22</FormAndLineReferenceDesc>
        <ExplanationTxt>CHARGES FOR PATIENTS WHO QUALIFY FOR FINANCIAL ASSISTANCE ARE BASED ON THE AVERAGE REIMBURSEMENT OF THE HOSPITAL'S THREE LARGEST PAYERS.</ExplanationTxt>
      </SupplementalInformationGrp>
      <FacilityNum>9</FacilityNum>
      <OthHlthCareFcltsNotHospitalGrp>
        <OthHlthCareFcltsGrp>
          <BusinessName>
            <BusinessNameLine1Txt>MASSACHUSETTS EYE &amp; EAR STONEHAM</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>ONE MONTVALE AVENUE</AddressLine1Txt>
            <CityNm>STONEHAM</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02180</ZIPCd>
          </USAddress>
          <FacilityTxt>LICENSED OUTPATIENT LOCATION</FacilityTxt>
        </OthHlthCareFcltsGrp>
        <OthHlthCareFcltsGrp>
          <BusinessName>
            <BusinessNameLine1Txt>MASSACHUSETTS EYE &amp; EAR E BRIDGEWATER</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>ONE COMPASS WAY SUITE 100</AddressLine1Txt>
            <CityNm>E BRIDGEWATER</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02333</ZIPCd>
          </USAddress>
          <FacilityTxt>LICENSED OUTPATIENT LOCATION</FacilityTxt>
        </OthHlthCareFcltsGrp>
        <OthHlthCareFcltsGrp>
          <BusinessName>
            <BusinessNameLine1Txt>MEEI VESTIBULAR CENTER AT BRAINTREE</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>250 POND STREET 1ST FLOOR</AddressLine1Txt>
            <CityNm>BRAINTREE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02184</ZIPCd>
          </USAddress>
          <FacilityTxt>LICENSED OUTPATIENT LOCATION</FacilityTxt>
        </OthHlthCareFcltsGrp>
        <OthHlthCareFcltsGrp>
          <BusinessName>
            <BusinessNameLine1Txt>MASSACHUSETTS EYE &amp; EAR QUINCY</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>500 CONGRESS STREET</AddressLine1Txt>
            <CityNm>QUINCY</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02169</ZIPCd>
          </USAddress>
          <FacilityTxt>LICENSED OUTPATIENT LOCATION</FacilityTxt>
        </OthHlthCareFcltsGrp>
        <OthHlthCareFcltsGrp>
          <BusinessName>
            <BusinessNameLine1Txt>MASSACHUSETTS EYE &amp; EAR AT JOSLIN</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>1 JOSLIN PLACE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02215</ZIPCd>
          </USAddress>
          <FacilityTxt>LICENSED OUTPATIENT LOCATION</FacilityTxt>
        </OthHlthCareFcltsGrp>
        <OthHlthCareFcltsGrp>
          <BusinessName>
            <BusinessNameLine1Txt>MASSACHUSETTS EYE &amp; EAR CONCORD</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>54 BAKER AVE EXTENSION 3RD FL STE</AddressLine1Txt>
            <CityNm>CONCORD</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>01742</ZIPCd>
          </USAddress>
          <FacilityTxt>LICENSED OUTPATIENT LOCATION</FacilityTxt>
        </OthHlthCareFcltsGrp>
        <OthHlthCareFcltsGrp>
          <BusinessName>
            <BusinessNameLine1Txt>MASSACHUSETTS EYE &amp; EAR LONGWOOD</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>800 HUNTINGTON AVENUE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02115</ZIPCd>
          </USAddress>
          <FacilityTxt>LICENSED OUTPATIENT LOCATION</FacilityTxt>
        </OthHlthCareFcltsGrp>
        <OthHlthCareFcltsGrp>
          <BusinessName>
            <BusinessNameLine1Txt>MASSACHUSETTS EYE &amp; EAR MEDFORD</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>101 MAIN STREET</AddressLine1Txt>
            <CityNm>MEDFORD</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02115</ZIPCd>
          </USAddress>
          <FacilityTxt>LICENSED OUTPATIENT LOCATION</FacilityTxt>
        </OthHlthCareFcltsGrp>
        <OthHlthCareFcltsGrp>
          <BusinessName>
            <BusinessNameLine1Txt>MASSACHUSETTS EYE &amp; EAR PLAINVILLE</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>30 MAN MAR DRIVE STE 2</AddressLine1Txt>
            <CityNm>PLAINVILLE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02762</ZIPCd>
          </USAddress>
          <FacilityTxt>LICENSED OUTPATIENT LOCATION</FacilityTxt>
        </OthHlthCareFcltsGrp>
      </OthHlthCareFcltsNotHospitalGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE H, PART I, LINE 3C</FormAndLineReferenceDesc>
        <ExplanationTxt>IN ADDITION TO FPG, THE ORGANIZATION CONSIDERS ASSETS, UNPAID MEDICAL EXPENSES, AND EXTRAORDINARY FINANCIAL CIRCUMSTANCES (UNEMPLOYMENT AND OTHER FINANCIAL STRESSES) WHEN REVIEWING AN INDIVIDUALS APPLICATION FOR FINANCIAL ASSISTANCE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE H, PART II</FormAndLineReferenceDesc>
        <ExplanationTxt>THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") AND ITS AFFILIATED ORGANIZATIONS (COLLECTIVELY "MEEI") PROVIDED COMMUNITY BUILDING HEALTH IMPROVEMENT ADVOCACY BY PROVIDING EDUCATIONAL OPPORTUNITIES AND SUPPORT, INCLUDING HOSTED SUPPORT GROUPS, FOCUSING ON HEALTH CONDITIONS IN OUR SPECIALTIES TO PATIENTS AND THE PUBLIC. PLEASE SEE PAGE 21 OF THE COMMUNITY BENEFITS PLAN POSTED ON THE MEEI WEBSITE, WWW.MASSEYEANDEAR.ORG, FOR DETAILS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE H, PART III, LINES 2 - 4</FormAndLineReferenceDesc>
        <ExplanationTxt>BAD DEBTS ARE WRITTEN OFF AT GROSS CHARGES. FOR UNINSURED CLAIMS (SELF-PAY), BAD DEBTS ARE DISCOUNTED TO COST USING THE HOSPITAL COST ACCOUNTING SYSTEM. ACCOUNTS RECEIVABLE RELATED TO CO-PAYS, DEDUCTIBLES, AND COINSURANCE THAT IS WRITTEN OFF AS BAD DEBT IS ALREADY REPORTED AT COST AND IS DEDUCTED FROM THE INSURANCE-ALLOWED AMOUNT. SEE FINANCIAL STATEMENT, PAGES 23 24.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE H, PART III, LINE 8</FormAndLineReferenceDesc>
        <ExplanationTxt>THE SHORTFALL REPORTED ON PART III, LINE 7 SHOULD BE CONSIDERED COMMUNITY BENEFIT BECAUSE REIMBURSEMENT FROM MEDICARE DOES NOT COVER THE COST OF TREATING PATIENTS. MEEI HAS A POLICY TO TREAT ALL PATIENTS, REGARDLESS OF THE PAYER. AS A PRIMARILY OUT-PATIENT FACILITY, WITH ONLY TWO SPECIALTIES, MEEI CANNOT BENEFIT FROM RELATIVELY HIGHER MEDICARE PAYMENTS FOR SOME SPECIALTIES OR HIGHER INPATIENT MEDICARE REIMBURSEMENT. WITHOUT COMPROMISING PATIENT CARE, MEEI HAS LIMITED MEANS FOR REDUCING COSTS. MEEI USES A COST ACCOUNTING SYSTEM THAT IS COMPRISED OF A STEP-DOWN METHODOLOGY FOR ALLOCATING HOSPITAL OVERHEAD THAT IS SIMILAR TO THAT USED FOR THE MEDICARE COST REPORT. ALL INDIRECT COSTS ARE ALLOCATED TO PATIENT CARE COST CENTER, TEACHING AND RESEARCH. FULLY-LOADED PATIENT CARE COSTS ARE ALLOCATED TO PATIENTS USING BILLED UNITS, UNIT COSTS, AND ALLOCATION ALGORITHMS SPECIFIC TO EACH COST CENTER.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE H, PART III, LINE 9B</FormAndLineReferenceDesc>
        <ExplanationTxt>PATIENTS ARE NOTIFIED ON ALL BILLING STATEMENTS OF THE AVAILABILITY OF FINANCIAL ASSISTANCE AND THE CONTACT INFORMATION OF THE APPROPRIATE STAFF MEMBERS WHO ARE AVAILABLE TO ASSIST IN THE PROCESS. MEEI'S POLICY INCORPORATES SPECIFIC BILLING PRACTICES RELATING TO PATIENTS WHO ARE ELGIBILE FOR FINANCIAL ASSISTANCE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE H, PART VI, LINE 2</FormAndLineReferenceDesc>
        <ExplanationTxt>MASS. EYE AND EAR ENGAGED THE SERVICES OF CONSULTANTS TO JOIN THE CB WORKING GROUP AND GUIDE THE ASSESSMENT PROCESSES, WHICH TOOK PLACE DURING THE FALL 2015/WINTER 2016. KENEFICK AND BAXTER HAD WORKED WITH MASS. EYE AND EAR ON ITS LAST TWO ASSESSMENTS AS WELL. THE NEEDS ASSESSMENT WAS A THREE-STEP PROCESS DESIGNED TO: (1) IDENTIFY THE MASS. EYE AND EAR TARGET AREAS AND POPULATIONS FOR ITS COMMUNITY BENEFIT PLAN (2) ASSESS UNMET NEEDS IN THE SERVICE AREA AND AMONG TARGET POPULATIONS (3) ASSESS NEEDS IN MISSION HILL FOR MOST MASSACHUSETTS HOSPITALS, COMMUNITY-LEVEL DATA AVAILABLE THROUGH THE MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH AND BOSTON PUBLIC HEALTH COMMISSION ARE USEFUL IN UNDERSTANDING THE SPECIFIC HEALTH NEEDS OF COMMUNITIES AND THOSE IN WHICH DISPARITIES EXIST. THESE DATA ARE TYPICALLY USED TO SELECT VULNERABLE COMMUNITIES AND POPULATIONS AND TO TARGET SERVICES TO ADDRESS PARTICULAR HEALTH ISSUES AND DISPARITIES. BECAUSE NEITHER THE BOSTON PUBLIC HEALTH COMMISSION NOR THE MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH COLLECT AND REPORT DATA ON VISION, HEARING AND OTHER HEAD AND NECK CONDITIONS IN MASSACHUSETTS COMMUNITIES, MASS. EYE AND EAR HAD TO RELY ON ITS OWN PATIENT DATA, CENSUS DATA, AND GUIDANCE FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION TO DEFINE ITS TARGET COMMUNITIES AND POPULATIONS AND TO FORMULATE OBJECTIVES FOR ITS COMMUNITY BENEFITS PLAN.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE H, PART VI, LINE 3</FormAndLineReferenceDesc>
        <ExplanationTxt>MEEI, AS A FACILITY, WORKS TO ACTIVELY INFORM PATIENTS OF OUR PROGRAMS AND RESOURCES AVAILABLE TO THEM TO HELP WITH FINANCIAL ASSISTANCE. BILLING BROCHURES ARE AVAILABLE IN ALL DEPARTMENTAL WAITING AREAS, WHICH EXPLAIN THE BILLING PROCESS AND THE PATIENT'S OPTIONS FOR FINANCIAL ASSISTANCE. IN ADDITION, THE MEEI EXTERNAL WEBSITE CONTAINS A DEDICATED PAGE WHICH HIGHLIGHTS THE BASIC FEDERAL, AND MASSACHUSETTS EYE AND EAR, PROGRAMS. IT ALSO PROVIDES CONTACT INFORMATION FOR MEEI'S FINANCIAL COORDINATORS. THE FINANCIAL COORDINATION PROCESS IS DESIGNED TO EVALUATE THE PATIENTS' FINANCIAL ABILITY TO PAY AND TO RECOMMEND AND ASSIST THE PATIENT WITH ENROLLING IN ANY APPLICABLE GOVERNMENT OR PRIVATE PROGRAMS. WHEN ALL AVENUES HAVE BEEN EXHAUSTED, CHARITABLE CARE CRITERIA ARE REVIEWED.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE H, PART VI, LINE 4</FormAndLineReferenceDesc>
        <ExplanationTxt>STEP 1. IDENTIFY MASS. EYE AND EAR'S TARGET AREA AND POPULATIONS FOR ITS COMMUNITY BENEFITS PLAN THE ASSESSMENT TO INFORM THE NEXT MASS. EYE AND EAR COMMUNITY BENEFIT PLAN BEGAN WITH ANALYSIS OF 12 MONTHS OF PATIENT DATA (APRIL 1, 2014 THROUGH MARCH 31, 2015) TO BETTER UNDERSTAND THE POPULATION SERVED. PATIENTS FROM OUTSIDE OF MASSACHUSETTS WERE EXCLUDED FROM ANALYSES, LEAVING A REPRESENTATIVE SAMPLE OF 91,915 PATIENTS WHO UTILIZED SERVICES AT MASS. EYE AND EAR'S MAIN CAMPUS AND ITS LONGWOOD FACILITY. BELOW, OBSERVATIONS ABOUT PATIENTS SEX, RACE/ETHNICITY, AGE, SES, AND THEIR GEOGRAPHIC LOCATIONS ARE PROVIDED. THESE DATA WERE USED TO GUIDE THE SELECTION OF COMMUNITIES AND/OR POPULATIONS OF FOCUS. BELOW, THE FINDINGS ABOUT PATIENTS' SEX, RACE/ETHNICITY, GEOGRAPHIC LOCATION, AND SES ARE PROVIDED AND ARE FOLLOWED BY PROFILES OF MASS. EYE AND EAR'S PATIENTS OF COLOR, LOW-INCOME AND UN/UNDER-INSURED PATIENTS, AND ITS PEDIATRIC AND GERIATRIC PATIENTS. SEX: OVER HALF (54.7%) OF PATIENTS INCLUDED IN THE DATA SET ARE FEMALE. RACE/ETHNICITY: ROUGHLY 81% OF PATIENTS IN THE SAMPLE ELECTED TO PROVIDE DATA ABOUT THEIR RACE AND ETHNICITY AT THE TIME OF REGISTRATION AT MASS. EYE AND EAR. FIGURE BELOW SHOWS THE RACIAL/ETHNIC BREAKDOWN OF PATIENTS IN THE DATA SET, THE MAJORITY OF WHOM (64.4%) ARE WHITE. RACE/ETHNICITY OF MASS. EYE AND EAR PATIENTS AMERICAN INDIAN/ALASKA NATIVE 191 0.2% ASIAN 4,126 4.2% BLACK/AFRICAN AMERICAN 6,062 6.6% HISPANIC 3,961 4.3% PACIFIC ISLANDER 38 .3% WHITE 59,166 64.4% OTHER 685 0.7% UNKNOWN 17,686 19.2% TOTAL 91,915 100.0% GEOGRAPHY: JUST UNDER 20% OF MASS. EYE AND EAR'S PATIENTS RESIDE IN BOSTON. ANOTHER 39.7% LIVE IN THE SUBURBAN COMMUNITIES AROUND BOSTON AND WITHIN THE 128 BELT, AND 25.4% LIVE WEST OF 128, BUT STILL EAST OF INTERSTATE 495. THE REMAINING 15.5% OF PATIENT LIVE ELSEWHERE IN MA (E.G., WEST OF INTERSTATE 495 OR ON THE CAPE OR ISLANDS). GEOGRAPHIC LOCATION OF MASS. EYE AND EAR PATIENTS LIVING IN MASSACHUSETTS BOSTON 17,794 19.4% WITHIN 128 (EXCEPT BOSTON) 36,517 39.7% EAST OF 495/WEST OF 128 23,336 25.4% ELSEWHERE IN MA 14,268 15.5% BOSTON IS HOME TO THE LARGEST CONCENTRATION OF MASS. EYE AND EAR PATIENTS (19.4%) FOLLOWED BY 15 OTHER COMMUNITIES. WITH THE EXCEPTION OF ANDOVER, 14 OF THESE 15 COMMUNITIES ARE WITHIN THE 128 BELT. TOGETHER WITH BOSTON, THESE COMMUNITIES ARE HOME TO 47.2% OF MASS. EYE AND EAR'S PATIENTS. COMMUNITIES OUTSIDE OF BOSTON THAT ARE HOME TO LARGEST CONCENTRATIONS OF PATIENTS CAMBRIDGE 3,476 3.8% REVERE 2,187 2.40% NEWTON 2,080 2.3% QUINCY 1,983 2.20% SOMERVILLE 1,976 2.10% BROOKLINE 1,840 2.0% CHELSEA 1,769 1.9% MEDFORD 1,700 1.8% MALDEN 1,672 1.8% LYNN 1,434 1.6% EVERETT 1,326 1.4% ANDOVER 1,117 1.2% ARLINGTON 1,101 1.2% WALTHAM 979 1.10% WINTHROP 890 1.00% TOTAL 25,530 27.8%</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>NOTE THAT WITHIN THE DATA SET, SOME PATIENTS WERE LISTED AS LIVING IN</FormAndLineReferenceDesc>
        <ExplanationTxt>BOSTON WITH NO SPECIFIED NEIGHBORHOOD, WHEREAS OTHERS WERE LISTED AS LIVING IN ONE OF BOSTONS 21 NEIGHBORHOODS. IN FACT, DATA WERE AVAILABLE FOR 13 OF THE 21 NEIGHBORHOODS. RATHER THAN ROLL THE DATA FOR THE 13 NEIGHBORHOODS INTO THE BOSTON NUMBERS, THE CONSULTANTS KEPT THE DATA SEPARATE TO UNDERSTAND WHICH NEIGHBORHOODS HAVE SIGNIFICANT NUMBERS OF MASS. EYE AND EAR PATIENTS. HOWEVER, IT SHOULD BE NOTED THAT THE ACTUAL NUMBERS ASSOCIATED WITH THOSE NEIGHBORHOODS SHOULD BE HIGHER, AS SOME PATIENTS LIVING IN THOSE NEIGHBORHOODS ARE SIMPLY CLASSIFIED AS LIVING IN BOSTON. OTHER NEIGHBORHOODS OF BOSTON MAY ALSO BE HOME TO LARGE NUMBERS OF MASS. EYE AND EAR PATIENTS BUT, BECAUSE THEY ARE NOT BROKEN OUT, WE DO NOT KNOW HOW MANY PATIENTS RESIDE IT THOSE NEIGHBORHOODS. NEIGHBORHOOD OF MASS. EYE AND EAR'S PATIENTS WHO RESIDE IN BOSTON BOSTON 5,590 31.4% SOUTH BOSTON 893 5.0% DORCHESTER 2,692 15.1% WEST ROXBURY 776 4.4% EAST BOSTON 1,353 7.6% HYDE PARK 719 4.0% CHARLESTOWN 1,195 6.7% ROSLINDALE 713 4.0% JAMAICA PLAIN 1,171 6.6% MATTAPAN 560 3.1% BRIGHTON 917 5.2% ALLSTON 321 1.8% ROXBURY 894 5.0% SOCIO-ECONOMIC STATUS: DETERMINING THE SOCIO-ECONOMIC STATUS (SES) OF PATIENTS IS CHALLENGING. HOWEVER, MEANS-TESTED PUBLIC HEALTH INSURANCE PLANS (E.G., MASSHEALTH, NETWORK HEALTH, BMC HEALTH NET, HEALTH SAFETY NET) MAY BE USED AS A PROXY FOR LOWER SES. ADDITIONALLY, THOSE WHOSE PAYER WAS LISTED AS A SOURCE OF CHARITABLE CARE OR WHO ARE LISTED AS SELF-PAY ARE CONSIDERED UNINSURED OR UNDERINSURED. THESE PROXIES LIKELY LEAD TO AN UNDER-ESTIMATION OF THE PERCENTAGE OF LOW-INCOME PATIENTS. FOR EXAMPLE, MOST PATIENTS WHO ARE 65 AND OVER HAVE SOME FORM OF MEDICARE AS THEIR PAYMENT METHOD, WHICH PROVIDES NO INDICATION OF SES. DESPITE SUCH LIMITATIONS, THE DATA INDICATE THAT AT LEAST 15.1% OF MASS. EYE AND EAR'S PATIENTS ARE LOW-INCOME AND 2.2% ARE UNINSURED OR UNDER-INSURED. PROFILES OF MASS. EYE AND EAR'S LOW-INCOME PATIENTS AND PATIENTS OF COLOR: PATIENTS WITH LOW SES OR WHO ARE UN/UNDER-INSURED BASED ON PAYMENT METHOD DATA, AT LEAST 15,846 (17.2%) OF MASS. EYE AND EAR PATIENTS ARE OF LOWER SES OR ARE UNINSURED OR UNDER-INSURED. MORE THAN HALF (55.1%) OF THESE PATIENTS ARE WOMEN. THE MEAN AGE OF THESE PATIENTS IS 40.82 WITH A RANGE OF 2 TO 102. PEOPLE OF COLOR MAKE UP 30.2% OF THE PATIENTS WHO HAVE LOWER SES AND WHO ARE UN- OR UNDER-INSURED COMPARED TO 16.4% OF THE TOTAL MASS. EYE AND EAR PATIENT POPULATION. RACIAL CATEGORY OF PATIENT WITH LOW SES OR WHO ARE UN/UNDER-INSURED (TOTAL PATIENT POPULATION -- LOW SES &amp; UN/UNDER-INSURED) RACE/ETHNICITY: #; % -- #; % WHITE 59,166; 64.4% -- 7,184; 45.3% PEOPLE OF COLOR 15,063; 16.4% -- 4,789; 30.2% UNKNOWN 17,686; 19.2% -- 3,873; 24.4% TOTAL: 91,915; 100.0% -- 15,846; 100.0% JUST OVER 70% OF PATIENTS WITH LOWER SES OR WHO ARE UN- OR UNDER-INSURED LIVE WITHIN THE 128 BELT, WITH 23.9% OF THOSE RESIDING IN BOSTON. GEOGRAPHIC LOCATION OF MASS. EYE AND EAR'S LOW-INCOME OR UN/UNDER-INSURED PATIENTS BOSTON: 3,794; 23.9% WITHIN 128 (EXCLUDING BOSTON): 7,330; 46.3% EAST OF 495/WEST OF 128: 2,688; 17.0% ELSEWHERE IN MA: 2,034; 12.8% TOTAL: 15,846; 100.0%</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>OUTSIDE OF BOSTON, 14 COMMUNITIES ARE HOME TO THE HIGHEST</FormAndLineReferenceDesc>
        <ExplanationTxt>CONCENTRATION OF PATIENTS WITH LOW SES OR WHO ARE UNINSURED OR UNDER-INSURED. WITH THE EXCEPTION OF BROCKTON AND LAWRENCE, ALL OF THESE COMMUNITIES ARE WITHIN THE 128 BELT. COMMUNITIES OUTSIDE BOSTON WITH HIGHEST CONCENTRATION OF PATIENTS WITH LOW SES OR WHO ARE UN/UNDER-INSURED. CHELSEA: 895; 5.6% REVERE 735; 4.6% CAMBRIDGE: 559; 3.5% LYNN: 542; 3.4% EVERETT: 531; 3.4% MALDEN: 470; 3.0% SOMERVILLE: 439; 2.8% QUINCY; 351; 2.2% MEDFORD: 307; 1.9% NEWTON: 198; 1.2% BROCKTON: 192; 1.2% LAWRENCE: 181; 1.1% WALTHAM: 180; 1.1% SAUGUS: 153; 1.0% TOTAL: 5,733; 36.0% PATIENTS OF COLOR: JUST OVER ONE-THIRD (35.6%) OF MASS EYE AND EAR PATIENTS IDENTIFIED AS BEING HISPANIC OR OF A RACE OTHER THAN WHITE. MOST OF THESE PATIENTS OF COLOR SELF-IDENTIFIED AN ETHNIC IDENTITY AS WELL: ASIAN (E.G., CAMBODIAN, CHINESE, JAPANESE, KOREAN, LAOTIAN, VIETNAMESE, ASIAN INDIAN); BLACK/AFRICAN AMERICAN (E.G., AFRICAN, CAPE VERDEAN, CARIBBEAN ISLANDER, HAITIAN); AND HISPANIC (E.G., BRAZILIAN, CUBAN, DOMINICAN, GUATEMALAN, HONDURAN, MEXICAN, PORTUGUESE, PUERTO RICAN, SALVADORAN). MANY WHO IDENTIFIED THEIR RACE AS "OTHER" OFFERED MIDDLE EASTERN OR NORTH AFRICAN AS THEIR ETHNICITY. IN ALL, 15,063 (16.4%) OF MASS. EYE AND EAR'S PATIENTS ARE HISPANIC OR A RACE OTHER THAN WHITE. OF THESE PATIENTS, 57.5% ARE FEMALE. THE AVERAGE AGE OF THESE PATIENTS IS 48.27 WITH A RANGE OF 2 TO 104. 76.7% OF THESE PATIENTS OF COLOR LIVE IN BOSTON (34.5%) AND SUBURBAN COMMUNITIES WITHIN THE ROUTE 128 BELT (42.2%). THE LARGEST CONCENTRATIONS OF PATIENTS OF COLOR OUTSIDE OF BOSTON ARE IN EIGHT COMMUNITIES WITHIN THE 128 BELT. GEOGRAPHIC LOCATION OF MASS. EYE AND EAR'S PATIENTS OF COLOR BOSTON: 5,194; 34.5% WITHIN 128 (EXCLUDING BOSTON): 6,352; 42.2% EAST OF 495/WEST OF 128: 2,210; 14.7% ELSEWHERE IN MA: 1,307; 8.6% TOTAL: 15,063; 100.0% A COMPARISON OF THE COMMUNITIES OUTSIDE OF BOSTON WITH THE HIGHEST CONCENTRATION OF PATIENTS WITH LOW SES OR WHO ARE UN- OR UNDER-INSURED WITH THOSE COMMUNITIES OUTSIDE OF BOSTON WITH THE HIGHEST CONCENTRATION OF PATIENT OF COLOR SHOW OVERLAP. COMMUNITIES OUTSIDE BOSTON WITH HIGHEST CONCENTRATION OF PATIENTS OF COLOR CAMBRIDGE*: 843; 5.6% CHELSEA*: 677; 4.5% MALDEN*: 532; 3.5% LYNN*: 449; 3.0% REVERE*: 421; 2.8% EVERETT*: 401; 2.7% SOMERVILLE*: 386; 2.6% QUINCY*: 374; 2.5% BROCKTON*: 341; 2.3% MEDFORD*: 286; 1.9% BROOKLINE: 271; 1.8% RANDOLPH: 272; 1.8% NEWTON*: 243; 1.6% WALTHAM*: 166; 1.1% LAWRENCE*: 159; 1.1% LEXINGTON: 157; 1.0% *COMMUNITIES OUTSIDE OF BOSTON WITH THE HIGHEST CONCENTRATION OF PATIENTS WITH LOW SES OR WHO ARE UN/UNDER-INSURED</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>BASED ON PAYMENT METHOD, 29.8% OF MASS. EYE AND EAR'S PATIENTS</FormAndLineReferenceDesc>
        <ExplanationTxt>OF COLOR HAVE LOW SES AND 2% ARE UNINSURED OR UNDER-INSURED. MOST (81%) OF THESE PATIENTS LIVE WITHIN THE 128 BELT WITH 32.7% OF THEM RESIDING IN BOSTON. FIGURE BELOW SHOWS THE COMMUNITIES OUTSIDE OF BOSTON WITH THE HIGHEST CONCENTRATION OF PATIENTS OF COLOR WITH LOW SES OR WHO ARE UNINSURED OR UNDER-INSURED. ALL BUT LOWELL APPEAR ON BOTH THE LIST OF COMMUNITIES OUTSIDE OF BOSTON WITH THE HIGHEST CONCENTRATION OF PATIENTS OF COLOR AND PATIENTS WITH LOW SES AND WHO ARE UN- OR UNDER-INSURED. COMMUNITIES OUTSIDE OF BOSTON WITH THE HIGHEST CONCENTRATION OF PATIENTS OF COLOR WITH LOW SES OR WHO ARE UN/UNDER-INSURED BROCKTON*+: 97; 2.0% BROOKLINE*: 54; 1.0% CAMBRIDGE*+: 218; 4.6% EVERETT*+: 207; 4.3% LOWELL 50; 1.0% LYNN*+: 229; 4.8% MALDEN*+: 200; 4.2% MEDFORD*+: 87; 1.6% QUINCY*+: 109; 2.3% REVERE*+: 209; 4.4% SOMERVILLE*+: 147; 3.1% WALTHAM*+: 52; 1.1% *COMMUNITIES OUTSIDE OF BOSTON WITH THE HIGHEST CONCENTRATION OF PATIENTS WITH LOW SES OR WHO ARE UN/UNDER-INSURED +COMMUNITIES OUTSIDE OF BOSTON WITH THE HIGHEST CONCENTRATION OF PATIENTS OF COLOR THE OVERLAP IN COMMUNITIES SUGGESTS THAT CONCENTRATING IN THE COMMUNITIES IN WHICH THE HIGHEST CONCENTRATION OF PATIENTS WITH LOW SES OR WHO ARE UN- OR UNDER-INSURED WILL ALSO ENSURE THAT COMMUNITY BENEFIT ACTIVITIES REACH THOSE COMMUNITIES IN WHICH THE HIGHEST CONCENTRATION OF MASS. EYE AND EAR'S PATIENTS OF COLOR LIVE, INCLUDING THOSE WHO HAVE LOW SES OR WHO ARE UN- OR UNDERINSURED. GIVEN THE LOCATION OF MOST OF THE THESE COMMUNITIES, IT MAKES SENSE TO CONCENTRATE MASS. EYE AND EAR'S COMMUNITY BENEFIT ACTIVITIES WITHIN THE 128 BELT TO HELP TO ENSURE THAT ITS PATIENTS OF COLOR AND THOSE WITH LOW SES AND LITTLE OR NO INSURANCE WILL BENEFIT. PROFILE OF MASS. EYE AND EAR'S GERIATRIC AND PEDIATRIC POPULATIONS: MASS. EYE AND EAR HAS CLINICAL EXPERTISE IN SERVING PEDIATRIC AND GERIATRIC PATIENTS. THESE POTENTIALLY VULNERABLE GROUPS WERE SELECTED BY THE COMMUNITY BENEFITS STEERING COMMITTEE AS PRIORITY POPULATIONS FOR MASS. EYE AND EAR'S COMMUNITY BENEFITS PLAN DUE TO THE IMPACT OF HEARING/VISION IMPAIRMENT ON CHILDREN'S DEVELOPMENT AND HEARING/VISION IMPAIRMENT AND BALANCE ISSUES ON THE HEALTH AND SAFETY OF ELDERS. SENIORS (AGE 65+): PATIENTS AGED 65 AND OVER MAKE UP 31.6% OF THOSE SEEN AT MASS. EYE AND EAR DURING THE SELECTED TIMEFRAME, A TOTAL OF 29,060 INDIVIDUALS. AMONG SENIOR PATIENTS, 56.2% ARE FEMALE. THE AVERAGE AGE OF THE SENIOR GROUP IS 74.67 WITH A RANGE OF 65 TO 104. FOR MASS. EYE AND EAR'S SENIORS IN GENERAL, NEARLY 60% LIVE WITHIN THE 128 BELT WITH 18.6% OF THOSE RESIDING IN BOSTON. GEOGRAPHIC LOCATION OF MASS. EYE AND EAR'S GERIATRIC PATIENTS BOSTON: 5,404; 18.6% WITHIN 128 (EXCLUDING BOSTON): 11,812; 40.6% EAST OF 495/WEST OF 128: 7,258; 25.0% ELSEWHERE IN MA: 4,586; 15.8% TOTAL: 29,060; 100.0% BECAUSE MOST SENIORS HAVE SOME FORM OF MEDICARE FOR HEALTH CARE COVERAGE, THE PAYER DATA ARE NOT PARTICULARLY USEFUL IN HELPING US TO UNDERSTAND WHICH OF THE SENIOR PATIENTS ARE LOW-INCOME. AMONG THE 29,060 SENIOR PATIENTS, 1,095 (3.8%) HAD SOME FORM OF MEDICAID (E.G., MASSHEALTH, EMERGENCY MEDICAID, NETWORK HEALTH) AS THEIR PAYER AND 508 (1.7%) WERE LISTED AS SELF-PAY, WHICH LIKELY INDICATES THAT THEY HAD NO COVERAGE FOR THE SERVICES THEY RECEIVED AT MASS. EYE AND EAR. AMONG THE SENIORS WHO MAY BE LOW INCOME OR WHO ARE UN- OR UNDER-INSURED, 72.5% LIVE WITHIN THE 128 BELT WITH 21.9% OF THOSE SENIORS LIVING IN BOSTON. FIGURE BELOW SHOWS THE 15 COMMUNITIES WITH THE LARGEST CONCENTRATION OF MASS. EYE AND EAR'S SENIOR PATIENTS, AS WELL AS THOSE WHERE THE LARGEST CONCENTRATION OF LOW-INCOME OR UN- OR UNDER-INSURED SENIORS RESIDE. COMMUNITIES OUTSIDE BOSTON WITH HIGHEST CONCENTRATION OF MASS. EYE AND EAR'S SENIORS AND SENIORS WITH LOW SES OR WHO ARE UN/UNDER-INSURED (SENIORS -- LOW INCOME SENIORS) CAMBRIDGE: 1,112; 3.8% -- 80; 5.0% NEWTON: 772; 2.7% -- 45; 2.8% REVERE: 679; 2.3% -- 61; 3.8% BROOKLINE: 672; 2.3% -- 51; 3.2% QUINCY: 665; 2.3% -- 33; 2.1% SOMERVILLE 553; 1.9% -- 45; 2.8% MALDEN 486; 1.7% -- 45; 2.8% CHELSEA: 391; 1.3% -- 54; 3.4% ARLINGTON: 376; 1.3% -- 26; 1.6% ANDOVER*: 370; 1.3% LYNN: 369 1.3% -- 49; 3.1% WINTHROP: 352; 1.2% EVERETT: 333; 1.1% -- 31; 1.9% LEXINGTON: 317; 1.1% WALTHAM: 283; 1.0% -- 20; 1.2% MEDFORD: 39; 2.4% FRAMINGHAM*:24; 1.5% WATERTOWN: 20; 1.2%</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>BECAUSE PAYOR DATA PROVIDE LITTLE INSIGHT INTO THE SES OF THE</FormAndLineReferenceDesc>
        <ExplanationTxt>LARGER GERIATRIC PATIENT POPULATION, U.S. CENSUS DATA WERE ALSO EXAMINED TO UNDERSTAND THE DEMOGRAPHIC PROFILES (I.E., PROPORTION OF SENIORS AND THOSE LIVING BELOW THE POVERTY LEVEL) WHO LIVE IN EACH OF THE 18 COMMUNITIES OUTSIDE OF BOSTON WITH THE HIGHEST CONCENTRATION OF MASS. EYE AND EAR'S GERIATRIC PATIENTS. SEVEN OF THE COMMUNITIES HAVE A LARGER PROPORTION OF SENIOR RESIDENTS THAN THE STATE IN GENERAL AND EIGHT HAVE A LARGER PROPORTION OF RESIDENTS LIVING BELOW THE POVERTY LEVEL THAN THE STATE IN GENERAL. ALTHOUGH REVERE IS THE ONLY OF THE COMMUNITIES WITH A HIGHER PROPORTION OF BOTH GROUPS THAN MASSACHUSETTS IN GENERAL, MANY OF THE 15 COMMUNITIES WITH THE HIGHEST CONCENTRATION OF MASS. EYE AND EAR'S GERIATRIC PATIENTS ALSO HAVE HIGH RATES OF POVERTY. EXCEPT FOR ANDOVER, ALL OF THESE COMMUNITIES ARE WITHIN THE 128 BELT, WHICH SUGGESTS THAT CONCENTRATING COMMUNITY BENEFIT PROGRAMMING ON COMMUNITIES WITHIN THE 128 BELT WILL HAVE THE GREATEST LIKELIHOOD OF REACHING MASS. EYE AND EAR'S GERIATRIC PATIENTS, INCLUDING MANY WHO LIVE IN COMMUNITIES THAT ARE DISPROPORTIONATELY AFFECTED BY POVERTY. U.S. CENSUS DATA ON RESIDENTS 65+ AND POVERTY IN COMMUNITIES IN WHICH THE LARGEST CONCENTRATION OF MASS. EYE AND EAR SENIOR PATIENTS RESIDE (2014 US CENSUS POPULATION ESTIMATE; RESIDENTS 65+; RESIDENTS LIVING BELOW POVERTY LEVEL) MASSACHUSETTS: 6,745,408; 13.8%; 11.4% CAMBRIDGE: 109,694; 9.5%; 14.7% NEWTON: 88,287; 15.2%; 5.7% REVERE: 54,157; 14.5%; 15.4% BROOKLINE*: 58,732; 12.8%; 11.5% QUINCY: 93,397; 15.1%; 10.5% SOMERVILLE: 78,901; 9.1%; 14.8% MALDEN: 60,859; 11.8%; 16.0% CHELSEA: 38,861; 8.7%; 23.7% ARLINGTON*: 42,844; 15.8%; 3.9% ANDOVER*: 8,762; 18.5%; 7.4% LYNN: 92,137; 11.4%; 21.0% WINTHROP: 18,352; 16.5%; 9.2% EVERETT: 44,231; 11.5%; 13.2% LEXINGTON*: 31,394; 18.6%; 3.9% WALTHAM: 63,014; 12.3%; 10.1% *2014 ESTIMATE NOT AVAILABLE. DATA ARE FROM 2010 U.S. CENSUS CHILDREN (UNDER 18 YEARS OLD): IN THE SELECTED TIMEFRAME, MASS. EYE AND EAR PROVIDED SERVICES TO 8,725 PATIENTS UNDER THE AGE OF 18. THESE CHILDREN COMPRISE 9.5% OF THE TOTAL PATIENT POPULATION. THE PEDIATRIC POPULATION IS MADE UP OF MORE MALES (56.3%) THAN FEMALES AND WHITE (56%) PATIENTS THAN THOSE IN OTHER RACIAL/ETHNIC GROUPS. THE PAYER SOURCE FOR THESE PATIENTS INDICATES THAT 30.2% ARE OF LOWER SES AND 1% IS UN- OR UNDER-INSURED. OVER HALF (53.5%) LIVE WITHIN THE 128 BELT WITH 12.1% RESIDING IN BOSTON. GEOGRAPHIC LOCATION OF MASS. EYE AND EAR'S PEDIATRIC PATIENTS (N=8,725) BOSTON: 1,057; 12.1% WITHIN 128 (EXCLUDING BOSTON): 3,610; 41.4% EAST OF 495/WEST OF 128: 2,679; 30.7% ELSEWHERE IN MA: 1,379; 15.8% OVER TWO-THIRDS (67.7%) OF PEDIATRIC PATIENTS WITH LOW SES OR WHO ARE UN- OR UNDER-INSURED LIVE IN COMMUNITIES WITHIN THE 128 BELT, INCLUDING BOSTON (15.1%). FIGURE BELOW SHOWS THE COMMUNITIES OUTSIDE OF BOSTON WITH THE HIGHEST CONCENTRATION OF PEDIATRIC PATIENTS, AS WELL AS THOSE WITH THE HIGHEST CONCENTRATION OF PEDIATRIC PATIENTS WHO HAVE LOW SES OR WHO ARE UN- OR UNDER-INSURED. TWELVE COMMUNITIES OUTSIDE OF BOSTON THAT ARE HOME TO THE HIGHEST CONCENTRATION OF PEDIATRIC PATIENTS ARE ALSO HOME TO THE HIGHEST CONCENTRATION OF CHILDREN WHO HAVE LOW SES OR WHO ARE UN- OR UNDER-INSURED. WITH THE EXCEPTION OF BROCKTON, LAWRENCE, AND HAVERHILL, ALL OF THE HIGHEST CONCENTRATION COMMUNITIES IN WHICH THESE LOW-INCOME CHILDREN LIVE ARE WITHIN THE 128 BELT. THESE DATA SUGGEST THAT CONCENTRATING COMMUNITY BENEFIT PROGRAMMING ON COMMUNITIES WITHIN THE 128 BELT WILL HAVE THE GREATEST LIKELIHOOD OF REACHING MASS. EYE AND EAR'S PEDIATRIC PATIENTS, INCLUDING MANY WHO ARE LOW-INCOME. COMMUNITIES OUTSIDE BOSTON WITH HIGHEST CONCENTRATION OF MASS. EYE AND EAR'S PEDIATRIC PATIENTS AND THOSE WITH LOW SES OR WHO ARE UN/UNDER-INSURED</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>(CHILDREN ; LOW INCOME CHILDREN)</FormAndLineReferenceDesc>
        <ExplanationTxt>CHELSEA 322 3.7% ; 253 9.3% REVERE: 284 3.3% ; 197 7.2% CAMBRIDGE: 252 2.9% ; 87 3.2% EVERETT: 209 2.4% ; 149 5.5% NEWTON: 200 2.3% LYNN: 187 2.1% ; 132 4.9% SOMERVILLE: 170 1.9% ; 87 3.2% MALDEN: 164 1.9% ; 98 3.6% QUINCY: 160 1.8% ; 54 2.0% BROOKLINE: 129 1.5% ANDOVER: 120 1.4% WALTHAM: 112 1.3% ; 32 1.2% BROCKTON: 107 1.2% ; 56 2.1% MEDFORD: 103 1.2% ; 36 1.3% MILTON: 103 1.2% HAVERHILL: 97 1.1% ; 41 1.5% BRAINTREE: 92 1.1% LEXINGTON: 88 1.0% NATICK: 86 1.0% WELLESLEY: 85 1.0% LAWRENCE: 34 1.3% PEABODY: 27 1.0% SAUGUS: 29 1.1% WINTHROP: 26 1.0% SUFFOLK COUNTY AND MUCH OF MIDDLESEX COUNTY ARE LOCATED WITHIN THE 128 BELT, WHERE MOST OF MASS. EYE AND EAR'S PATIENTS RESIDE AND WHERE THE LARGEST CONCENTRATIONS OF VULNERABLE PATIENTS (E.G., CHILDREN, SENIORS, THOSE WITH LOW SES OR WHO ARE UN/UNDER-INSURED) LIVE. THE U.S. CENSUS DATA FOR MASSACHUSETTS' COUNTIES SHOW THAT: SUFFOLK COUNTY IS HOME TO THE LARGEST NUMBER AND HIGHEST PERCENTAGE OF THE STATE'S RESIDENTS LIVING BELOW THE FEDERAL POVERTY LEVEL. TOGETHER, SUFFOLK AND MIDDLESEX COUNTIES ARE HOME TO 28.9% OF THE COMMONWEALTH'S RESIDENTS WHO LIVE BELOW THE POVERTY LINE. MIDDLESEX COUNTY IS HOME TO THE LARGEST NUMBER OF SENIOR CITIZENS (AGE 65 AND OVER) AND THAT, TOGETHER, MIDDLESEX AND SUFFOLK COUNTIES ARE HOME TO 35% OF THE COMMONWEALTH'S SENIORS. MIDDLESEX COUNTY IS HOME TO THE LARGEST NUMBER AND HIGHEST PERCENTAGE OF THE STATE'S CHILDREN (UNDER AGE 18) AND, TOGETHER, MIDDLESEX AND SUFFOLK COUNTIES ARE HOME TO 37.9% OF THE COMMONWEALTH'S CHILDREN UNDER AGE 18. SENIORS, CHILDREN, AND THOSE LIVING BELOW THE POVERTY LINE IN MA COUNTIES. (POPULATION : # LIVING BELOW POVERTY LINE ; % LIVING BELOW POVERTY LINE ; # OF SENIORS (65+) ; % SENIORS (65+) ; # OF CHILDREN (UNDER 18) ; % OF CHILDREN (UNDER 18)) MASSACHUSETTS: 674,540: 768,977 11.4%; 930,866 13.8%; 1,389,554 20.6% BARNSTABLE: 214,914: 19,987 9.3%; 59,746 27.8%; 34,171 15.9% BERKSHIRE: 128,715: 16,476 12.8%; 26,901 20.9%; 23,040 17.9% BRISTOL: 554,194: 68,720 12.4%; 87,008 15.7%; 116,935 21.1% DUKES: 17,356: 1,753 10.1%; 3,436 19.8%; 3,176 18.3% ESSEX: 769,091: 86,138 11.2%; 119,978 15.6%; 169,200 22.0% FRANKLIN: 70,862: 8,574 12.1%; 12,897 18.2%; 12,897 18.2% HAMPDEN: 468,161: 82,864 17.7%; 71,629 15.3%; 105,336 22.5% HAMPSHIRE: 160,939: 20,922 13.0%; 23,658 14.7%: 25,106 15.6% MIDDLESEX: 1,570,315: 127,196 8.1%; 219,844 14.0%; 323,485 20.6% NANTUCKET: 10,856: 1,129 10.4%; 1,455 13.4%; 2,269 20.9% NORFOLK: 692,254: 45,689 6.6%; 108,684 15.7%; 149,527 21.6% PLYMOUTH: 507,022: 38,534 7.6% ; 82,138 16.2%; 114,080 22.5% SUFFOLK: 767,254: 159,589 20.8%; 84,398 11.0%; 132,735 17.3% WORCESTER: 813,475: 91,109 11.2%; 114,700 14.1%; 178,965 22.0% BY CONCENTRATING ON THE 128 BELT WITH SOME EFFORTS THAT EXTEND STATEWIDE (ESPECIALLY IN THE AREA BETWEEN 128 AND INTERSTATE 495), MASS. EYE AND EAR WILL LIKELY REACH THE GREATEST CONCENTRATION OF ITS CURRENT PATIENTS, ITS MOST VULNERABLE PATIENTS (I.E., SENIORS, CHILDREN, THOSE WITH LOW SES), AS WELL AS NON-PATIENTS WHO ARE SENIORS, CHILDREN, AND THOSE LIVING IN POVERTY WHO MAY BENEFIT FROM MASS. EYE AND EAR'S COMMUNITY BENEFIT ACTIVITIES. ACCORDING TO THE DONAHUE INSTITUTE AT THE UNIVERSITY OF MASSACHUSETTS, THE SENIOR POPULATION (65+) IS PROJECTED TO STEADILY INCREASE OVER THE NEXT 15 YEARS WHEREAS THE POPULATION OF CHILDREN WILL REMAIN RELATIVELY STABLE PROJECTED PROPORTIONS OF SENIORS AND CHILDREN IN MA (2015-2030)</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>(SENIORS; CHILDREN)</FormAndLineReferenceDesc>
        <ExplanationTxt>2015: 15.3%; 22.9% 2020: 16.9%; 22.4% 2025: 19.1%; 22.3% 2030: 21.1%; 22.5% THESE PROJECTIONS SUGGEST THAT THE NEED FOR MASS. EYE AND EAR'S COMMUNITY BENEFIT ACTIVITIES TARGETING SENIORS AND CHILDREN WILL PERSIST (AND EVEN GROW FOR SENIORS) OVER THE THREE YEARS OF THIS PLAN. CONCLUSIONS: BASED ON THE CENSUS DATA AND MASS EYE AND EAR'S OWN PATIENT DATA, THE COMMUNITY BENEFITS COMMITTEE CONCLUDED THAT, ALTHOUGH MASS. EYE AND EAR CARES FOR PATIENTS FROM ALL OVER THE COMMONWEALTH, THE HOSPITALS PRIMARY SERVICE AREA INCLUDES THE COMMUNITIES WITHIN THE ROUTE 128 BELT. ANALYSES ALSO SHOWED THAT LARGE NUMBERS OF CHILDREN, ELDERLY, AND LOW-INCOME PATIENTS AND PATIENTS OF COLOR RESIDE WITHIN THIS SERVICE AREA. THE COMMITTEE FURTHER CONCLUDED THAT, GIVEN THE NUMBER OF LOW INCOME COMMUNITIES AND PROPORTION OF PEOPLE OF COLOR RESIDING WITHIN ITS PRIMARY SERVICE AREA, MEMBERS OF MASS EYE AND EAR'S TARGET POPULATION ARE VERY LIKELY TO EXPERIENCE BARRIERS TO CARE RELATED TO DIVERSITY (E.G., LANGUAGE) AND SOCIO-ECONOMIC FACTORS. DUE TO THE FACTORS THAT MAKE CHILDREN, SENIORS AND LOW-INCOME INDIVIDUALS AND PEOPLE OF COLOR VULNERABLE, THESE GROUPS WILL BE PRIORITIZED WITHIN THE COMMUNITY BENEFITS PLAN. ALTHOUGH THE PLAN SHOULD NOT EXCLUDE THOSE LIVING OUTSIDE THE METRO-BOSTON AREA, IT SHOULD EMPHASIZE SERVICES FOR THOSE LIVING WITHIN IT BECAUSE RESIDENTS ARE SO LIKELY TO EXPERIENCE BARRIERS TO CARE. MASS. EYE AND EAR SHOULD BUILD UPON A SOLID FOUNDATION OF OUTREACH AND SERVICE PROVISION TO METRO-BOSTON COMMUNITIES AND INCLUDE STRATEGIES FOR IMPROVING ACCESS TO CARE IN THE COMMUNITY BENEFITS PLAN.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>STEP 2. ASSESS UNMET NEEDS IN THE SERVICE AREA AND AMONG THE TARGET</FormAndLineReferenceDesc>
        <ExplanationTxt>POPULATIONS WITH DATA FROM PROVIDERS AND STAFF AT MASS. EYE AND EAR AND EXTERNAL PARTNERS AT ORGANIZATIONS SERVING THE TARGET POPULATIONS AND COMMUNITIES, THE CB WORKING GROUP IDENTIFIED THE UNMET NEEDS THAT, AS AN INSTITUTION, MASS. EYE AND EAR IS UNIQUELY POSITIONED TO ADDRESS BECAUSE OF ITS CLINICAL SERVICES AND EXPERTISE. THROUGH ON-GOING DIALOG AND CONVERSATIONS OVER THE FALL AND WINTER, THE CB WORKING GROUP LED THE PROCESS TO IDENTIFY THE RESOURCE NEEDS. THE NEEDS ARE SIMILAR TO THOSE IDENTIFIED IN THE HOSPITAL'S LAST COMMUNITY BENEFITS PLAN. - TO EXTEND VISION SCREENING AND HEARING EXAMINATIONS AND FOLLOW UP CARE TO INDIVIDUALS WHO HAVE NO OR VERY LIMITED ACCESS TO SUCH SERVICES. - FOR RECONSTRUCTIVE SURGICAL SERVICES FOR SURVIVORS OF VIOLENCE WHO EXPERIENCED PHYSICAL INJURIES TO THE HEAD AND/OR NECK. - FOR EDUCATION, SCREENING AND SUPPORT FOR HEAD AND NECK CANCERS. - FOR EDUCATION AND SUPPORT RELATED TO FACIAL PARALYSIS AND CONDITIONS THAT AFFECT SMELL AND TASTE. - FOR RESOURCES TO IMPROVE ACCESS TO CARE FOR MEMBERS OF THE TARGET COMMUNITIES WHO WOULD BENEFIT FROM MASS. EYE AND EAR SERVICES BUT WHO ARE UNABLE TO GET THE CARE THEY NEED DUE TO LINGUISTIC OR FINANCIAL ISSUES, LACK OF TRANSPORTATION, OR A LACK OF KNOWLEDGE ABOUT THEIR CONDITIONS AND THE SERVICES TO ADDRESS THEM. - FOR FINANCIAL SUPPORT OF NON-PROFITS ENGAGED IN UNIQUE AND HIGH QUALITY WORK TO ADDRESS VISION, HEARING OR OTHER CONCERNS OF THE HEAD AND NECK IN THE TARGET COMMUNITIES AND/OR AMONG THE TARGET POPULATIONS. WITH GROWTH IN THE SENIOR POPULATION, THE INCREASE IN INCOME DISPARITIES, AND THE SMALL NUMBER OF INSTITUTIONS OFFERING THE CLINICAL EXPERTISE AND SERVICES AVAILABLE AT MASS. EYE AND EAR WITHIN METRO BOSTON, THE COMMUNITY BENEFITS COMMITTEE CONCLUDED THAT THE NEEDS ARE LIKELY TO PERSIST FOR MANY YEARS TO COME. SOME OF THE IDENTIFIED NEEDS (I.E., THOSE RELATED TO AWARENESS AND EDUCATION) AFFECT LARGE NUMBERS OF PEOPLE IN THE TARGET AREA. OTHERS AFFECT SMALLER GROUPS OF PEOPLE, EITHER BECAUSE POCKETS OF PEOPLE EXPERIENCE IMPEDED ACCESS TO SERVICES THAT ARE OTHERWISE GENERALLY AVAILABLE OR BECAUSE A CLINICAL CONDITION IS RARE AND THE RESOURCES TO ADDRESS IT ARE EXTREMELY LIMITED. CONCLUSION: THE CB WORKING GROUP AND THE HOSPITAL LEADERSHIP CONCLUDED THAT THE UNMET NEEDS IDENTIFIED DURING THE METRO BOSTON ASSESSMENT WERE ALIGNED WITH THE CAPABILITIES OF THE HOSPITAL AND ITS COMMUNITY PARTNERS AND SHOULD BE USED TO FORMULATE GOALS FOR THE FY16-18 COMMUNITY BENEFITS PLAN.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>STEP 3. ASSESS NEEDS IN MISSION HILL</FormAndLineReferenceDesc>
        <ExplanationTxt>AS NOTED EARLIER, MASS. EYE AND EAR DECIDED TO BROADEN ITS COMMUNITY BENEFITS WORK TO PROVIDE TARGETED PROGRAMMING IN THE MISSION HILL NEIGHBORHOOD IN 2012 WITH THE OPENING OF A MULTI-SPECIALTY AMBULATORY CARE CENTER AT 800 HUNTINGTON AVENUE ON MISSION HILL. MISSION HILL IS ONE SQUARE MILE, THREE-QUARTERS OF WHICH IS RESIDENTIAL. THE OTHER QUARTER IS COMPRISED OF THE LONGWOOD MEDICAL AREA. ACCORDING A REPORT BASED ON 2010 CENSUS DATA, MISSION HILL IS HOME TO 16,305 RESIDENTS, 19.7% OF WHOM ARE HISPANIC/LATINO. JUST UNDER 46% OF THE POPULATION IS A RACE OTHER THAN WHITE. ROUGHLY 21% OF THE MISSION HILL POPULATION IS 19 YEARS OF AGE OR YOUNGER AND 9.1% IS 65 YEARS OF AGE OR OLDER. AN AMERICAN COMMUNITY SURVEY (2005-2009) ESTIMATE REPORT ESTIMATES THAT 3,711 OR 28.1% OF MISSION HILL RESIDENTS WERE BORN OUTSIDE OF THE U.S. AND THAT 48.5% OF THOSE ARE NOT CURRENTLY U.S. CITIZENS. THE RANGE OF COUNTRIES OF ORIGIN DEMONSTRATES THE RICH ETHNIC DIVERSITY OF MISSION HILL RESIDENTS. ROUGHLY HALF OF MISSION HILL'S CHILDREN AND 60% OF ADULTS SPEAK A FOREIGN LANGUAGE AT HOME AND MANY EXPERIENCE LINGUISTIC ISOLATION BECAUSE THEY SPEAK LITTLE OR NO ENGLISH. LANGUAGES REPRESENTED INCLUDE SPANISH (35.1%), INDO-EUROPEAN LANGUAGES (38%), ASIAN AND PACIFIC ISLAND LANGUAGES (31.5%), AND OTHER LANGUAGES (17.4%). PLACE OF BIRTH FOR MISSION HILL'S FOREIGN-BORN POPULATION CHINA: 899; 24.2% SINGAPORE: 70; 1.9% INDIA: 422; 11.4% FRANCE: 66; 1.8% DOMINICAN REPUBLIC: 399; 10.8% CROATIA: 53; 1.4% IRELAND: 168; 4.5% CANADA: 53; 1.4% RUSSIA: 142; 3.8% TRINIDAD &amp; TOBAGO: 51; 1.4% VIETNAM: 138; 3.7% GREECE: 46; 1.2% KOREA: 120; 3.2% JAPAN: 45; 1.2% COLOMBIA: 100; 2.7% JAMAICA: 42; 1.1% ERITREA: 90; 2.4% UZBEKISTAN: 41; 1.1% UKRAINE: 76; 2.0% NICARAGUA: 40; 1.1% FOR MISSION HILL ADULTS OVER THE AGE OF 25 (N=8,014), 18.5% HAVE LESS THAN A HIGH SCHOOL DIPLOMA, 21.7% HAVE A HIGH SCHOOL DEGREE OR GED, 17.4% HAVE SOME COLLEGE OR AN ASSOCIATE'S DEGREE, AND 42.5% HAVE A BACHELOR'S DEGREE OR HIGHER. IN 2009, AN ESTIMATED 19.3% OF MISSION HILL RESIDENTS EARNED LESS THAN $10,000 A YEAR. MORE THAN HALF (53.6%) EARNED LESS THAN $40,000 PER YEAR. IN CONTRAST, 12.6% EARNED $100,000 OR MORE IN THE SAME 12 MONTHS. THE PER CAPITA INCOME IN THE PAST 12 MONTHS (IN 2009 INFLATION-ADJUSTED DOLLARS) WAS $24,121. OF THE 7,190 PEOPLE WHO CONSIDER THEMSELVES LABOR FORCE ELIGIBLE, 88.4% ARE EMPLOYED. MISSION HILL IS HOME TO MORE THAN 20 HEALTH CARE, RESEARCH AND ACADEMIC INSTITUTIONS. JUST OVER 48% OF MISSION HILL EMPLOYEES HOLD PROFESSIONAL AND MANAGERIAL ROLES. ANOTHER 18.3% ARE IN SERVICE OCCUPATIONS, 23.9% ARE IN SALES AND OFFICE JOBS, AND 9.4% ARE IN A RANGE OF OTHER OCCUPATIONS, INCLUDING CONSTRUCTION, TRANSPORTATION, AND OTHER TYPES OF LABOR. ACCORDING TO THE 2010 CENSUS, OF THE 6,332 OCCUPIED HOUSING UNITS IN MISSION HILL, ONLY 11.4% ARE OWNER OCCUPIED AND 33.6% ARE OCCUPIED BY FAMILIES. SEVERAL HUNDRED HOUSING UNITS IN MISSION HILL ARE OWNED AND RENTED BY THE BOSTON HOUSING AUTHORITY. SENIORS (65+) RESIDE IN 17.8% OF MISSION HILL HOUSEHOLDS WHILE CHILDREN UNDER THE AGE OF 18 ARE IN 16.9% OF HOUSEHOLDS. IN SUMMARY, MISSION HILL IS A SMALL BUT DIVERSE COMMUNITY. ALTHOUGH HOME TO SOME OF THE CITY'S LARGEST EMPLOYERS AND SEVERAL HUNDRED MIDDLE AND UPPER INCOME RESIDENTS, MISSION HILL IS PRIMARILY A NEIGHBORHOOD OF LOWER-INCOME RESIDENTS. TO LEARN ABOUT MASS. EYE AND EARS PATIENTS WHO RESIDE IN MISSION HILL, THE CONSULTANTS ANALYZED DATA FROM THE LARGER DATA SET FOR PATIENTS WHOSE ZIP CODE IS 02120 (THE ZIP CODE FOR MISSION HILL). DURING THE TIMEFRAME FROM WHICH PATIENT DATA WERE DRAWN, MASS. EYE AND EAR CARED FOR 311 PATIENTS WHO LIVE IN MISSION HILL (1.9% OF THE MISSION HILL POPULATION). THE NUMBER OF MISSION HILL RESIDENTS INCREASED SLIGHTLY FROM 2012 (UP 48 FROM 2012'S 263 INDIVIDUALS). WITH THE LONGWOOD FACILITY AND CONCENTRATED EFFORT TO PROVIDE SERVICES TO THE NEIGHBORHOOD THROUGH ITS COMMUNITY BENEFITS PROGRAMMING, WE EXPECT THE NUMBER OF MISSION HILL RESIDENTS SERVED BY MASS. EYE AND EAR TO INCREASE OVER TIME. FIGURE BELOW SHOWS THE DEMOGRAPHICS OF MASS. EYE AND EAR'S PATIENTS WHO LIVE IN MISSION HILL.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>DEMOGRAPHICS OF MASS. EYE AND EAR MISSION HILL PATIENTS (ZIP 02120) N=311</FormAndLineReferenceDesc>
        <ExplanationTxt>AGE MEAN 46.5 RANGE 3-95 UNDER 18 (PEDIATRIC) 8 (2.4%) 65+ (GERIATRIC) 69 (22.0%) SEX FEMALE 194 (62.4%) MALE 117 (37.6%) SES (USING PAYER AS PROXY) LOW SES: 89 (28.6%) UN/UNDER-INSURED: 6 (1.9%) RACE/ETHNICITY AMERICAN INDIAN/ALASKA NATIVE: 4 (1.3%) ASIAN: 26 (8.4%) BLACK/AFRICAN AMERICAN: 58 (18.6%) HISPANIC: 48 (15.4%) WHITE: 93 (29.9%%) OTHER: 1 (.3%) NOT AVAILABLE: 81 (26.0%)</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE H, PART VI, LINE 5</FormAndLineReferenceDesc>
        <ExplanationTxt>THE COMMUNITY BENEFITS PLAN THE CB WORKING GROUP USED THE ASSESSMENT FINDINGS TO DRAFT THE COMMUNITY BENEFIT PLAN. ONCE DRAFTED, JENNIFER STREET PRESENTED THE DRAFT PLAN TO THE HOSPITAL'S SENIOR LEADERSHIP FOR THEIR INPUT AND APPROVAL. AFTER INCLUDING THEIR FEEDBACK, THE PLAN WAS FINALIZED. THE PLAN IS POSTED PUBLICLY ON THE MASS. EYE AND EAR WEBSITE AND AS PART OF THE ANNUAL SUBMISSION TO THE OFFICE OF THE ATTORNEY GENERAL; THEREFORE THE TARGET POPULATIONS IDENTIFIED HEREIN ARE ALSO POSTED PUBLICLY AS REQUESTED BY THE OFFICE OF THE ATTORNEY GENERAL. PER THE ATTORNEY GENERALS COMMUNITY BENEFITS GUIDELINES, WE HAVE ESTABLISHED A THREE-YEAR PLAN. ALTHOUGH WE DO NOT CURRENTLY INTEND TO MODIFY THE PLAN, MASS. EYE AND EAR RECOGNIZES THAT CIRCUMSTANCES MAY ARISE OVER THE THREE YEARS OF THE PLAN THAT WOULD WARRANT A CHANGE (E.G., DUE TO INCREASES OR REDUCTIONS IN RESOURCES, NEW PARTNERSHIP OPPORTUNITIES, AN URGENT NEED THAT ARISES AMONG TARGET POPULATIONS THAT MUST BE PRIORITIZED). SHOULD SUCH CIRCUMSTANCES ARISE, THE CB WORKING GROUP WILL REVIEW THE PARTICULAR SITUATION AND PROPOSE AN APPROPRIATE SOLUTION (E.G., ADDING, MODIFYING OR ELIMINATING A STRATEGY). MASS. EYE AND EAR CONTINUES TO WORK TO STRENGHTEN ITS RELATIONSHIPS WITH THE MISSION HILL NEIGHBORHOOD. THESE EFFORTS INCLUDE INTERNSHIP PROGRAMS, SCREENINGS, FINANCIAL SUPPORT AND SPONSORSHIPS AND PARTICIPATION/VOLUNTEER IN LOCAL EVENTS. DEVELOPING COMMUNITY BENEFIT PLAN GOALS THE CB WORKING GROUP REVIEWED THE UNMET NEEDS IDENTIFIED DURING THE ASSESSMENT, INCLUDING THOSE IDENTIFIED IN MISSION HILL, AND DETERMINED THAT THEY WERE CONSISTENT WITH THE EXISTING GOALS OF MASS. EYE AND EAR'S COMMUNITY BENEFITS PLAN. THE COMMUNITY BENEFIT COMMITTEE RE-AFFIRMED THE EXISTING GOALS. THE GOALS ARE TO: 1. IMPROVE VISION AMONG MEMBERS OF MASS. EYE AND EARS DESIGNATED COMMUNITY AND TARGET POPULATIONS BY ENSURING ACCESS TO THE INFORMATION, SUPPORT, SCREENING AND CLINICAL SERVICES THEY NEED TO PREVENT AND ADDRESS VISION PROBLEMS. 2. IMPROVE HEARING AMONG MEMBERS OF MASS. EYE AND EARS DESIGNATED COMMUNITY AND TARGET POPULATIONS BY ENSURING ACCESS TO THE INFORMATION, SUPPORT, SCREENING AND CLINICAL SERVICES THEY NEED TO PREVENT AND ADDRESS HEARING PROBLEMS. 3. ENSURE THAT SURVIVORS OF VIOLENCE WHO EXPERIENCE SEVERE INJURY TO THE HEAD OR NECK RECEIVE CLINICAL CARE TO IMPROVE THEIR PHYSICAL AND EMOTIONAL WELL-BEING. 4. ENSURE THAT MEMBERS OF MASS. EYE AND EARS DESIGNATED COMMUNITY AND TARGET POPULATIONS HAVE APPROPRIATE INFORMATION AND EMOTIONAL SUPPORT RELATED TO HEAD AND NECK CANCERS, FACIAL PARALYSIS, AND CONDITIONS THAT AFFECT SMELL AND TASTE. 5. IMPROVE ACCESS TO CARE FOR MEMBERS OF THE DESIGNATED COMMUNITY AND TARGET POPULATIONS WHO MAY NOT BE ABLE TO GET THE SERVICES THEY NEED FOR VISION, HEARING OR HEAD/NECK CONDITIONS DUE TO LINGUISTIC, TRANSPORTATION, OR FINANCIAL BARRIERS OR LACK OF INFORMATION. 6. STRENGTHEN MASS. EYE AND EARS PARTNERSHIP WITH ORGANIZATIONS THAT SUPPORT MASS. EYE AND EARS COMMUNITY BENEFITS MISSION IN THE DESIGNATED COMMUNITY AND/OR WITH THE TARGET POPULATIONS. 7. INCREASE JOB READINESS OPPORTUNITIES FOR MEMBERS OF LOW-INCOME COMMUNITIES AND/OR HIGH RISK GROUPS. DEFINING OBJECTIVES, STRATEGIES AND TARGETS FOR THE COMMUNITY BENEFITS PLAN BECAUSE NEITHER THE BOSTON PUBLIC HEALTH COMMISSION NOR THE MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH COLLECT AND REPORT DATA ON VISION, HEARING AND OTHER HEAD AND NECK CONDITIONS IN MASSACHUSETTS COMMUNITIES, THE CB WORKING GROUP SOUGHT GUIDANCE FROM OTHER SOURCES TO DEVELOP OBJECTIVES THAT WOULD SUPPORT THE GOALS OF THE COMMUNITY BENEFITS PLAN. THE BEST GUIDANCE AVAILABLE FOR THIS PURPOSE CAME FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION. THE CDCS HEALTHY PEOPLE 2020 OBJECTIVES ESTABLISHED TARGETS RELATED TO VISION, HEARING, BALANCE, SMELL, TASTE, AND VOICE/SPEECH, ALL ISSUES RELATED TO THE SERVICES PROVIDED BY MASS. EYE AND EAR. MASSACHUSETTS WAS NOT AMONG THE STATES THAT COLLECTED DATA RELATED TO THESE OBJECTIVES. THE CB WORKING GROUP REVIEWED ALL OF THE RELEVANT HEALTHY PEOPLE 2020 OBJECTIVES TO UNDERSTAND WHICH SUPPORT THE LARGER COMMUNITY BENEFITS GOALS. ANOTHER BENEFIT OF UTILIZING THE HEALTHY PEOPLE 2020 OBJECTIVES IS THAT MASS. EYE AND EAR IS ABLE TO MAKE A CONTRIBUTION TOWARD NATIONAL PUBLIC HEALTH PRIORITIES BY ADDRESSING SELECTED NATIONAL OBJECTIVES IN MASSACHUSETTS. THE CB WORKING GROUP AFFIRMED ITS SEVEN VISION-RELATED OBJECTIVES (THAT SUPPORT GOAL 1), EIGHT HEARINGRELATED OBJECTIVES (THAT SUPPORT GOAL 2), AND NINE OTHER OBJECTIVES (THAT SUPPORT GOALS 3 - 7 AND ADDRESS OTHER UNMET NEEDS AND ACCESS ISSUES IDENTIFIED AS PART OF THE COMMUNITY BENEFITS NEEDS ASSESSMENT PROCESS). ONCE THE OBJECTIVES WERE IDENTIFIED, THE CB WORKING GROUP IDENTIFIED STRATEGIES THAT WOULD LEAD TO ACCOMPLISHMENT OF THE OBJECTIVES. THESE STRATEGIES WERE INFORMED BY THE INTERNAL AND EXTERNAL PARTNERS INVOLVED IN THE NEEDS ASSESSMENT. GIVEN MASS. EYE AND EARS CLINICAL SERVICES AND RESOURCES AND THE EXPERTISE OF ITS PARTNERS, THE CB WORKING GROUP WAS ABLE TO ASSEMBLE A COMPREHENSIVE SET OF STRATEGIES THAT FALL INTO FOUR CATEGORIES. THE CB WORKING GROUP ALSO ASKED THEIR PARTNERS TO GIVE INPUT ABOUT TARGETS OR EXPECTED OUTCOMES ASSOCIATED WITH EACH OBJECTIVE. WITH THEIR GUIDANCE AND USING AVAILABLE DATA ON NEEDS AND POTENTIAL DEMAND FOR SERVICES, AS WELL AS CAPACITY ASSOCIATED WITH EACH OF THE COMMUNITY BENEFITS STRATEGIES, THE CB WORKING GROUP ESTABLISHED TARGETS FOR EACH OF THE THREE YEARS OF THE PLAN. THE GOALS, OBJECTIVES, STRATEGIES, AND TARGETS/EXPECTED OUTCOMES FOR THE NEXT THREE YEARS ARE DISPLAYED ON THE MASS. EYE AND EAR COMMUNITY BENEFITS LOGIC MODEL. THE LOGIC MODEL PROVIDES A USER-FRIENDLY WAY OF EXPLAINING WHAT MASS. EYE AND EAR AND ITS PARTNERS WANT TO ACCOMPLISH (I.E., THE OBJECTIVES), HOW EACH OBJECTIVE WILL BE ACHIEVED (I.E., THE STRATEGIES), AND THE PROGRESS EXPECTED TOWARD THE OBJECTIVES EACH YEAR (I.E., THE TARGETS/EXPECTED OUTCOMES). SECTION IV OF THIS DOCUMENT PROVIDES DETAIL ABOUT EACH COMMUNITY BENEFITS STRATEGY, INCLUDING DESCRIPTIONS OF OUR PARTNERS, THE ATTORNEY GENERALS COMMUNITY BENEFITS CATEGORIES ADDRESSED BY EACH STRATEGY, THE COMMUNITIES AND POPULATIONS SERVED, INFORMATION ABOUT PROGRESS RELATED TO EACH STRATEGY, AND THE COMMUNITY BENEFITS RESOURCES EXPENDED TO SUPPORT EACH. THE FOLLOWING SECTION PROVIDES AN EVALUATION OF THE MOST RECENT YEAR'S PROGRESS TOWARD THE COMMUNITY BENEFITS PLAN TARGETS, INCLUDING INFORMATION ABOUT THE EXTENT TO WHICH THOSE ANNUAL TARGETS WERE MET AND OUR PLANS FOR IMPROVEMENT WHERE NEEDED. THE COMMUNITY BENEFITS STRATEGIES MASS. EYE AND EARS COMMUNITY BENEFITS STRATEGIES FOR ACHIEVING ITS OBJECTIVES AND ANNUAL TARGETS PROGRAM FALL INTO FOUR MAJOR CATEGORIES: 1. HEALTH SCREENING AND DIRECT SERVICES 2. COMMUNITY EDUCATION AND SUPPORT GROUPS 3. ACCESS TO SERVICES/RESOURCES/WORK EXPERIENCE 4. FINANCIAL SUPPORT (GRANTS, DONATIONS, FOUNDATION SUPPORT, SCHOLARSHIPS) CATEGORIES 1 AND 2 DRAW ON MASS. EYE AND EARS BROAD CLINICAL AND TEACHING EXPERTISE AND ENCOMPASS THE NEW JOB READINESS STRATEGIES. CATEGORY 3 RESPONDS TO BARRIERS AND OBSTACLES THAT LIMIT ACCESS TO SERVICES AND ALSO INCLUDES INITIATIVES THAT PROVIDE TARGETED POPULATIONS WITH OPPORTUNITIES TO GAIN WORK EXPERIENCE. CATEGORY 4 REPRESENTS MASS. EYE AND EARS OPPORTUNITY TO SUPPORT PARTNERS WHOSE MISSIONS ARE ALIGNED WITH THOSE OF MASS. EYE AND EAR AND WHO ARE PROVIDING SERVICES TO MASS. EYE AND EARS PRIORITY PATIENT GROUPS AND/OR GEOGRAPHIC AREAS. EACH CATEGORY BELOW OFFERS A DESCRIPTION OF THE ASSOCIATED STRATEGIES AND PARTNERSHIPS AND CONCLUDES WITH AN AT-A-GLANCE TABLE THAT DESCRIBES THE NUMBER OF INDIVIDUALS, TARGET AUDIENCE AND GEOGRAPHIC AREA SERVED, THE ATTORNEY GENERALS COMMUNITY BENEFITS CATEGORIES ADDRESSED, AND THE COSTS/RESOURCES EXPENDED FOR THE REPORTABLE YEAR (FY15) FOR EACH STRATEGY IN THE CATEGORY.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>CATEGORY 1: HEALTH SCREENING AND DIRECT SERVICES</FormAndLineReferenceDesc>
        <ExplanationTxt>MASS. EYE AND EAR PROVIDES HEALTH SCREENING AND DIRECT CLINICAL SERVICES TO A WIDE RANGE OF INDIVIDUALS AND GROUPS, FROM LOW-INCOME CHILDREN TO SENIORS TO SURVIVORS OF VIOLENCE. SPECIFIC INITIATIVES ARE DESCRIBED BELOW. NEIGHBORHOOD HOUSE CHARTER SCHOOL (NHCS): NHCS WAS FOUNDED IN 1995 TO PROVIDE A BETTER EDUCATIONAL OPTION FOR LOW-INCOME BOSTON FAMILIES AND TO INCUBATE INNOVATIVE PRACTICES THAT HAVE THE POTENTIAL TO IMPROVE PUBLIC EDUCATION FOR ALL STUDENTS. TODAY, NHCS SERVES 400 STUDENTS AND IS ONE OF THE MOST SOUGHT-AFTER SCHOOLS IN THE CITY, SUCCESSFULLY SERVING A DIVERSE COMMUNITY OF CHILDREN IN GRADES PRE-K THROUGH 8 FROM DORCHESTER AND SURROUNDING BOSTON NEIGHBORHOODS. MASS. EYE AND EARS DEPARTMENTS OF AUDIOLOGY AND OPHTHALMOLOGY PARTNER WITH NHCSS SCHOOL NURSE TO OFFER VISION AND HEARING SCREENING TO ALL STUDENTS. CHILDREN WHO NEED FOLLOW-UP CARE RECEIVE IT, FREE IF NECESSARY, AT MASS. EYE AND EAR. WORKING WITH NHCS SCHOOL NURSE, WE SET A GOAL OF SCREENING ALL CHILDREN IN ADVANCE OF FLU SEASON TO MAXIMIZE THE NUMBER OF CHILDREN IN ATTENDANCE FOR SCREENING. CAMP HARBOR VIEW: CREATED IN 2008 TO OFFER BOSTON CHILDREN A TRUE SUMMER CAMP EXPERIENCE, CAMP HARBOR VIEW IS AN INITIATIVE OF THE NOT-FOR-PROFIT CAMP HARBOR VIEW FOUNDATION, INC. IN PARTNERSHIP WITH THE CITY OF BOSTON AND THE BOYS &amp; GIRLS CLUBS OF BOSTON. THE CAMP OFFERS CHILDREN AGES 11 TO 14 LIVING IN BOSTONS AT-RISK NEIGHBORHOODS THE OPPORTUNITY TO LEAVE THE CITY DURING THE DAY AND PARTICIPATE IN A FOUR-WEEK SUMMER CAMP PROGRAM. RECOGNIZING MASS. EYE AND EARS EXPERTISE IN VISION SCREENING, LATE BOSTON MAYOR THOMAS MENINO REQUESTED THAT MASS. EYE AND EAR PLAY A ROLE AT CAMP HARBOR VIEW. MASS. EYE AND EAR HAS BEEN PARTNERING WITH THE CAMP SINCE ITS FIRST SEASON. MASS. EYE AND EAR STAFF MEMBERS TRAVEL TO CAMP HARBOR VIEW TO CONDUCT ON-SITE VISION SCREENINGS AND IDENTIFY THOSE IN NEED OF FOLLOW-UP CARE. IN 2015 MASS. EYE AND EAR HELD TWO DAYS OF SCREENING INVOLVING 40 MASS. EYE AND EAR STAFF MEMBERS. VISION COALITION/YEAR UP BOSTON: THE MISSION OF VISION COALITION MASSACHUSETTS IS TO REMOVE POOR VISION AS AN IMPEDIMENT TO LITERACY, EDUCATION, AND A BETTER WAY OF LIFE. VISION COALITION PROVIDES FREE VISION SCREENINGS AND FREE EYEGLASSES. MASS. EYE AND EAR PARTNERS WITH VISION COALITION MASSACHUSETTS BY PERFORMING FULL EYE EXAMS AND PROVIDING MEDICAL CARE FOR PARTICIPANTS IN YEAR UP BOSTON, WHICH THE VISION COALITION IDENTIFIED THROUGH SCREENING AS NEEDING VISION CARE. YEAR UP SERVES YOUNG URBAN ADULTS, PROVIDING THEM WITH THE SKILLS, EXPERIENCE, AND SUPPORT THAT WILL EMPOWER THEM TO REACH THEIR POTENTIAL THROUGH PROFESSIONAL CAREERS AND HIGHER EDUCATION. MASS. EYE AND EAR STAFF MEMBERS PROVIDE EYE EXAMS TO THESE YOUNG ADULTS, PROVIDE THOSE WHO NEED THEM WITH EYE GLASSES (WHICH ARE PURCHASED AT COST BY VISION COALITION), AND ENSURE THAT THOSE WHO NEED FOLLOW-UP CARE ARE LINKED TO SERVICES. FACING FORWARD (FORMERLY KNOWN AS R.O.S.E. FUND COLLABORATION): FACING FORWARD SCREENS AND REFERS TO MASS. EYE AND EAR SURVIVORS OF VIOLENCE IN NEED OF RECONSTRUCTIVE SURGERY. MASS. EYE AND EARS SURGEONS PERFORM THESE LIFE-ALTERING SURGERIES FREE OF CHARGE. ONE PATIENT WAS REFERRED AND SERVED IN FY16.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>CATEGORY 2: COMMUNITY EDUCATION AND SUPPORT GROUPS</FormAndLineReferenceDesc>
        <ExplanationTxt>MASS. EYE AND EARS CLINICIANS AND SOCIAL WORKERS DELIVER EDUCATION AND SUPPORT TO INDIVIDUALS COPING WITH VARIOUS MEDICAL CONDITIONS OR CHALLENGES (E.G., SINUSITIS, HEARING LOSS, VISION LOSS, FACIAL PARALYSIS). DETAILS ON THESE EDUCATIONAL AND SUPPORT STRATEGIES ARE PRESENTED BELOW. PUBLIC FORUM ON THE NOSE AND SINUSES (KNOW YOUR NOSE): THIS YEAR, MEMBERS OF MASS. EYE AND EARS DEPARTMENT OF ENT OFFERED A SERIES OF LECTURES ON THE NOSE AND SINUSES. AN INVITATION TO THIS EVENT WAS EXTENDED TO PATIENTS ON THE MASS. EYE AND EAR EMAIL LIST, POSTED ON MASSEYEANDEAR.ORG AND ON SOCIAL MEDIA. THE SESSIONS INCLUDED 'THE NOSE AND SINUSES,' 'MEDICAL TREATMENT OF SINUSITIS,' 'SURGICAL TREATMENT OF SINUSITIS,'THE BLEEDING NOSE.' LOW VISION SUPPORT GROUP: THE LOW VISION SUPPORT GROUP (PART OF MASS. EYE AND EARS VISION REHAB PROGRAM) HELPS PARTICIPANTS UNDERSTAND ISSUES RELATED TO LOW VISION, PROVIDING COPING STRATEGIES FOR DAILY LIVING, PROBLEM-SOLVING TECHNIQUES, AND GOAL-ORIENTED ACTION PLANS. THE GROUP ADDRESSES EMOTIONS EVOKED BY VISION LOSS (E.G., SADNESS/GRIEF, FRUSTRATION, UNCERTAINTY), AS WELL AS HOW TO COMMUNICATE WITH HEALTH CARE PROFESSIONALS, FAMILY, FRIENDS AND STRANGERS. MASS. EYE AND EAR ALSO ARRANGES FOR GUESTS SPEAKERS WHO ARE SPECIALISTS IN SUCH AREAS AS OCCUPATIONAL THERAPY, ORIENTATION AND MOBILITY. BOSTON CURED CANCER CLUB SUPPORT GROUP: THE BOSTON CURED CANCER GROUP FOR LARYNGECTOMEES SUPPORTS THE REHABILITATION OF LARYNGECTOMEES AND HELPS OFFER UNDERSTANDING TO PATIENTS AND THEIR LOVED ONES. MASS. EYE AND EAR HAS A STRONG COLLABORATIVE RELATIONSHIP WITH THIS ORGANIZATION, PROVIDING MEETING SPACE AND SPEAKERS FOR THE GROUPS. MASS. EYE AND EAR REFERS NEW LARYNGECTOMY PATIENTS TO THE BOSTON CURED CANCER GROUP, HOSTS THE SUPPORT GROUP, AND PROVIDES PARKING. PARTICIPANTS IN THE GROUPS, MOSTLY OLDER PEOPLE, ARE LARGELY FROM METRO BOSTON, BUT SOME COME FROM GREATER DISTANCES. FACIAL PARALYSIS SUPPORT GROUP: THE FACIAL PARALYSIS SUPPORT GROUP IS A FORUM FOR INDIVIDUALS WITH FACIAL PARALYSIS AND THOSE CLOSE TO THEM TO MEET AND SHARE THEIR EXPERIENCES AND TO DISCUSS SUPPORT, TREATMENT, COPING AND SELF-IMAGE. MASS. EYE AND EAR HOSTS THIS GROUP MONTHLY, PROVIDING MEETING SPACE AND SOCIAL WORK AND PHYSICIAN SUPPORT. WHILE THE GROUP IS OPEN TO ALL INDIVIDUALS WITH FACIAL PARALYSIS AND THEIR FAMILIES, PARTICIPANTS ARE GENERALLY FROM METRO BOSTON. MASS. EYE AND EAR PUBLICIZES THE SUPPORT GROUP VIA SOCIAL MEDIA AND THROUGH A PARTNERSHIP WITH THE FACIAL PARALYSIS SUPPORT NETWORK. HEAR@BOSTON: HEAR@BOSTON, A CHAPTER OF THE HEARING LOSS ASSOCIATION OF AMERICA, IS A COMMUNITY ORGANIZATION THAT HELPS EMPOWER PEOPLE WHO HAVE HEARING LOSS BY FACILITATING OPPORTUNITIES FOR SOCIAL ENGAGEMENT, EDUCATION AND SKILL DEVELOPMENT. MASS. EYE AND EAR DONATES MONTHLY MEETING SPACE, AND MASS. EYE AND EAR CLINICIANS SERVE AS SPEAKERS FOR MEETINGS AND EVENTS. MANY OF HEAR@BOSTONS MEMBERS ARE YOUNG PROFESSIONALS BETWEEN THE AGES OF 20 AND 45, BUT THE GROUP ENCOURAGES PEOPLE OF ALL AGES TO JOIN. GRAVES DISEASE/THYROID EYE DISEASE SUPPORT GROUP: MASS. EYE AND EAR OFFERS A THYROID EYE DISEASE (GRAVES DISEASE) SUPPORT GROUP, WHICH ALLOWS MEMBERS TO EXPRESS THEIR CONCERNS ABOUT THIS CHRONIC ILLNESS TO HELP FORM A SOCIAL CONNECTION WITH OTHERS AND IMPROVE COPING SKILLS. THE OPEN FORUM GIVES MEMBERS THE OPPORTUNITY TO EXCHANGE INFORMATION ABOUT GRAVES DISEASE AND GIVES PHYSICIAN SPEAKERS A CHANCE TO INFORM MEMBERS OF THE LATEST TREATMENTS. MASS. EYE AND EAR DONATES MEETING SPACE FOR THIS GROUP, WHICH MEETS QUARTERLY. PHYSICIANS FROM BOTH MASS. EYE AND EAR AND MASS. GENERAL HOSPITAL CONTRIBUTE TO THE PROGRAM. VISION REHABILITATION: IN THE AREA OF VISION REHABILITATION EDUCATION, MASS. EYE AND EAR STAFF RESPONDED TO A NUMBER OF REQUESTS FROM ORGANIZATIONS SERVING SENIORS TO PROVIDE SUPPORTIVE EDUCATION RELATED TO VISION REHABILITATION, INCLUDING THE FOLLOWING PRESENTATIONS: - MILTON COUNCIL ON AGING - ADVANCED TECHNOLOGY FOR THE VISUALLY IMPAIRED AT THE WINTHROP LOW VISION SUPPORT GROUP AT THE WINTHROP SENIOR CENTER. - VISION REHABILITATION MODEL AT MASS. EYE AND EAR AT THE JEWISH COMMUNITY CENTER LOW VISION SUPPORT GROUP, MARBLEHEAD - VISION REHABILITATION SERVICES AT MASS. EYE AND EAR AND ASSISTING SENIORS WITH AGE RELATED MACULAR DEGENERATION FOR SENIOR HEALTHWISE AT MASSACHUSETTS GENERAL HOSPITAL. MASS. EYE AND EAR ALSO ASSISTED IN HEALTH SCREENINGS FOR SENIORS AT SENIOR HEALTHWISE AT MASSACHUSETTS GENERAL HOSPITAL. HEALTH FAIRS: MASS. EYE AND EAR STAFF ATTENDED SEVERAL COMMUNITY FAIRS TO EDUCATE THE PUBLIC ABOUT EAR, NOSE, THROAT AND EYE CARE AND ABOUT AVAILABLE HEALTH SERVICE IN VARIOUS COMMUNITIES. THESE INCLUDED: - MISSION HILL HEALTH FAIR - EMERSON HEALTH AND WELLNESS EXPO - STONEHAM TOWN DAY</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>CATEGORY 3: ACCESS TO SERVICES/RESOURCES/WORK EXPERIENCE</FormAndLineReferenceDesc>
        <ExplanationTxt>THIS CATEGORY DESCRIBES MASS. EYE AND EAR STRATEGIES TO MAKE SERVICES AND RESOURCES AVAILABLE TO INDIVIDUALS WHO MIGHT NOT OTHERWISE BE ABLE TO ACCESS THEM. ALSO INCLUDED HERE ARE ACTIVITIES THAT PROVIDE TARGETED POPULATIONS WITH OPPORTUNITIES TO GAIN WORK EXPERIENCE. TRANSPORTATION FOR NEEDY PATIENTS: MASS. EYE AND EAR PROVIDES FREE TAXI TRANSPORTATION FOR PATIENTS AND FAMILIES IN EMERGENCY SITUATIONS. VOLUNTEER ESCORTS FOR PATIENTS: MASS. EYE AND EAR MANAGES A PROGRAM TO PROVIDE ESCORTS TO PATIENTS WHO NEED ASSISTANCE NAVIGATING THE HOSPITAL AND SURROUNDING AREA. THESE INCLUDE TAXI ESCORTS; ESCORTS TO TRAINS OR BUSES; ESCORTS TO ACCOMMODATIONS; ESCORTS WITHIN HOSPITALS (MASS. EYE AND EAR AND MASS. GENERAL HOSPITAL); AND ASSISTANCE WITH PATIENT MEDICAL PASSPORTS. FREE EYEGLASSES PROGRAM: SOCIAL WORK STAFF, PATIENT FINANCIAL COUNSELORS, AND OPTICAL SHOP STAFF COLLABORATE TO PROVIDE FREE GLASSES TO MASS. EYE AND EAR PATIENTS WHO MEET INCOME AND OTHER ELIGIBILITY GUIDELINES AND ARE UNABLE TO PAY FOR GLASSES. CONSULTATION FOR NON-MASS. EYE AND EAR PATIENTS: MASS. EYE AND EARS SOCIAL WORK STAFF PROVIDES INFORMATION AND REFERRAL FOR FINANCIAL RESOURCES, VISION AND HEARING RESOURCES, HOMECARE, AND EDUCATION TO NON-MASS. EYE AND EAR PATIENTS. FREE MEDICATIONS: MASS. EYE AND EARS NEEDY PATIENT FUND COVERS THE COST OF MEDICATIONS FOR PATIENTS WHO CANNOT AFFORD TO PAY. SOCIAL WORK CONSULTATIONS FOR PATIENTS NEEDING FINANCIAL ASSISTANCE: THE STAFF FROM MASS. EYE AND EARS DEPARTMENT OF SOCIAL WORK ASSISTS PATIENTS IN SECURING LODGING, MEAL VOUCHERS, PARKING VOUCHERS, AND OTHER SMALL NECESSITIES THAT MAKE IT POSSIBLE FOR PATIENTS AND FAMILIES TO RECEIVE TREATMENT AT MASS. EYE AND EAR. FINANCIAL COUNSELING ASSISTANCE: THE HOSPITALS FINANCIAL COUNSELORS WORK WITH PATIENTS TO ASSESS INSURANCE COVERAGE, IDENTIFY COVERAGE OPTIONS FOR WHICH THE UN/UNDER-INSURED MAY BE ELIGIBLE, AND TO PROVIDE ASSISTANCE IN APPLYING FOR AND ACCESSING COVERAGE. HOWE LIBRARY: MASS. EYE AND EARS RESEARCH LIBRARY STAFF REGULARLY ASSISTS PATIENTS WHO ARE SEEKING INFORMATION ABOUT THEIR MEDICAL CONDITIONS. SERVICES INCLUDE COMPUTER SEARCHING AND RETRIEVAL OF ARTICLES, FINDING BOOKS FOR USERS, AND PROVIDING COMPUTERS, COPIERS, PRINTERS, AND ASSISTANCE TO PEOPLE IN USING THEM. THE HEARING AID CENTER: THE MASS. EYE AND EAR HEARING AID CENTER PROVIDES SUPPORT, INCLUDING EDUCATION, TO PATIENTS WITH HEARING LOSS. THESE SERVICES ARE PROVIDED TO PATIENTS AS WELL AS MEMBERS OF THE COMMUNITY THROUGH PARTICIPATION AT LOCAL HEALTH FAIRS AND SCHOOL SCREENINGS. FREE PARKING: MASS. EYE AND EAR OFFERS FREE PARKING TO PATIENTS AND THEIR FAMILIES THAT ENABLES THEM TO COME FOR CARE AND PARTICIPATE IN SUPPORT GROUPS. MASS. EYE AND EAR ALSO EXTENDS FREE PARKING TO SUPPORT GROUPS SUCH AS THE GLAUCOMA SUPPORT GROUP AND HEAR@BOSTON. PROJECT SEARCH: THIS PILOT PROJECT IN PARTNERSHIP WITH THE MASS. COMMISSION FOR THE BLIND AND THE POLUS CENTER FOR SOCIAL AND ECONOMIC DEVELOPMENT PROVIDED INTERNSHIPS FOR FOUR INDIVIDUALS WITH VISUAL IMPAIRMENT, AN OPPORTUNITY THAT ALLOWED THEM TO DEVELOP TRANSFERRABLE JOB SKILLS. CHARITABLE CARE: ADDITIONALLY FOR THIS CATEGORY, MASS. EYE AND EAR PROVIDES FREE OR DISCOUNTED CARE TO PATIENTS WHO ARE UNABLE TO COVER THE FULL COST OF THE SERVICES THEY UTILIZE. THIS FREE OR DISCOUNTED CARE MEETS MASS. EYE AND EARS FINANCIAL ASSISTANCE POLICY. WE MAKE EVERY EFFORT TO IDENTIFY APPROPRIATE INSURANCE COVERAGE FOR OUR PATIENTS AND TO HELP THEM ACCESS THE COVERAGE FOR WHICH THEY ARE ELIGIBLE. HOWEVER, EACH YEAR MASS. EYE AND EAR EXTENDS CARE TO PATIENTS THAT IS NOT FULLY REIMBURSED. IN 2016 OUR NET CHARITY CARE TOTALED $2,152,229, WHICH INCLUDES THE HEALTH SAFETY NET (HSN) ASSESSMENT AND SHORTFALL, HSN DENIED CLAIMS, AND FREE OR DISCOUNTED CARE PROVIDED TO PATIENTS THAT MEET MASS. EYE AND EARS FINANCIAL ASSISTANCE POLICY. THE NET CHARITY CARE PROVIDED EACH YEAR IS A REFLECTION OF MASS. EYE AND EARS AND THE COMMUNITY BENEFITS COMMITTEES COMMITMENT TO THE DELIVERY OF HIGH-QUALITY CARE TO OUR PATIENTS AND IS AN IMPORTANT STRATEGY FOR ENSURING ACCESS TO CARE IN OUR COMMUNITY BENEFITS PLAN. BELOW, DETAIL RELATED TO THE HOSPITALS NET CHARITY CARE, TOTAL REVENUE, TOTAL PATIENT CARE RELATED EXPENSES, AND BAD DEBT IS PROVIDED.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>CATEGORY 4: FINANCIAL SUPPORT (GRANTS, DONATIONS, FOUNDATION SUPPORT,</FormAndLineReferenceDesc>
        <ExplanationTxt>AND SCHOLARSHIPS) MASS. EYE AND EAR DESIGNATES A PORTION OF ITS COMMUNITY BENEFITS RESOURCES TO PROVIDE FINANCIAL SUPPORT TO A SELECT NUMBER OF ORGANIZATIONS WHOSE MISSIONS ALIGN WITH THAT OF MASS. EYE AND EAR AND WHO SUPPORT THE HOSPITAL'S COMMUNITY BENEFITS GOALS AND ADDRESS ISSUES AFFECTING THE TARGET COMMUNITIES AND PRIORITY POPULATIONS OF THE HOSPITAL'S COMMUNITY BENEFIT PLAN. EACH OF THESE ORGANIZATIONS PROMOTES WELLNESS AMONG THEIR TARGET POPULATION AND SERVES PEOPLE FROM ACROSS THE COMMONWEALTH.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE H, PART VI, LINE 6</FormAndLineReferenceDesc>
        <ExplanationTxt>NOT APPLICABLE</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE H, PART VI, LINE 7</FormAndLineReferenceDesc>
        <ExplanationTxt>LIST OF STATES RECEIVING COMMUNITY BENEFIT REPORT: MA</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleH>
    <IRS990ScheduleI documentId="IRS990ScheduleI">
      <GrantRecordsMaintainedInd>true</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>BOSTON CHILDREN'S HOSPITAL</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>300 LONGWOOD AVE</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02115</ZIPCd>
        </USAddress>
        <RecipientEIN>042774441</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>183589</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>BRIGHAM AND WOMEN'S HOSPITAL</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>75 FRANCIS ST</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02115</ZIPCd>
        </USAddress>
        <RecipientEIN>042312909</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>584291</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>JOHNS HOPKINS UNIV SCHOOL OF MEDICINE</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>733 N BROADWAY STE 117</AddressLine1Txt>
          <CityNm>BALTIMORE</CityNm>
          <StateAbbreviationCd>MD</StateAbbreviationCd>
          <ZIPCd>21205</ZIPCd>
        </USAddress>
        <RecipientEIN>521479934</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>20114</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>MASSACHUSETTS GENERAL HOSPITAL</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>55 FRUIT ST</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02114</ZIPCd>
        </USAddress>
        <RecipientEIN>042697983</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>629829</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>MAYO CLINIC</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>200 1ST ST SW</AddressLine1Txt>
          <CityNm>ROCHESTER</CityNm>
          <StateAbbreviationCd>MN</StateAbbreviationCd>
          <ZIPCd>55905</ZIPCd>
        </USAddress>
        <RecipientEIN>416011702</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>13141</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>SCHEPENS EYE RESEARCH INSTITUTE</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>20 STANIFORD ST</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02114</ZIPCd>
        </USAddress>
        <RecipientEIN>042129889</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>326459</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF MIAMI</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1400 NW 10TH AVE</AddressLine1Txt>
          <CityNm>MIAMI</CityNm>
          <StateAbbreviationCd>FL</StateAbbreviationCd>
          <ZIPCd>33136</ZIPCd>
        </USAddress>
        <RecipientEIN>590624458</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>102024</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>MEDICAL COLLEGE OF WISCONSIN</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>8701 WATERTOWN PLANK RD</AddressLine1Txt>
          <CityNm>MILWAUKEE</CityNm>
          <StateAbbreviationCd>WI</StateAbbreviationCd>
          <ZIPCd>53226</ZIPCd>
        </USAddress>
        <RecipientEIN>390806261</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>29100</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>MASSACHUSETTS EYE AND EAR ASSOCIATES INC</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>243 CHARLES STREET</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02114</ZIPCd>
        </USAddress>
        <RecipientEIN>222658209</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>14799398</CashGrantAmt>
        <PurposeOfGrantTxt>INSTITUTIONAL SUPPORT</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>RHODE ISLAND HOSPITAL</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>593 Eddy Street</AddressLine1Txt>
          <CityNm>Providence</CityNm>
          <StateAbbreviationCd>RI</StateAbbreviationCd>
          <ZIPCd>029034923</ZIPCd>
        </USAddress>
        <RecipientEIN>050258954</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>227757</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>10900 Euclid Ave</AddressLine1Txt>
          <CityNm>Cleveland</CityNm>
          <StateAbbreviationCd>OH</StateAbbreviationCd>
          <ZIPCd>441067015</ZIPCd>
        </USAddress>
        <RecipientEIN>341018992</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>111662</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>SCHEPENS EYE RESEARCH INSTITUTE</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>20 STANIFORD ST</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02114</ZIPCd>
        </USAddress>
        <RecipientEIN>042129889</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>203326</CashGrantAmt>
        <PurposeOfGrantTxt>INSTITUTIONAL SUPPORT</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>BIONIC EYE TECHNOLOGIES INC</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>4 WILLOW LAKE DRIVE</AddressLine1Txt>
          <CityNm>FISHKILL</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>12524</ZIPCd>
        </USAddress>
        <RecipientEIN>465766628</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>521788</CashGrantAmt>
        <PurposeOfGrantTxt>RESERACH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>CHICAGO ASSOC FOR RESEARCH &amp; EDUCATION IN SCIENCE</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>5000 SOUTH 5TH AVENUE</AddressLine1Txt>
          <CityNm>HINES</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60141</ZIPCd>
        </USAddress>
        <RecipientEIN>363334177</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>159157</CashGrantAmt>
        <PurposeOfGrantTxt>RESERACH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>EMORY UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1599 CLIFTON ROAD</AddressLine1Txt>
          <CityNm>ATLANTA</CityNm>
          <StateAbbreviationCd>GA</StateAbbreviationCd>
          <ZIPCd>303224250</ZIPCd>
        </USAddress>
        <RecipientEIN>580566256</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>27745</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>HARVARD MEDICAL SCHOOL</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>25 SHATTUCK STREET</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02115</ZIPCd>
        </USAddress>
        <RecipientEIN>042103580</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>33767</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>PRESIDENT &amp; FELLOWS OF HARVARD</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>MASSACHUSETTS HALL</AddressLine1Txt>
          <CityNm>CAMBRIDGE</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02138</ZIPCd>
        </USAddress>
        <RecipientEIN>042103580</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>805183</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>MAYO MEDICAL LABRATORIES</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>200 FIRST STREET SW</AddressLine1Txt>
          <CityNm>ROCHESTER</CityNm>
          <StateAbbreviationCd>MN</StateAbbreviationCd>
          <ZIPCd>55905</ZIPCd>
        </USAddress>
        <RecipientEIN>416011702</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>82925</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>NATIONWIDE CHILDREN'S HOSPITAL</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>700 CHILDRENS DRV</AddressLine1Txt>
          <CityNm>COLUMBUS</CityNm>
          <StateAbbreviationCd>OH</StateAbbreviationCd>
          <ZIPCd>432052664</ZIPCd>
        </USAddress>
        <RecipientEIN>316056230</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>61429</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>SALUS UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>8360 OLD YORK RD</AddressLine1Txt>
          <CityNm>ELKINS PARK</CityNm>
          <StateAbbreviationCd>PA</StateAbbreviationCd>
          <ZIPCd>190271598</ZIPCd>
        </USAddress>
        <RecipientEIN>231413680</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>68422</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>PORTLAND VA RESEARCH FOUNDATION INC</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>HOSPITAL ROAD</AddressLine1Txt>
          <CityNm>PORTLAND</CityNm>
          <StateAbbreviationCd>OR</StateAbbreviationCd>
          <ZIPCd>972392964</ZIPCd>
        </USAddress>
        <RecipientEIN>943090170</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>88209</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF MAINE</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>5717 CORBETT HALL</AddressLine1Txt>
          <CityNm>ORONO</CityNm>
          <StateAbbreviationCd>ME</StateAbbreviationCd>
          <ZIPCd>044695717</ZIPCd>
        </USAddress>
        <RecipientEIN>016000769</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>40303</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF PITTSBURGH</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>203 LOTHROP ST</AddressLine1Txt>
          <CityNm>PITTSBURGH</CityNm>
          <StateAbbreviationCd>PA</StateAbbreviationCd>
          <ZIPCd>152132588</ZIPCd>
        </USAddress>
        <RecipientEIN>250965591</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>10427</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF WISCONSIN</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>21 NPARK ST</AddressLine1Txt>
          <CityNm>MADISON</CityNm>
          <StateAbbreviationCd>WI</StateAbbreviationCd>
          <ZIPCd>537151218</ZIPCd>
        </USAddress>
        <RecipientEIN>396006492</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>69752</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>WILLS EYE HOSPITAL</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>840 WALNUT ST</AddressLine1Txt>
          <CityNm>PHILADELPHIA</CityNm>
          <StateAbbreviationCd>PA</StateAbbreviationCd>
          <ZIPCd>191075109</ZIPCd>
        </USAddress>
        <RecipientEIN>236000204</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>13868</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>DUKE UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>2200 W MAIN ST</AddressLine1Txt>
          <CityNm>DURHAM</CityNm>
          <StateAbbreviationCd>NC</StateAbbreviationCd>
          <ZIPCd>277054677</ZIPCd>
        </USAddress>
        <RecipientEIN>560532129</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>13884</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF MICHIGAN</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>3003 S STATE ST</AddressLine1Txt>
          <CityNm>ANN ARBOR</CityNm>
          <StateAbbreviationCd>MI</StateAbbreviationCd>
          <ZIPCd>481091287</ZIPCd>
        </USAddress>
        <RecipientEIN>386006309</RecipientEIN>
        <IRCSectionDesc>501(c)(3)</IRCSectionDesc>
        <CashGrantAmt>23096</CashGrantAmt>
      </RecipientTable>
      <Total501c3OrgCnt>27</Total501c3OrgCnt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE I, PART I, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>SUBRECIPIENT MONITORING POLICY AND PROCEDURES SUBAWARDS ARE ISSUED THROUGH A CONSORTIUM AGREEMENT BETWEEN THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") AND THE RECIPIENT INSTITUTION. THE AGREEMENT SPECIFIES THE TERMS OF THE SUBAWARD AND INCLUDES A DETAILED BUDGET AND SCOPE OF WORK TO BE PERFORMED BY THE RECIPIENT INSTITUTION. AWARDED FUNDS ARE ENCUMBERED BY A PURCHASE ORDER THAT IS ASSIGNED TO A UNIQUE FUND NUMBER. PAYMENTS TO RECIPIENT INSTITUTIONS MADE AGAINST THE PURCHASE ORDER ARE RECORDED IN THE MEEI ACCOUNTING SYSTEM SO THAT INDIVIDUAL PAYMENTS AND PURCHASE ORDERS BALANCES CAN BE MONITORED. DISBURSEMENT OF FUNDS FOR SUBAWARDS REQUIRES THE WRITTEN APPROVAL OF THE PRINCIPAL INVESTIGATOR ("PI"). FREQUENT PROGRESS REPORTS AND OTHER FORMS OF COMMUNICATION ARE REQUIRED BETWEEN THE PI AND THE SUBAWARD RECIPIENT INSTITUTE TO ENSURE THAT THE SCOPE OF WORK IS PROGRESSING AT A SATISFACTORY PACE. RESEARCH ADMINISTRATION ALSO CONDUCTS AN ANNUAL INVENTORY OF INSTITUTIONS TO WHICH RESERACH HAS BEEN SUBAWARDED. A RISK ASSESSMENT MATRIX IS EMPLOYED, ALONG WITH A REVIEW OF THE SUB-RECIPIENTS' MOST RECENT A133 AUDIT REPORT, TO DETERMINE THE LEVEL OF RISK REGARDING THE SUB-RECIPIENTS' ABILITY TO COMPLY WITH FEDERAL GUIDELINES.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="IRS990ScheduleJ">
      <CompensationCommitteeInd>X</CompensationCommitteeInd>
      <IndependentConsultantInd>X</IndependentConsultantInd>
      <CompensationSurveyInd>X</CompensationSurveyInd>
      <BoardOrCommitteeApprovalInd>X</BoardOrCommitteeApprovalInd>
      <SeverancePaymentInd>false</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>true</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>false</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>false</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>false</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>false</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>false</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>true</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>false</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>JOHN R FERNANDEZ</PersonNm>
        <TitleTxt>PRESIDENT</TitleTxt>
        <BaseCompensationFilingOrgAmt>734263</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>200000</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>139392</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>229746</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>21440</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>1324841</TotalCompensationFilingOrgAmt>
        <CompReportPrior990FilingOrgAmt>120000</CompReportPrior990FilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>JOAN W MILLER MD</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <CompensationBasedOnRltdOrgsAmt>718928</CompensationBasedOnRltdOrgsAmt>
        <BonusRelatedOrganizationsAmt>142920</BonusRelatedOrganizationsAmt>
        <OtherCompensationRltdOrgsAmt>20322</OtherCompensationRltdOrgsAmt>
        <DeferredCompRltdOrgsAmt>36475</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsRltdOrgsAmt>21981</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationRltdOrgsAmt>940626</TotalCompensationRltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>MAUREEN KELLEY</PersonNm>
        <TitleTxt>ASST SECRETARY</TitleTxt>
        <BaseCompensationFilingOrgAmt>189446</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>4000</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>404</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>5890</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>20680</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>220420</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>CAROLANN WILLIAMS</PersonNm>
        <TitleTxt>CFO &amp; VP FINANCE AND ADMIN</TitleTxt>
        <BaseCompensationFilingOrgAmt>406712</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>74599</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>810</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>12810</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>21374</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>516305</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>BARBARA J SCULLY</PersonNm>
        <TitleTxt>DIRECTOR PROF REV CYCLE</TitleTxt>
        <BaseCompensationFilingOrgAmt>177329</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>6800</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>359</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>15415</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>20576</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>220479</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>EILEEN O LOWELL</PersonNm>
        <TitleTxt>CNO &amp; VP PAT CARE SVS</TitleTxt>
        <BaseCompensationFilingOrgAmt>261995</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>42593</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>1849</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>16427</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>20623</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>343487</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>ALAN K LONG</PersonNm>
        <TitleTxt>VP RESEARCH ADMINISTRATION</TitleTxt>
        <BaseCompensationFilingOrgAmt>196989</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>19484</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>21183</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>9327</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>18192</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>265175</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>KENNETH HOLMES</PersonNm>
        <TitleTxt>CFO MEEA</TitleTxt>
        <BaseCompensationFilingOrgAmt>228938</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>38234</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>21061</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>17625</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>21063</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>326921</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>JEFFREY J PIKE</PersonNm>
        <TitleTxt>CHIEF OPERATING OFFICER</TitleTxt>
        <BaseCompensationFilingOrgAmt>321328</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>45684</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>525</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>12187</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>8474</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>388198</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>JENNIFER STREET</PersonNm>
        <TitleTxt>VP COMMUNICATIONS &amp; PLANNING</TitleTxt>
        <BaseCompensationFilingOrgAmt>321274</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>59852</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>1237</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>12681</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>21362</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>416406</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>MELISSA M PAUL</PersonNm>
        <TitleTxt>CHIEF DEVELOPMENT OFFICER</TitleTxt>
        <BaseCompensationFilingOrgAmt>213423</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>38990</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>18562</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>20055</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>20953</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>311983</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>GLENN W BUNTING</PersonNm>
        <TitleTxt>VOICE &amp; SPEECH CLINICAL DIR</TitleTxt>
        <BaseCompensationFilingOrgAmt>179768</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>1200</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>4595</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>20348</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>20643</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>226554</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>GREGORY J DONNELLY</PersonNm>
        <TitleTxt>EXEC. DIRECTOR, CLINICAL SRVCS</TitleTxt>
        <BaseCompensationFilingOrgAmt>194622</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>7500</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>4122</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>2921</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>20597</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>229762</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>RALPH T PELOSI</PersonNm>
        <TitleTxt>DIRECTOR FACILITIES PLANNING</TitleTxt>
        <BaseCompensationFilingOrgAmt>176832</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>7500</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>1011</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>9203</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>17023</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>211569</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>MARTHA PYLE FARRELL</PersonNm>
        <TitleTxt>ASST SECRETARY</TitleTxt>
        <BaseCompensationFilingOrgAmt>282191</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>61720</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>19131</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>11637</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>20628</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>395307</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>D BRADLEY WELLING</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <CompensationBasedOnRltdOrgsAmt>885677</CompensationBasedOnRltdOrgsAmt>
        <BonusRelatedOrganizationsAmt>122920</BonusRelatedOrganizationsAmt>
        <OtherCompensationRltdOrgsAmt>19548</OtherCompensationRltdOrgsAmt>
        <DeferredCompRltdOrgsAmt>36475</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsRltdOrgsAmt>21981</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationRltdOrgsAmt>1086601</TotalCompensationRltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>DEBRA ROGERS</PersonNm>
        <TitleTxt>VP OPHTHALMOLOGY</TitleTxt>
        <BaseCompensationFilingOrgAmt>229411</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>48050</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>19720</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>10404</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>20591</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>328176</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>RACHEL WASSERSTROM</PersonNm>
        <TitleTxt>VP OTOLARYNGOLOGY</TitleTxt>
        <BaseCompensationFilingOrgAmt>242220</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>38050</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>400</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>10080</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>20587</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>311337</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>MICHAEL RICCI</PersonNm>
        <TitleTxt>CHIEF INFORMATION OFFICER</TitleTxt>
        <BaseCompensationFilingOrgAmt>234414</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>10000</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>4975</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>10666</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>20841</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>280896</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>BARBARA H GRAY</PersonNm>
        <TitleTxt>CLINICAL RESOURCE NURSE</TitleTxt>
        <BaseCompensationFilingOrgAmt>183000</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>500</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>379</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>10954</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>20017</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>214850</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE J, PART I, LINE 4B:</FormAndLineReferenceDesc>
        <ExplanationTxt>JOHN FERNANDEZ PARTICIPATES IN A DEFERRED COMPENSATION ARRANGEMENT WITH MASSACHUSETTS EYE AND EAR. UNDER THIS AGREEMENT, MR. FERNANDEZ WILL BE CREDITED $200,000 FOR CALENDAR YEAR 2015. EACH ANNUAL CREDIT WILL VEST ON THE FOURTH ANNIVERSARY OF THE DATE SUCH CREDIT WAS MADE OR UPON (1) THE ATTAINMENT OF THE AGE OF 65 WHILE EMPLOYED; (2) TERMINATION WITHOUT CAUSE OR RESIGNATION FOR GOOD REASON; (3) DEATH; (4) DISABILITY; OR (5) CHANGE OF CONTROL OF MASSACHUSETTS EYE AND EAR WITHIN THE MEANING OF SECTION 409A OF THE INTERNAL REVENUE CODE. MR. FERNANDEZ RECEIVED A PAYOUT OF $138,150 FROM THE DEFERRED COMPENSATION AGREEMENT IN 2015.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE J, PART I, LINE 7:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE BOARD OF TRUSTEES OF THE MASSACHUSETTS EYE AND EAR INFIRMARY, UPON RECOMMENDATIONS OF THE COMPENSATION COMMITTEE, APPROVE A BONUS PROGRAM FOR CERTAIN INDIVIDUALS LISTED ON THE SCHEDULE J. THE PROGRAM REQUIRES THAT SUPERVISORY PERSONNEL MAKE THE DETERMINATION OF (1) ELIGIBILITY AND (2) AMOUNT OF BONUS DOLLARS BASED ON OVERALL JOB PERFORMANCE. THE CEO OF THE INFIRMARY HAS THE AUTHORITY TO (1) OVERRULE RECOMMENDATIONS MADE BY SUPERVISORS AND (2) MAKE BONUS DETERMINATIONS FOR VICE PRESIDENT LEVEL PERSONNEL. THE COMPENSATION COMMITTEE OF THE BOARD HAS THE FINAL AUTHORITY FOR BONUSES PAID TO THE CEO AS WELL AS THE VICE PRESIDENTS AND CHIEFS. THE COMPENSATION COMMITTEE MEETING WAS HELD ON NOVEMBER 18, 2015. TOTAL COMPENSATION FOR LISTED INDIVIDUALS, INCLUDING BONUS PAYMENTS, WAS ANALYZED BY INDEPENDENT COMPENSATION CONSULTANTS, DETERMINED TO BE REASONABLE COMPENSATION, AND APPROVED BY THE BOARD. NO COMPENSATION PAYMENT CAN BE MADE IN EXCESS OF THESE AMOUNTS.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleJ>
    <IRS990ScheduleK documentId="IRS990ScheduleK">
      <TaxExemptBondsIssuesGrp>
        <BondReferenceCd>A</BondReferenceCd>
        <IssuerName>
          <BusinessNameLine1Txt>MASSACHUSETTS HEALTH AND EDUCATIONAL FACILITIES</BusinessNameLine1Txt>
        </IssuerName>
        <BondIssuerEIN>042456011</BondIssuerEIN>
        <CUSIPNum>57586EWL1</CUSIPNum>
        <BondIssuedDt>2010-09-29</BondIssuedDt>
        <IssuePriceAmt>63156092</IssuePriceAmt>
        <PurposeDesc>FACILITY IMPROVEMENTS</PurposeDesc>
        <DefeasedInd>false</DefeasedInd>
        <OnBehalfOfIssuerInd>false</OnBehalfOfIssuerInd>
        <PoolFinancingInd>false</PoolFinancingInd>
      </TaxExemptBondsIssuesGrp>
      <TaxExemptBondsIssuesGrp>
        <BondReferenceCd>B</BondReferenceCd>
        <IssuerName>
          <BusinessNameLine1Txt>MASSACHUSETTS HEALTH AND EDUCATIONAL FACILITIES</BusinessNameLine1Txt>
        </IssuerName>
        <BondIssuerEIN>043431814</BondIssuerEIN>
        <CUSIPNum>000000000</CUSIPNum>
        <BondIssuedDt>2015-12-30</BondIssuedDt>
        <IssuePriceAmt>70394000</IssuePriceAmt>
        <PurposeDesc>REFNDNG(2010)&amp;FACILITY IMPROVEMNTS</PurposeDesc>
        <DefeasedInd>false</DefeasedInd>
        <OnBehalfOfIssuerInd>false</OnBehalfOfIssuerInd>
        <PoolFinancingInd>false</PoolFinancingInd>
      </TaxExemptBondsIssuesGrp>
      <TaxExemptBondsProceedsGrp>
        <BondReferenceCd>A</BondReferenceCd>
        <RetiredAmt>5105000</RetiredAmt>
        <BondDefeasedAmt>0</BondDefeasedAmt>
        <TotalProceedsAmt>63156092</TotalProceedsAmt>
        <InReserveFundAmt>5028889</InReserveFundAmt>
        <CapitalizedInterestAmt>5191181</CapitalizedInterestAmt>
        <RefundingEscrowAmt>0</RefundingEscrowAmt>
        <IssuanceCostsFromProceedsAmt>1243623</IssuanceCostsFromProceedsAmt>
        <CreditEnhancementAmt>0</CreditEnhancementAmt>
        <WorkingCapitalExpendituresAmt>0</WorkingCapitalExpendituresAmt>
        <CapitalExpendituresAmt>51707858</CapitalExpendituresAmt>
        <OtherSpentProceedsAmt>0</OtherSpentProceedsAmt>
        <UnspentAmt>0</UnspentAmt>
        <SubstantialCompletionYr>2015</SubstantialCompletionYr>
        <CurrentRefundingInd>false</CurrentRefundingInd>
        <AdvanceRefundingInd>false</AdvanceRefundingInd>
        <FinalAllocationMadeInd>true</FinalAllocationMadeInd>
        <AdequateBooksAndRecMaintInd>true</AdequateBooksAndRecMaintInd>
      </TaxExemptBondsProceedsGrp>
      <TaxExemptBondsProceedsGrp>
        <BondReferenceCd>B</BondReferenceCd>
        <RetiredAmt>306071</RetiredAmt>
        <BondDefeasedAmt>0</BondDefeasedAmt>
        <TotalProceedsAmt>70394000</TotalProceedsAmt>
        <InReserveFundAmt>0</InReserveFundAmt>
        <CapitalizedInterestAmt>0</CapitalizedInterestAmt>
        <RefundingEscrowAmt>0</RefundingEscrowAmt>
        <IssuanceCostsFromProceedsAmt>441892</IssuanceCostsFromProceedsAmt>
        <CreditEnhancementAmt>0</CreditEnhancementAmt>
        <WorkingCapitalExpendituresAmt>0</WorkingCapitalExpendituresAmt>
        <CapitalExpendituresAmt>20844395</CapitalExpendituresAmt>
        <OtherSpentProceedsAmt>15079333</OtherSpentProceedsAmt>
        <UnspentAmt>34028380</UnspentAmt>
        <CurrentRefundingInd>true</CurrentRefundingInd>
        <AdvanceRefundingInd>false</AdvanceRefundingInd>
        <FinalAllocationMadeInd>false</FinalAllocationMadeInd>
        <AdequateBooksAndRecMaintInd>true</AdequateBooksAndRecMaintInd>
      </TaxExemptBondsProceedsGrp>
      <TaxExemptBondsPrivateBusUseGrp>
        <BondReferenceCd>A</BondReferenceCd>
        <OwningBondFinancedPropertyInd>false</OwningBondFinancedPropertyInd>
        <AnyLeaseArrangementsInd>false</AnyLeaseArrangementsInd>
        <MgmtContractBondFincdPropInd>false</MgmtContractBondFincdPropInd>
        <AnyResearchAgreementsInd>false</AnyResearchAgreementsInd>
        <PrivateBusUseByOthersPct>0</PrivateBusUseByOthersPct>
        <BondIssMeetPrvtSecPymtTestInd>false</BondIssMeetPrvtSecPymtTestInd>
        <ProcsNonqualifiedBondRemdtdInd>true</ProcsNonqualifiedBondRemdtdInd>
      </TaxExemptBondsPrivateBusUseGrp>
      <TaxExemptBondsPrivateBusUseGrp>
        <BondReferenceCd>B</BondReferenceCd>
        <OwningBondFinancedPropertyInd>false</OwningBondFinancedPropertyInd>
        <AnyLeaseArrangementsInd>false</AnyLeaseArrangementsInd>
        <MgmtContractBondFincdPropInd>false</MgmtContractBondFincdPropInd>
        <AnyResearchAgreementsInd>false</AnyResearchAgreementsInd>
        <PrivateBusUseByOthersPct>0</PrivateBusUseByOthersPct>
        <BondIssMeetPrvtSecPymtTestInd>false</BondIssMeetPrvtSecPymtTestInd>
        <ProcsNonqualifiedBondRemdtdInd>true</ProcsNonqualifiedBondRemdtdInd>
      </TaxExemptBondsPrivateBusUseGrp>
      <TaxExemptBondsArbitrageGrp>
        <BondReferenceCd>A</BondReferenceCd>
        <Form8038TFiledInd>false</Form8038TFiledInd>
        <NoRebateDueInd>true</NoRebateDueInd>
        <VariableRateIssueInd>false</VariableRateIssueInd>
        <HedgeIdentifiedInBksAndRecInd>false</HedgeIdentifiedInBksAndRecInd>
        <HedgeProviderName>
          <BusinessNameLine1Txt>0</BusinessNameLine1Txt>
        </HedgeProviderName>
        <GrossProceedsInvestedInGICInd>false</GrossProceedsInvestedInGICInd>
        <GICProviderName>
          <BusinessNameLine1Txt>0</BusinessNameLine1Txt>
        </GICProviderName>
        <GrossProceedsInvestedInd>false</GrossProceedsInvestedInd>
        <WrittenProcToMonitorReqsInd>false</WrittenProcToMonitorReqsInd>
      </TaxExemptBondsArbitrageGrp>
      <TaxExemptBondsArbitrageGrp>
        <BondReferenceCd>B</BondReferenceCd>
        <Form8038TFiledInd>false</Form8038TFiledInd>
        <RebateNotDueYetInd>true</RebateNotDueYetInd>
        <VariableRateIssueInd>true</VariableRateIssueInd>
        <HedgeIdentifiedInBksAndRecInd>true</HedgeIdentifiedInBksAndRecInd>
        <HedgeProviderName>
          <BusinessNameLine1Txt>CITIZENS BANK</BusinessNameLine1Txt>
        </HedgeProviderName>
        <TermOfHedgePct>10.</TermOfHedgePct>
        <SuperintegratedHedgeInd>false</SuperintegratedHedgeInd>
        <HedgeTerminatedInd>false</HedgeTerminatedInd>
        <GrossProceedsInvestedInGICInd>false</GrossProceedsInvestedInGICInd>
        <GICProviderName>
          <BusinessNameLine1Txt>0</BusinessNameLine1Txt>
        </GICProviderName>
        <GrossProceedsInvestedInd>false</GrossProceedsInvestedInd>
        <WrittenProcToMonitorReqsInd>false</WrittenProcToMonitorReqsInd>
      </TaxExemptBondsArbitrageGrp>
      <ProceduresCorrectiveActionGrp>
        <BondReferenceCd>A</BondReferenceCd>
        <ProceduresCorrectiveActionInd>true</ProceduresCorrectiveActionInd>
      </ProceduresCorrectiveActionGrp>
      <ProceduresCorrectiveActionGrp>
        <BondReferenceCd>B</BondReferenceCd>
        <ProceduresCorrectiveActionInd>true</ProceduresCorrectiveActionInd>
      </ProceduresCorrectiveActionGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, BOND (A), COLUMN (F):</FormAndLineReferenceDesc>
        <ExplanationTxt>THE PROJECT CONSISTS OF RENOVATION AND IMPROVEMENT OF EXISTING SPACE AND ACQUISITION OF MISCELLANEOUS EQUIPMENT LOCATED IN MEEI'S MAIN CLINICAL BUILDING, INCLUDING BUT NOT LIMITED TO THE FOLLOWING: THE AMBULATORY AND INPATIENT OPERATING ROOMS, THE SINUS CLINIC, THE NEURO-OPTHALMOLOGY CLINIC, THE OTOLARYNGOLOGY LASER CENTER, THE ENT CLINIC FOCUSING ON HEAD AND NECK CONDITIONS, THE PRE-ADMISSION TESTING SUITE, THE OPHTHALMOLOGY OUTPATIENT CLINICS LOCATED ON THE FIRST FLOOR, THE GROUND FLOOR (INCLUDING THE LOBBY AREA, EMERGENCY DEPARTMENT AND RADIOLOGY DEPARTMENT), THE PEDIATRIC OPHTHALMOLOGY CLINIC, THE HEAD AND NECK CLINIC, THE LASER CENTER, THE PEDIATRIC INPATIENT UNIT, THE OPHTHALMOLOGY PLASTICS OUTPATIENT CLINIC, THE OTOLARYNGOLOGY FACULTY OFFICE SUITE AND THE DESIGN AND ARCHITECTURAL FEES RELATING TO THE RECONSTRUCTING OF THE GROUND, FIRST, SECOND AND THIRD FLOORS FOR ADDITIONAL CLINICAL SPACE. IMPROVEMENTS TO EXISTING BUILDING INFRASTRUCTURE. PLANNING AND DESIGN COSTS RELATED TO A REPLACEMENT RESEARCH OR CLINICAL BUILDING TO BE LOCATED AT 309-325 CAMBRIDGE STREET. COSTS OF ISSUANCE AND CAPITALIZED INTEREST ON THE BONDS FINANCING THE PROJECTS DESCRIBED IN THIS SECTION FOR A PERIOD OF UP TO THREE YEARS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART IV, BOND (A), LINE 2C:</FormAndLineReferenceDesc>
        <ExplanationTxt>A REBATE CALCULATION WAS PERFORMED FOR THE BONDS ON OCTOBER 13, 2015 FOR THE REBATE PERIOD ENDED SEPTEMBER 30, 2015. NO ARBITRAGE REBATE WAS DUE.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleK>
    <IRS990ScheduleL documentId="IRS990ScheduleL">
      <TotalBalanceDueAmt>0</TotalBalanceDueAmt>
      <BusTrInvolveInterestedPrsnGrp>
        <NameOfInterested>
          <PersonNm>JOAN MILLER MD</PersonNm>
        </NameOfInterested>
        <RelationshipDescriptionTxt>DRCTR IS LICENSOR TO ORG</RelationshipDescriptionTxt>
        <TransactionAmt>162969</TransactionAmt>
        <TransactionDesc>PATENT LICENSE PROCEEDS</TransactionDesc>
        <SharingOfRevenuesInd>false</SharingOfRevenuesInd>
      </BusTrInvolveInterestedPrsnGrp>
      <BusTrInvolveInterestedPrsnGrp>
        <NameOfInterested>
          <PersonNm>SALLY A REILEY</PersonNm>
        </NameOfInterested>
        <RelationshipDescriptionTxt>DAUGHTER OF DIRECTOR</RelationshipDescriptionTxt>
        <TransactionAmt>73935</TransactionAmt>
        <TransactionDesc>EMPLOYMENT AGREEMENT</TransactionDesc>
        <SharingOfRevenuesInd>false</SharingOfRevenuesInd>
      </BusTrInvolveInterestedPrsnGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE L, PART V, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS</FormAndLineReferenceDesc>
        <ExplanationTxt>(A) NAME OF PERSON: JOAN MILLER, MD (D) DESCRIPTION OF TRANSACTION: INVENTOR PROCEEDS FOR PATENT RIGHTS ARE MADE IN ACCORDANCE WITH WRITTEN MEEI POLICY IN RESPECT OF INTELLECTUAL PROPERTY.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleL>
    <IRS990ScheduleO documentId="IRS990ScheduleO">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 PART I, LINE 1 &amp; PART III, LINE 1</FormAndLineReferenceDesc>
        <ExplanationTxt>THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") IS A NOT-FOR-PROFIT TEACHING HOSPITAL CONDUCTING PATIENT CARE AND RESEARCH. THE INFIRMARY IS A TEACHING HOSPITAL OF HARVARD MEDICAL SCHOOL AND AN INTERNATIONAL CENTER FOR RESEARCH. IT HAS THE MOST COMPETITIVE PROGRAM IN THE COUNTRY FOR EYE, EAR, NOSE, AND THROAT RESIDENCY TRAINING AND THE WORLD'S LARGEST OPHTHALMIC FELLOWSHIP PROGRAM. IT IS PART OF A SYSTEM OF RELATED ENTITIES THAT PROVIDE SPECIALIZED MEDICAL CARE COLLECTIVELY KNOWN AS "MASSACHUSETTS EYE AND EAR INFIRMARY" ("MEEI"). FORM 990, PART III, LINE 4A: Massachusetts Eye and Ear is a specialty hospital dedicated to excellence in the care of disorders that affect the eye, ear, nose, throat and adjacent regions of the head and neck. 2016 was an exceptional year: U.S. News &amp; World Report ranked the Mass. Eye and Ear Department of Otolaryngology #1 in the nation for the second consecutive year and the Department of Opthalmology #4 in the nation; growth throughout eighteen clinical locations; advancements in research; academic excellence; commitment to community; and the implementation of two major technology transitions, PeopleSoft, which is the system Mass. Eye and Ear uses for all enterprise resource planning (payroll, general ledger, HR) and Epic, our new, unified patient care system. They are both considered the premier products in their field and have an impact on virtually every person in the Mass. Eye and Ear community.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>RESEARCH</FormAndLineReferenceDesc>
        <ExplanationTxt>Ophthalmology Significant Awards/Honors Ula Jurkunas, MD: American Academy of Ophthalmology Achievement Award Richard Masland, PhD: Distinguished Research Achievement Awardee, Harvard Ophthalmology Eric Pierce, MD, PhD: 2016 Alcon Research Institute Award David Sullivan, PhD: ARVO Gold Fellow Demetrios Vavvas, MD, PhD: Pfizer Ophthalmics Carl Camras Translational Research Award Janey Wiggs, MD, PhD: Inducted into Academia Ophthalmologica Internationalis AMD Center of Excellence Patients with high-risk macular degeneration show improvement with high-dose statin treatment Joan W. Miller, MD, and Demetrios Vavvas, MD, PhD, led colleagues from Mass. Eye and Ear/Harvard Medical School and a University in a Phase I/II clinical trial that found that high dose statin treatment carries the potential for clearing lipid debris that is associated with vision impairment in patients with high-risk macular degeneration. Their findings not only furthered the connection among lipids, age-related macular degeneration (AMD) and atherosclerosis, but also present a potential therapy for some patients with dry AMD, for which treatments are currently lacking. As a next step, investigators are planning a larger, prospective multicenter trial to further investigate the efficacy of the treatment in a larger sample of patients with dry AMD. Researchers shed light on the anti-adhesive molecule in vascular endothelium suggesting new direction for anti-inflammatory therapy Mass. Eye and Ear researchers led by Patricia DAmore, PhD, MBA and Pablo Argeso, PhD have gained new insight into how a non-inflammatory state is maintained in the body. Their findings suggest that promoting the expression of endomucin may prevent the recruitment of white blood cells that is the hallmark of inflammation. The research shows that in healthy, non-inflamed tissue, endomucin plays a critical role in preventing neutrophils from sticking to the endothelium. During inflammatory conditions, however, the endomucin on the endothelial cell surface is dramatically reduced and the levels of pro-adhesives molecules on the endothelium increase, resulting in neutrophil accumulation. The researchers showed both adherence and infiltration of inflammatory cells could be blocked by experimentally expressing excess endomucin in the vascular endothelium. This new knowledge may be used to develop treatments for inflammation by promoting the expression of endomucin to prevent the movement of inflammatory cells from the capillaries into inflamed tissues. Cornea Center of Excellence Translational Research on Lubricin Demonstrates Significant Improvement of Multiple Signs and Symptoms of Dry Eye Disease David A. Sullivan, PhD, in collaboration with colleagues from several institutions worldwide, evaluated the use of recombinant human lubricin as a treatment for patients with dry eye disease. A clinical trial based on this research, the results of which were published ahead of print in September by The Ocular Surface, showed significant improvement in signs and symptoms of dry eye disease compared to sodium hyaluronate without adverse events during the investigation. Researchers find stem cells in normal and Fuchs corneal endothelium Ula Jurkunas, MD, was the principal investigator of a study that has, for the first time, identified stem cells not only in normal corneal endothelium but also in corneal endothelium of patients with Fuchs' endothelial corneal dystrophy (FECD). Corneal transplantation is the only currently accepted therapy for FECD. This finding holds promise for new therapies to be developed that possibly promote the division of patients' own stem cells and allow the cornea to clear without a need for corneal transplantation in FECD patients. Restoration of Corneal Transparency by Mesenchymal Stem Cells A study led by Sunil Chauhan, PhD, has identified hepatocyte growth factor (HGF), secreted by mesenchymal stem cells, as the key factor responsible for restoring corneal transparency and promoting wound healing in preclinical models of corneal injury. The findings suggest that HGF-based treatments may be effective in restoring vision in patients with severely scarred corneas. Researchers identify factors responsible for chronic nature of autoimmune disease Reza Dana, MD, MSc, MPH, and colleagues uncovered two factors responsible for the chronic, lifelong nature of autoimmune disorders, which tend to flare up intermittently in affected patients. These two factors are cell-signaling proteins called cytokines - specifically Interleukin-7 and -15 (IL-7 and IL-15)-that are secreted by cells of the immune system and help modulate memory Th17 cells, a subset of T cells which are known to contribute to autoimmune disorders. Until now, it was unclear how Th17 cells maintained memory; the study results show that IL-7 and IL-15 signal the Th17 cells to chronically reside in the body. These findings may lead to the development of new therapies to address a variety of chronic autoimmune disorders. Diabetic Eye Disease Center of Excellence Growth factor shown to protect the retina in early stage diabetes Mara Lorenzi, MD, and colleagues have shown that a slight increase in transforming growth factor beta (TGF-), which is present in preclinical animal models with diabetic eye disease, protects retinal blood vessels from damage that commonly occurs in the early stages of the disease (known as diabetic retinopathy). Their findings may lead to targeted therapeutics that delay or prevent the development of the disease in patients. Glaucoma Center of Excellence Three new genes identified that contribute to primary open-angle glaucoma In the largest genome-wide study of its kind, Janey Wiggs, MD, PhD and collaborators from HMS Ophthalmology and Case Western Reserve University School of Medicine, identified three genes that contribute to the primary open-angle glaucoma (POAG), which is the most common type of glaucoma. Researchers conducted a meta-analysis of genome-wide association study (GWAS) results from 3,853 people with POAG and compared them to a control group of 33,480 people of European descent using human genomes collected through the NEIGHBORHOOD consortium, a National Eye Institute collaborative. After replicating the analysis using data from an Australian study, and comparing the analysis to three more data sets (Australia, Europe, China), three susceptibility loci were identified: TXNRD2, ATXN2, and FOXC1. The findings provide key insight that ultimately may be used to develop gene-based testing and treatment strategies for glaucoma. Infectious Disease Institute Mass. Eye and Ear Team Discovers and Successfully Treats New Variant of Antibiotic-resistant Bacterium Michael Gilmore, PhD, and colleagues discovered and successfully treated a new mutation in a highly antibiotic-resistant strain of E. coli that resists clearance by the bodys own immune system by inhibiting white blood cells that ordinarily kill and remove bacteria. They found that, in addition to its elevated resistance to antibiotics, this bacterium produced a layer of slime on its surface that prevented white blood cells from trapping and killing the microbe, something researchers have not seen before in this type of E. coli. Mobility Enhancement and Vision Rehabilitation Center of Excellence Research aims to reduce pedestrian collisions in crowded and chaotic open space environments Vision scientists may have discovered how to reduce pedestrian collisions in crowded and chaotic open space environments like bus terminals, shopping malls and city plazas involving individuals with partial blindness. Eli Peli, OD, and colleagues have determined from which direction collisions with partially blind pedestrians are most likely to originate by creating a mathematical model to determine risk, and comparing that risk to the limited vision of 42 patients with retinitis pigmentosa. This understanding will guide the development of new glasses that expand the sight of a person with limited peripheral vision. Ocular Genomics Institute Gene therapy restores hearing in deaf mice...down to a whisper</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>In the summer of 2015, a team at Boston Childrens Hospital and</FormAndLineReferenceDesc>
        <ExplanationTxt>Harvard Medical School reported restoring rudimentary hearing in genetically deaf mice using gene therapy. Now the Boston Childrens research team reports restoring a much higher level of hearing - down to 25 decibels, the equivalent of a whisper - using an improved gene therapy vector developed at Massachusetts Eye and Ear. While previous vectors have only been able to penetrate the cochleas inner hair cells, the first Nature Biotechnology study showed that a new synthetic vector, Anc80, safely transferred genes to the hard-to-reach outer hair cells when introduced into the cochlea. This studys three Harvard Medical School senior investigators were Jeffrey R. Holt, PhD, of Boston Childrens Hospital; Konstantina Stankovic, MD, PhD, of Mass. Eye and Ear and Luk H. Vandenberghe, PhD, who led Anc80s development in 2015 at Mass. Eye and Ears Grousbeck Gene Therapy Center. Other Research New Insights into Thyroid Eye Disease Treatments Nahyoung Grace Lee, MD, Leo Kim, MD, PhD, and colleagues identified new mechanisms of proptosis, or bulging of the eyes, in patients with acute thyroid eye disease, which opens a path to exploring non-surgical treatments for thyroid eye disease. Currently, oral or IV steroids and major surgery (to break the bones behind the eyes) are the only viable option to prevent severe and permanent vision loss in patients with thyroid eye disease, but these results suggest that it might be possible to treat the inflammation and swelling by stopping the blood vessels from forming and leaking fluid, or, alternatively, by finding a way to promote lymphatic vessel formation and enhance drainage of fluid. Otolaryngology FY16 New Faculty - Yoojin Chung, PhD (promoted from training status) - Nima Maftoon, PhD (promoted from training status) - Sunil Puria, PhD Faculty Accomplishments - Dr. David Jung won the 2016 American Neurotology Society AAO-HNSF Herbert Silverstein Otology and Neurotology Research Award. - Dr. Leila Mankarious became the Harvard Medical School Director of Hearing Registries at Mass. Eye and Ear. - Dr. Xiying Guan received the Emerging Research Grant from the Hearing Health Foundation for his research proposal on hyperacusis. - Dr. M. Charles Liberman was appointed Committee Chair to write the 2017 2021 Strategic Plan for the National Institute for Deafness and Other Communicative Disorders. - A story on "hidden hearing loss," featuring research from Drs. Stphane Maison and Charlie Liberman, appeared in the print edition of the Wall Street Journal, the highest circulation newspaper in the U.S., on September 27. Anesthesia Research successes Grants: Andres Macias, MD - "Identifying and Correcting Preventable Errors by Improving Communication Between Providers in The Post-Anesthesia Care Unit through Implementation of an Automated Electronic Checklist" ending October 2016 Poster presentations: Comins J, Hartnick C, Sahani N. What should we know about Hypoglossal Nerve Stimulator in adolescent patients with Obstructive sleep apnea? Poster presentation at Harvard Pediatric Clinical Update., Boston Childrens Hospital, Boston, May 2016 Publications: Macias AA, Eappen S, Malikin I, Goldfarb J, Kujawa S, Konowitz PM, Kamani D, Randolph GW. Successful intraoperative electrophysiologic monitoring of the recurrent laryngeal nerve, a multidisciplinary approach: The Massachusetts Eye and Ear Infirmary monitoring collaborative protocol with experience in over 3000 cases. Head Neck. 2016 Apr 9. Lectures: Joseph Bayes, MD- invited speaker on Perioperative Management of Adults with Obstructive Sleep Apnea, at the MEE/Harvard Course on Obstructive Sleep Apnea at MEE. September 2016. Radiology Highlights The radiologists wrote or participated in 40 papers including: - Fuller JC, Sinha S, Caruso PA, Hersch CJ, Butler WE, Krishnamoorty KS, Hartnick CJ. Chiari malformations: An important cause of pediatric aspiration. Int J Pediatr Otorhinolaryngol. 2016 Sep;88:124-8. - Eichler FS, Li J, Guo Y, Caruso PA, et al. CSF1R mosaicism in a family with hereditary diffuse leukoencephalopathy with spheroids. Brain. 2016 J eun;139(Pt 6):1666-72. - Cunnane MB, Curtin HD. Imaging of orbital disorders. Handb Clin Neurol. 2016;135:659-72. - Radhakrishnan R, Cornelius R, Cunnane MB, Golnik K, Morales H. MR imaging findings of endophthalmitis. Neuroradiol J. 2016 Apr;29(2):122-9. - Kandathil CK, Cunnane MB, McKenna MJ, Curtin HD, Stankovic KM. Correlation between aspirin intake and reduced growth of human vestibular schwannoma: Volumetric analysis. Otol Neurotol. 2016 Oct;37(9):1428-34. - Curtin HD. Imaging of conductive hearing loss with a normal tympanic membrane. Am J Roentgenol. 2016 Jan;206(1):49-56. - Juliano AF, Ting EY, Mingkwansook V, Hamberg LM, Curtin HD. Vestibular aqueduct measurements in the 45? oblique (Pschl) plane. Am J Neuroradiol. 2016 Jul;37(7):1331-7. - Ochoa-Escudero M, Juliano AF. Unilateral hypoplasia with contralateral hypertrophy of anterior belly of digastric muscle: A case report. Surg Radiol Anat. 2016 Oct;38(8):973-4. - Kelly HR, Curtin HD. Imaging of skull base lesions. Handb Clin Neurol. 2016;135:637-57 (PubMed in process). - Lam S, Gupta R, Kelly HR, Curtin HD, Forghani R. Multiparametric evaluation of head and neck squamous cell carcinoma using a single-source dual-energy CT with fast kVp switching: State of the art. Cancers (Basel). 2016 Nov 6;7(4):2201-16. - Leung KJ, Quesnel AM, Juliano AF, Curtin HD. Correlation of CT, MR and histopathology in incomplete partition-II cochlear anomaly. Otol Neurotol. 2016 Jun;37(5):434-7. - Qu J, Qin L, Cheng S, Leung K, et al: Residual low ADC and high FA at the resection margin correlate with poor chemoradiation response and overall survival in high-grade glioma patients. Eur J Radiol. 2016 Mar;85(3):657-64. - Garzorz N, Diercks GR, Lin HW, Faquin WC, Romo LV, Hartnick CJ. A case of pediatric parapharyngeal space ganglioneuroma. Ear Nose Throat J. 2016 Apr-May;95(4-5):E16-20. Other achievements Several faculty members were invited speakers and presented scientific papers at the following societies: - American Society of Head and Neck Radiology (ASHNR) - American Society of Neuroradiology (ASNR) - Eastern Neuroradiological Society (ESNR) - North American Skull Base Society (NASBS) - Radiological Society of North America (RSNA) Research successes -Dr. Amy Juliano has a new NIH grant as co-investigator: Extraorally Delivered Low Level Light Therapy for Prevention of Oropharyngeal Mucositis in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation: Sponsor name: National Institutes of Health; Principal Investigator: Nathaniel Treister, DMD, DMSc. This is a joint project with BWH, DFCI and the University of Massachusetts, Lowell. Accreditation -The department is currently accredited by the American College of Radiology (ACR) for CT and MRI and remains in good standing.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART III, LINE 4B</FormAndLineReferenceDesc>
        <ExplanationTxt>Education Harvard Medical School Training Programs A Harvard Medical School teaching hospital, Mass. Eye and Ear trains future medical leaders in ophthalmology and otolaryngology, through residency as well as clinical and research fellowships. Academic Programs Ophthalmology -24 Residents -32 Clinical Fellows -125 Research Fellows -1 Optometry Resident Otolaryngology -18 Residents -11 Clinical Fellows -55 Research Fellows -2 Research Residents - Joan W. Miller, MD elected to the National Academy of Medicine - Stacey T. Gray, MD chair elect for American Academy of Otolaryngology-Head and Neck Surgery Rhinology and Allergy Education Committee Endowed Chairs - Demetrios G. Vavvas, MD, PhD first incumbent of the Monte J. Wallace Ophthalmology Chair in Retina at Mass. Eye and Ear - Gregory Randolph, MD first incumbent of the Claire and John Bertucci Professorship in Otolaryngology at Harvard Medical School Leaders in community service - More than 500 vision and hearing screenings for children - Innovative internship programs for high school students and visually impaired adults - Free public seminars/health fairs to share research and clinical advances in specialties - Community organization sponsorships and volunteerism Opthalmology Significant Awards/Honors Joseph Arboleda-Velasquez, MD, PhD: Young Mentor Award, HMS Patricia D'Amore, PhD, MBA: William Silen Lifetime Achievement in Mentoring Award, HMS Reza Dana, MD, MSc, MPH: Elected to Academia Ophthalmologica Internationalis Reza Dana, MD, MSc, MPH: 2016 Endre A. Balazs Prize, International Society for Eye Research Reza Dana, MD, MSc, MPH: Kersley Medal, British Ocular Surface Society Claes Dohlman, MD, PhD, and Joan W. Miller, MD: Appointed honorary Heed Fellows Facility/Programmatic - Launch of the Altschuler Surgical Training Lab - New, one-year medical retina fellowship directed by Deeba Husain, MD (will be offered in July, 2017) Note: This fellowship is in addition to the existing Medical Retina Fellowship at MEE - New, one-year anterior segment fellowship directed by Kathryn Hatch, MD (will be offered in July, 2017) - The ACGME-accredited Oculoplastics Surgery Fellowship received accreditation from the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS), directed by Michael Yoon, MD Otolaryngology Faculty Accomplishments - Dr. Alicia Quesnel was named the recipient of the 2016 Eleanor and Miles Shore Fellowship Program Award for Scholars in Medicine. - Dr. Aaron Remenschneider received the MGH Research Fellow Poster Award for Excellence - Dr. Elliott Kozin was selected as one of eleven 2016 Star Reviewers for the journal Otolaryngology - Head and Neck Surgery - Dr. Michael McKenna gave the AAO-HNSF/International Hearing Foundation/Michael M. Paparella, MD Endowed Lecture for Distinguished Contributions in Clinical Otology. Facility/Programmatic Headlines - The 14th Triennial International Otopathology Meeting was held at Mass. Eye and Ear. Radiology Highlights - For FY16, the Department of Radiology had a total of 81 residents and fellows join Dr. Curtin and faculty for daily read out sessions and head and neck imaging training (39 from MGH, 28 from BWH, and 14 from BIDMC). Faculty awards and prizes - Dr. Paul Caruso won the Derek Harwood-Nash award for the best oral presentation for the American Society of Pediatric Neuroradiology at the American Society of Neuroradiology meeting in May 2016 in Washington, DC. The presentation was on "Effect of Early MRI on the Management of Pediatric Traumatic Brain Injury". Pediatric Traumatic Brain Injury". FORM 990, PART III, LINE 4C Clinical Care - Completed renovation of 12 surgical suites (ORs) on main campus - Opened new ophthalmology surgical training lab - Opened new ear, nose, throat, and hearing care service in Wellesley. - Launched Center for Thyroid Eye Disease and Orbital Surgery (Joint EYE/ENT) - Joan Miller, MD: elected into the National Academy of Medicine - Dr. Gregory Randolph was elected President of the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS). He served as President Elect from October 2015 to September 2016 and starting in October 2016, he began serving as President. - Dr. Steven Rauch received the 2015 Champion of Vestibular Medicine award from the Vestibular Disorders Association. - Dr. Michael Cohen became the Director of the Multidisciplinary Pediatric Hearing Loss Clinic at Mass. Eye and Ear. - Sunil Eappen, MD promoted to - Associate Professor of Anesthesia - Anesthesia MOR office renovation - Office 712D office renovation - 23 MindRay Anesthesia machines - 5 Glidescope video laryngoscopes - Radiology will be implementing a new voice recognition program with Nuance Powerscribe (which is currently used at both MGH &amp; BWH). - Radiology implemented Radimetrics, a new radiation dose management system from Bayer. New Hires: Radiology - Dr. Katherine Leung, full time staff radiologist Anesthesiology - Stephen Campo, MD- Staff Anesthesiologist - Ivanka Choumanova, MD- Staff Anesthesiologist - Susan Darrah, MD- Staff Anesthesiologist - Iuliu Fat, MD- Staff Anesthesiologist - Lisa Hammond, MD- Staff Anesthesiologist - Yuka Kiyota, MD- Staff Anesthesiologist - Suzanna Panitsas, MD- Staff Anesthesiologist - Yana Levin, MD- Staff Anesthesiologist - Matthew Mulholland, CRNA - Laura Weiner, CRNA Ophthalmology - Ryan Vasan, MD - Jan Kylstra, MD - Seanna Grob, MD - Veena Rao, MD - Richard Watson, MD - Milica Margeta, MD, PhD - Hajirah Saeed, MD - Xiaohong Zhou, OD - Silas Wang, MD Otolaryngology - Blake C. Alkire, MD, MPH - Caroline A. Banks, MD - Samir M. Bhatt, MD (named ENT Medical Director of Newton-Wellesley) - Gillian R. Diercks, MD - Nathan Jowett, MD, FRCSC - Aaron K. Remenschneider, MD, MPH - Jeremy D. Richmon, MD - Jeremy D. Richmon, MD</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, LINE 1A</FormAndLineReferenceDesc>
        <ExplanationTxt>THE INFIRMARY'S BYLAWS STATE THE FOLLOWING: THERE SHALL BE AN EXECUTIVE COMMITTEE CONSISTING OF THOSE INDIVIDUALS WHO ARE SERVING AS MEMBERS OF THE EXECUTIVE COMMITTEE OF THE MEMBER. THE EXECUTIVE COMMITTEE SHALL HAVE THE POWER TO TRANSACT ALL EMERGENCY BUSINESS OF THE CORPORATION DURING THE PERIOD BETWEEN THE MEETINGS OF THE BOARD OF DIRECTORS. THE EXECUTIVE COMMITTEE SHALL ALSO TRANSACT SUCH BUSINESS, PERFORM SUCH DUTIES, AND EXERCISE SUCH POWERS AS MAY BE DIRECTED OR DELEGATED BY THE BOARD OF DIRECTORS FROM TIME TO TIME. THE EXECUTIVE COMMITTEE SHALL KEEP A RECORD OF ITS PROCEEDINGS. ALL ACTIONS OF THE EXECUTIVE COMMITTEE SHALL BE REPORTED TO THE BOARD OF DIRECTORS AT ITS NEXT REGULAR MEETING. FORM 990, PART VI, LINE 7A: THE GOVERNOR OF THE COMMONWEALTH HAS THE AUTHORITY TO APPOINT TWO DIRECTORS. THE BYLAWS OF THE INFIRMARY STATE THAT THE REMAINING DIRECTORS ARE THOSE INDIVIDUALS SERVING AS DIRECTORS OF ITS SOLE MEMBER, THE FOUNDATION OF THE MASSACHUSETTS EYE AND EAR INFIRMARY, INC. ("THE FOUNDATION").</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, LINE 7B</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION IS THE SOLE MEMBER OF THE INFIRMARY AND RETAINS THE AUTHORITY TO MAKE DECISIONS REGARDING THE INFIRMARY.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>THE INFIRMARY'S FORM 990 IS PREPARED BY PRICEWATERHOUSECOOPERS, LLP USING INFORMATION PREPARED BY MANAGEMENT. AFTER THE FORM 990 IS COMPLETED, IT IS REVIEWED BY THE MANAGER OF INVESTMENTS AND FOUNDATION ACCOUNTING. THE FORM 990 IS THEN PRESENTED TO THE FINANCE COMMITTEE FOR REVIEW AND APPROVAL AS AUTHORIZED BY THE BOARD OF DIRECTORS. THE BOARD OF DIRECTORS ARE ALSO GIVEN THE FORM 990 FOR REVIEW WITH TIME TO SUBMIT COMMENTS AND QUESTIONS BEFORE FINAL FILING.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>MEMBERS OF THE STAFF ARE REQUIRED TO DISCLOSE CONFLICTS OF INTEREST TO THEIR CHIEF OF SERVICE OR DEPARTMENT AND DIRECTOR OF LABORATORY/UNIT. MEMBERS OF THE BOARD OF DIRECTORS ARE REQUIRED TO DISCLOSE ANNUALLLY, IN WRITING, ANY INTERESTS THAT COULD GIVE RISE TO CONFLICTS. THE OFFICE OF THE INTERNAL LEGAL COUNSEL OBTAINS AND REVIEWS THE ANNUAL CONFLICTS OF INTEREST STATEMENTS SUBMITTED BY MEMBERS OF THE BOARD OF DIRECTORS, AND REPORTS ON THE SAME TO THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD. WITH RESPECT TO INTERESTS DISCLOSED BY BOARD MEMBERS THAT COULD GIVE RISE TO CONFLICTS OF INTEREST, THE INTERNAL LEGAL COUNSEL REVIEWS ALL TRANSACTIONS BETWEEN SUCH INTERESTS AND AFFILIATES OF THE INFIRMARY, TO DETERMINE WHETHER THESE TRANSACTIONS WERE CONDUCTED AT ARM'S LENGTH.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, LINE 15</FormAndLineReferenceDesc>
        <ExplanationTxt>THE CHAIRMAN OF THE COMPENSATION COMMITTEE OF THE BOARD OF THE INFIRMARY PRESENTS A RECOMMENDATION TO THE COMPENSATION COMMITTEE WHO HAVE FINAL APPROVAL OF THE CEO'S BASE SALARY AND BONUS AMOUNT. THE CEO RECOMMENDS THE SALARIES OF THE CHIEFS AND VICE PRESIDENTS TO THE COMPENSATION COMMITTEE OF THE BOARD WHO HAS FINAL AUTHORIZATION TO APPROVE IT. COMPENSATION OF THOSE AT THE DIRECTOR LEVEL, INCLUDING THE DIRECTOR OF PROFESSIONAL REVENUE CYCLE, DIRECTOR OF FACILITIES PLANNING, AND CHIEF INFORMATION OFFICER IS REVIEWED AND APPROVED BY THE VICE PRESIDENT OF OPERATIONS. THE COMPENSATION COMMITTEE MEETING WAS HELD ON NOVEMBER 18, 2015. TOTAL COMPENSATION FOR THE CEO, CHIEFS AND VICE PRESIDENTS, INCLUDING BONUS PAYMENTS, INCLUDING COMPARABILITY DATA, IS ANALYZED BY INDEPENDENT COMPENSATION CONSULTANTS AND IS DETERMINED TO BE REASONABLE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>SUMMARIZED FINANCIAL STATEMENTS ARE AVAILABLE ON THE INFIRMARY'S WEBSITE: WWW.MASSEYEANDEAR.ORG. AUDITED FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. THE INFIRMARY'S GOVERNING DOCUMENTS AND FORM 990 ARE AVAILABLE UPON REQUEST. THE CONFLICT OF INTEREST POLICY IS ALSO AVAILABLE UPON REQUEST.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART XI, LINE 9</FormAndLineReferenceDesc>
        <ExplanationTxt>OTHER CHANGES IN NET ASSETS OR FUND BALANCES: ADJUSTMENT FOR PENSION AND POSTRETIREMENT RELATED CHANGES OTHER THAN NET PERIODIC PENSION COST: $3,337,981</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
    <IRS990ScheduleR documentId="IRS990ScheduleR">
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>FDN OF THE MASS EYE &amp; EAR INFIRMARYINC</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>243 CHARLES STREET</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02114</ZIPCd>
        </USAddress>
        <EIN>042785453</EIN>
        <PrimaryActivitiesTxt>SUPPORT</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>MA</LegalDomicileStateCd>
        <ExemptCodeSectionTxt>501(C)(3)</ExemptCodeSectionTxt>
        <PublicCharityStatusTxt>9</PublicCharityStatusTxt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>NA</BusinessNameLine1Txt>
        </DirectControllingEntityName>
        <ControlledOrganizationInd>false</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>MASSACHUSETTS EYE &amp; EAR ASSOCIATES INC</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>243 CHARLES STREET</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02114</ZIPCd>
        </USAddress>
        <EIN>222658209</EIN>
        <PrimaryActivitiesTxt>PATIENT CARE</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>MA</LegalDomicileStateCd>
        <ExemptCodeSectionTxt>501(C)(3)</ExemptCodeSectionTxt>
        <PublicCharityStatusTxt>9</PublicCharityStatusTxt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>FOUNDATION</BusinessNameLine1Txt>
        </DirectControllingEntityName>
        <ControlledOrganizationInd>true</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>CIRCLE COMPANY INC</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>243 CHARLES STREET</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02114</ZIPCd>
        </USAddress>
        <EIN>042801791</EIN>
        <PrimaryActivitiesTxt>TITLE HOLDING</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>MA</LegalDomicileStateCd>
        <ExemptCodeSectionTxt>501(C)(25)</ExemptCodeSectionTxt>
        <PublicCharityStatusTxt>N/A</PublicCharityStatusTxt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>FOUNDATION</BusinessNameLine1Txt>
        </DirectControllingEntityName>
        <ControlledOrganizationInd>true</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>EMBANKMENT SERVICES INC</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>14 DAVID MUGAR WAY</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02114</ZIPCd>
        </USAddress>
        <EIN>043272965</EIN>
        <PrimaryActivitiesTxt>SUPPORT</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>MA</LegalDomicileStateCd>
        <ExemptCodeSectionTxt>501(C)(3)</ExemptCodeSectionTxt>
        <PublicCharityStatusTxt>11 - TYPE 1</PublicCharityStatusTxt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>FOUNDATION</BusinessNameLine1Txt>
        </DirectControllingEntityName>
        <ControlledOrganizationInd>true</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>MASS EYE &amp; EAR INFIRMARY PENSION PLAN</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>243 CHARLES STREET</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02114</ZIPCd>
        </USAddress>
        <EIN>046067238</EIN>
        <PrimaryActivitiesTxt>PENSION PLAN</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>MA</LegalDomicileStateCd>
        <ExemptCodeSectionTxt>401(A)</ExemptCodeSectionTxt>
        <PublicCharityStatusTxt>N/A</PublicCharityStatusTxt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>NA</BusinessNameLine1Txt>
        </DirectControllingEntityName>
        <ControlledOrganizationInd>false</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>SCHEPENS EYE RESEARCH INSTITUTE INC</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>20 STANIFORD STREET</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02114</ZIPCd>
        </USAddress>
        <EIN>042129889</EIN>
        <PrimaryActivitiesTxt>RESEARCH</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>MA</LegalDomicileStateCd>
        <ExemptCodeSectionTxt>501(C)(3)</ExemptCodeSectionTxt>
        <PublicCharityStatusTxt>7</PublicCharityStatusTxt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>FOUNDATION</BusinessNameLine1Txt>
        </DirectControllingEntityName>
        <ControlledOrganizationInd>true</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <ReceiptOfIntAnntsRntsRyltsInd>false</ReceiptOfIntAnntsRntsRyltsInd>
      <GiftGrntOrCapContriToOthOrgInd>true</GiftGrntOrCapContriToOthOrgInd>
      <GiftGrntCapContriFromOthOrgInd>true</GiftGrntCapContriFromOthOrgInd>
      <LoansOrGuaranteesToOtherOrgInd>false</LoansOrGuaranteesToOtherOrgInd>
      <LoansOrGuaranteesFromOthOrgInd>false</LoansOrGuaranteesFromOthOrgInd>
      <DivRelatedOrganizationInd>false</DivRelatedOrganizationInd>
      <AssetSaleToOtherOrgInd>false</AssetSaleToOtherOrgInd>
      <AssetPurchaseFromOtherOrgInd>false</AssetPurchaseFromOtherOrgInd>
      <AssetExchangeInd>false</AssetExchangeInd>
      <RentalOfFacilitiesToOthOrgInd>false</RentalOfFacilitiesToOthOrgInd>
      <RentalOfFcltsFromOthOrgInd>false</RentalOfFcltsFromOthOrgInd>
      <PerformOfServicesForOthOrgInd>false</PerformOfServicesForOthOrgInd>
      <PerformOfServicesByOtherOrgInd>false</PerformOfServicesByOtherOrgInd>
      <SharingOfFacilitiesInd>false</SharingOfFacilitiesInd>
      <PaidEmployeesSharingInd>true</PaidEmployeesSharingInd>
      <ReimbursementPaidToOtherOrgInd>true</ReimbursementPaidToOtherOrgInd>
      <ReimbursementPaidByOtherOrgInd>true</ReimbursementPaidByOtherOrgInd>
      <TransferToOtherOrgInd>true</TransferToOtherOrgInd>
      <TransferFromOtherOrgInd>true</TransferFromOtherOrgInd>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>CIRCLE COMPANY INC</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>O</TransactionTypeTxt>
        <InvolvedAmt>123409</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>CASH</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>CIRCLE COMPANY INC</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>Q</TransactionTypeTxt>
        <InvolvedAmt>170660</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>CASH</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>EMBANKMENT SERVICES INC</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>Q</TransactionTypeTxt>
        <InvolvedAmt>825580</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>CASH</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>EMBANKMENT SERVICES INC</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>O</TransactionTypeTxt>
        <InvolvedAmt>791655</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>LEASED EMP EXP</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>MASSACHUSETTS EYE AND EAR PENSION PLAN</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>R</TransactionTypeTxt>
        <InvolvedAmt>8732004</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>CASH</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>MASSACHUSETTS EYE AND EAR ASSOCIATES INC</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>Q</TransactionTypeTxt>
        <InvolvedAmt>360186</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>CASH</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>MASSACHUSETTS EYE AND EAR ASSOCIATES INC</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>B</TransactionTypeTxt>
        <InvolvedAmt>14799398</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>CASH</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>MASSACHUSETTS EYE AND EAR ASSOCIATES INC</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>C</TransactionTypeTxt>
        <InvolvedAmt>2501639</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>CASH</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>SCHEPENS EYE RESEARCH INSTITUTE INC</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>C</TransactionTypeTxt>
        <InvolvedAmt>46104</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>CASH</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>SCHEPENS EYE RESEARCH INSTITUTE INC</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>Q</TransactionTypeTxt>
        <InvolvedAmt>1678747</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>CASH</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>SCHEPENS EYE RESEARCH INSTITUTE INC</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>P</TransactionTypeTxt>
        <InvolvedAmt>2445318</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>CASH</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>MASSACHUSETTS EYE AND EAR ASSOCIATES INC</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>P</TransactionTypeTxt>
        <InvolvedAmt>861982</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>CASH</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>SCHEPENS EYE RESEARCH INSTITUTE INC</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>B</TransactionTypeTxt>
        <InvolvedAmt>203325</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>CASH</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>SCHEPENS EYE RESEARCH INSTITUTE INC</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>B</TransactionTypeTxt>
        <InvolvedAmt>326459</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>CASH</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>MASSACHUSETTS EYE AND EAR ASSOCIATES INC</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>O</TransactionTypeTxt>
        <InvolvedAmt>24898961</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>CASH</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>CIRCLE COMPANY INC</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>S</TransactionTypeTxt>
        <InvolvedAmt>1388701</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>CASH</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>CIRCLE COMPANY INC</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>S</TransactionTypeTxt>
        <InvolvedAmt>2735704</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>FUND BAL TRANS</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>EMBANKMENT SERVICES INC</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>R</TransactionTypeTxt>
        <InvolvedAmt>321066</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>FUND BAL TRANS</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE R, PART V, LINE 15:</FormAndLineReferenceDesc>
        <ExplanationTxt>CONTRIBUTIONS REPRESENT AMOUNTS CONTRIBUTED BY THE INFIRMARY FOR EMPLOYEE RETIREMENT BENEFITS AS REQUIRED BY THE PENSION PLAN'S FUNDING POLICY.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleR>
  </ReturnData>
</Return>